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SYNOPSIS 
This thesis describes the chemistry developed during a study of ruthenium catalysed 
reactions of amines and alcohols. 
Chapter 2 describes a one-pot two-step process to access primary amines using 
borrowing hydrogen methodology with masked ammonia sources. This unique 
approach allows selective access to primary amines without the over alkylation seen 
when using other ammonia sources. Furthermore, the borrowing hydrogen reaction 
can be coupled with an in-situ palladium catalysed hydrogenolysis/deprotection to 
afford primary amines. 
Chapter 3 describes the modification of an existing ruthenium catalysed borrowing 
hydrogen reaction to allow the synthesis of cyclic tertiary amines from diols. This 
improved system has a lower catalyst loading than previously reported and has been 
applied to a wide range of substrates. 
Chapter 4 focuses on attempts to improve the existing ruthenium catalysed C-N 
bond forming reactions by reducing the reaction time, reaction temperature or catalyst 
loading. A comparison of structurally related catalysts already present in the 
literature, using ionic liquids as an alternative reaction solvent and the application of 
microwave heating is described. 
Chapter 5 details a novel application of benzylic alcohols in a tandem oxidation/C-H 
activation process. Further exploration of the chemistry resulted in a three-step one-
pot oxidation/C-H activation/reduction procedure resulting in alkylated benzylic 
alcohols. This three-step process demonstrates the use of ruthenium in three 
fundamentally different catalytic processes back to back. 
Chapter 6 details the application of nucleophilic aromatic substitution with 
borrowing hydrogen, hydrogen transfer and a successful tandem 
isomerisation/substitution. The reaction scope including the nucleophile, reaction 
solvent, suitable catalyst and electrophile were all evaluated, resulting in specific 
reaction conditions for a range of para-fluoro substituted aromatic vinylic and allylic 
alcohols. 
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dpppent - 1,5-Bis(diphenylphosphino)pentane 
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i  - Iso 
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m. p.  - Melting point 
MS  - Molecular Sieves 
MW  - Microwave 
p-MeOC6H4 - p-Methoxyphenyl 
NMR  - Nuclear Magnetic Resonance 
o  - Ortho 
p  - Para 
PG  - Protecting Group 
Ph  - Phenyl 
PPh3  - Triphenylphosphine 
ppm  - Parts per million 
i-Pr  - iso-Propyl 
n-Pr  - n-Propyl 
r. t.  - Room temperature 
SES-NH2 - 2-(Trimethylsilyl)ethanesulfonamide 
Tf  - Trifluoromethanesulfonyl 
TFA  - Trifluoroacetic acid 
THF  - Tetrahydrofuran 
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TLC  - Thin Layer Chromatography 
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1 INTRODUCTION 
1.1 C-N Bond Forming Borrowing Hydrogen Reactions 
Alcohols have a limited range of reactivity and require either activation or oxidation 
to facilitate substitution reactions due to the poor electrophilicity of most alcohols. 
However, because of this, alcohols are stable and widely available. Oxidations 
usually require stoichiometric metal reagents, however, more catalytic methods are 
being applied and the use of the mild Swern oxidation is present in many routes to 
pharmaceuticals. The activation of alcohols involves conversion into halides or 
sulfonates on scale, both of which require an extra step which generates more waste 
and results in poor atom economy. More importantly, most alkyl halides and 
sulfonates are classified as genotoxic and the pharmaceutical industry is required to 
control these compounds to extremely low levels in APIs for patient safety. It follows 
that any methodology that avoids the need to convert alcohols to halides or sulfonates 
will offer significant benefits to both industry and synthesis. The equivalent carbonyl 
compound, on the other hand, is much more reactive, allowing a broader range of 
reactions to be conducted. This increased reactivity however, is a trade-off, as the 
carbonyl compounds are prone to decomposition due to the increased reactivity and 
are often difficult to form selectively, i.e. without over oxidation. An ideal system 
would allow the use of stable, non-toxic alcohols while maintaining the reactivity of 
the carbonyl compound. One way to achieve this is known as Borrowing Hydrogen, 
where an alcohol is temporarily oxidised by a catalyst to a carbonyl compound, which 
undergoes a condensation reaction with a nucleophile, before being reduced by the 
same catalyst that performed the oxidation, all in one pot (Scheme 1). 
 
Scheme 1 - Borrowing Hydrogen Methodology 
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Many different examples of Borrowing Hydrogen have been used successfully, and 
this chapter will illustrate the wide variety of applications and catalysts available.
 
 
Scheme 2 - Early Examples of Borrowing Hydrogen 
The first reports of borrowing hydrogen can be attributed to two authors; Grigg (who 
used a rhodium catalyst
1
) and Watanabe (ruthenium
2
) who independently reported the 
N-alkylation of amines with alcohols in 1981. Murahashi also reported the alkylation 
of amines with alcohols using an alternative ruthenium
3
 catalyst a year later (1982). 
These first reports (Scheme 2) demonstrated that noble metals such as rhodium, 
ruthenium and later iridium could catalyse borrowing hydrogen reactions. 
 
Scheme 3 - N-Alkylation of Primary Amides and N-Heterocyclization of Diols 
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The initial work demonstrated the principal, but suffered from a lack of selectivity, 
with both secondary and tertiary amines being formed, and harsh reaction conditions 
(180 °C). However, this did not stop Watanabe from expanding the scope of the 
catalyst to include the synthesis of secondary amides
4
 and cyclic tertiary amines
5
 
(Scheme 3). 
Watanabe was able to tune the reaction conditions to selectively form either 
secondary or tertiary amines from primary amines by altering the stoichiometry
6
 and 
later applied similar conditions to the N-alkylation of aminopyridines
7
 (Scheme 4). 
 
Scheme 4 - Selective N-Alkylation of N-Heteroaromatics 
Scheme 5 - Selective Mono- or Di- Alkylation of Diols 
Selectivity was also an issue with the amination of short chain diols. Work published 
by Marsella
8
 showed that under milder conditions than those used by Watanabe, it 
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was possible to isolate 1,2-amino alcohols as the major products when using 
secondary amines (Scheme 5). However, this selectivity was reversed when 
RuCl3.xH2O was used as the catalyst instead of RuCl2(PPh3)3. Furthermore, he later 
showed that selectivity could be determined by sterics.
9 
After the initial reports it was almost 20 years before new catalysts appeared to 
improve and expand the scope of this type of C-N bond formation. Yamaguchi and 
Fujita were the first, demonstrating that [Cp
*
IrCl2]2, in the presence of an activating 
base, was capable of cyclizing amino alcohols to form 1,2,3,4-tetrahydroquinolines
10
 
(Scheme 6) under milder conditions (90-111 °C) than those reported by Watanabe. 
They were then able to demonstrate that this catalyst was not limited to 
intramolecular reactions, but could also be applied to intermolecular, examples 
alkylating anilines and other amines with a range of alcohols
11
 successfully, as well as 
forming cyclic tertiary amines from primary amines and diols.
12 
 
Scheme 6 - Iridium Catalysed C-N Bond Formation 
 
Scheme 13 - Alternative Iridium Based Catalyst 
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Williams and co-workers also demonstrated the use of an iridium based catalyst to 
effect C-N bond formation with a range of primary and secondary amines (Scheme 
7).
13
 
With the advances being made in iridium-catalysed C-N borrowing hydrogen, new 
ruthenium catalysts were not far behind with work published by Beller
14
 and 
Williams
15
 in quick succession. 
Beller and co-workers applied a ruthenium carbonyl cluster, Ru3(CO)12, as a 
precatalyst with tri(o-tolyl)phosphine (1.1) added as the ligand. However, they found 
that the activity was significantly improved with the cataCXium
®
 ligand
16
 (1.2) 
(Scheme 14). Both catalyst systems offer advantages over the previous work with this 
precatalyst.
9,17
 The modified catalyst was then applied to the synthesis of tertiary 
amines
18
 and selective mono-alkylation of vicinal diols,
19
 demonstrating both the 
scope and selectivity that the catalyst offered (Scheme 14). 
Scheme 14 - Ru3(CO)12 Borrowing Hydrogen Reactions 
Williams and co-workers had also approached the problem in a similar fashion, 
screening ruthenium precatalysts for activity and then a series of phosphine ligands. 
They found that the combination of [Ru(p-cymene)Cl2]2 and a bidentate phosphine 
(dppf) in the presence of an activating base gave an active catalyst for the selective 
formation of secondary amines
15
 (Scheme 15).  However, when applying this system 
to the synthesis of tertiary amines
20
 the base was not necessary. Furthermore, they, 
like Beller found an alternative ligand, DPEphos (1.3) which led to increased catalyst 
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activity resulting in a lower catalyst loading. Later Williams was able to demonstrate 
that the activating base was not necessary for catalytic activity
 
and had little effect on 
the isolated yield of the reaction.
21
 
Scheme 15 - Initial Work by the Williams Group  
 
Scheme 16 - Ru/DPEphos Borrowing Hydrogen Reactions 
Indeed, the combination of [Ru(p-cymene)Cl2]2 and DPEphos has proven to be 
applicable to a wide range of C-N bond forming reactions including the coupling of 
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sulphonamides and secondary alcohols although at hi gher reaction temperatures (150 
°C) (Scheme 16).
21 
 
Scheme 17 - Pharmaceutical Accessed via Borrowing Hydrogen 
The utility of this methodology was also demonstrated by applying it successfully to 
the synthesis of several drug molecules, Piribedil (1.4), Antergan (1.5), 
Tripelennamine (1.6), Pheniramine (1.7) and Chlorpheniramine (1.8) (Scheme 17). 
 
Scheme 18 - Expanded Scope of C-N Bond Formation with [Cp
*
IrCl2]2 
Yamaguchi and co-workers were also able to expand the scope of their iridium 
catalyst system to the alkylation of secondary amines
22
 and sulphonamides
23
 
including the use of secondary alcohols, which had not been previously covered by 
Williams and co-workers. Furthermore, they successfully alkylated primary amides 
Chapter 1 
8 
 
and carbamates at milder temperatures
24
 (130-140 °C) than previous reported by 
Watanabe
3
 or Jenner
25
 (Scheme 18), although with some limitations on substrate 
scope. 
Scheme 19 - N-Alkylation of Heteroarmatic Amines Using a P-N Ligand 
With Borrowing Hydrogen firmly established as a viable method, more interest and 
research into custom made ligands and catalysts to improve selectivity and reactivity 
followed. Building on earlier work by van Koten and co-workers,
26
 Kempe and co-
workers developed a series of P,N ligands
27
 which when combined with an iridium 
precatalyst gave an active catalyst for the selective mono-alkylation of anilines and 
aminopyridines. Kempe went on to demonstrate that the catalyst was also active for 
the synthesis of diamines by monoalkylation of amino alcohols
 
(Scheme 20).
28 
 
Scheme 20 - Synthesis of Diamines Using a P-N Ligand 
 
Scheme 21 - Low Temperature C-N Bond Formation via Borrowing Hydrogen 
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Kempe and co-workers were also able to show that their catalyst had advantages over 
the previous commerically available catalysts by performing C-N bond formation at 
70 °C (Scheme 21).
29-30
 The disadvantage of their catalyst system, however, comes in 
the substrate scope. Whilst the catalyst is not deactivated by heteroaromatic amines or 
diamines, the reaction only works well for aromatic amines (anilines) with benzylic 
and aliphatic amines being reported to give poor results.
27
 
 
Scheme 22 - Carbene and Pincer Ligand Based Catalysts 
Bӧrner and co-workers31 also approached the design of new catalyst from the ligand, 
choosing to develop a pincer ligand in combination with [IrCl(coe)2]2. This catalyst 
(1.10) has a wider substrate scope, being suitable for the coupling of aliphatic, 
benzylic and secondary amines; however, high reaction temperatures (120-140 °C) 
are required to achieve results similar to those obtained with the commercially 
available catalysts. 
 
Scheme 23 - Carbene Based Catalysts for C-N Bond Formation via Borrowing 
Hydrogen Methodology 
An alternative to pincer ligands has been the application of carbene ligands. These 
ligands have allowed the catalyst loadings of reactions to be lowered to ~1 mol% in 
most cases, but despite several articles describing a selection of catalysts, the 
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reactions either require longer reaction times (typically 48 h)
32
 or lack the selectivity 
of previous catalysts due to their increased reactivity (Scheme 23).
33 
Scheme 24 - Work of Marr and Co-Workers 
The use of carbene ligands whilst suffering from disadvantages, does offer increased 
catalyst stability. Marr and co-workers
34
 found that this increased stability offered 
several advantages over previously reported systems. Their catalyst (1.13) could be 
used to effect selective mono-alkylation and dehydration of 1,3-propanediol to yield 
N-propylaniline (1.16) only, with the expected diamine (1.15) and amino alcohol 
(1.14) not being detected. This is a unique reaction not reported previously in the 
Borrowing Hydrogen literature. Furthermore, this reaction could be carried out at 42 
°C in a biphasic mixture consisting of the an aqueous solution of the crude 1,3-
propanediol (from a bacteria fermentation of glycerol) and an ionic liquid (methyl 
trioctyl ammonium bis triflimide). Whilst this stability and reactivity in terms of 
reaction temperature and product is unique, the low temperature meant that the 
reaction proceeded slowly, only generating a 10% conversion at 42 °C after 48 hours 
(Scheme 24). 
The use of ammonia
35
 and its salts
20, 36
 has resulted in the synthesis of tertiary amines, 
or secondary amines
36
 by careful control of the stoichiometry or the acidity of the 
counter ion used in the salt. Even the use of sterically demanding secondary alcohols, 
leads to over alkylation and secondary amine formation (Scheme 25).
35
 This is due to 
the increased nucleophilicity of the intermediate primary amine formed over the 
ammonia/ammonium salt used. This means that the second alkylation, from primary 
to secondary amine, is quicker than the first, and as a result the reaction is difficult to 
control. 
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Scheme 25 - The Use of Ammonia and Ammonium Salts in Borrowing Hydrogen 
Primary amines can be selectively accessed by using a pressurised atmosphere of 
ammonia. Milstein and co-workers were the first to achieve this successfully using a 
preformed pincer ligand catalyst.
37
 Milstein also found that the reaction could also be 
performed with water as the solvent (Scheme 26), although this is not the first 
example of water being used as a solvent in borrowing hydrogen reactions.
35,38-40 
 
Scheme 26 - Milstein’s Primary Amine Synthesis 
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More recently Beller
41
 and Vogt
42
 published, simultaneously, similar conditions for 
primary amine synthesis using the Ru3(CO)12/cataCXium
®
 ligand (2) system although 
the reactions required elevated temperatures (140-150 °C) and were only applicable 
to secondary alcohols (Scheme 27). 
 
Scheme 27 - Beller and Vogt Primary Amine Syntheses 
Beller and co-workers continued to work on this area and were successful again, 
finding an alternative ruthenium based catalyst system to access diamines from diols, 
where both amines were primary amines. The catalyst was also suitable for the 
synthesis of amino esters from hydroxy esters (Scheme 28). Comparison of this 
catalyst by Beller against the previously published system illustrated that this new 
system was superior, returning more than double the conversion and isolated yield of 
adamantamine under identical conditions.
43 
 
Scheme 28 - Primary Diamines From Diols 
Williams and co-workers have also published a borrowing hydrogen based method to 
access primary amines. Accepting that under standard reaction conditions the use of 
ammonia and its salts led to over alkylation. They chose to approach the problem via 
masked ammonia sources such as benzylic amines and sulfonamides forming N- 
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protected secondary amines. The amines and amides could be selectively 
monoalkylated, avoiding the selectivity problems of using ammonia, before a second 
deprotection step revealed the primary amine. This process was possible with both 
benzylic amines and sulfonamides, and the deprotection could be performed in-situ, a 
one-pot two step synthesis (Scheme 29).
44 
 
Scheme 29 - Primary Amines From via a Masked Amine Approach 
 
Scheme 30 - Advantageous N-Alkylation In Water and Ionic Liquids 
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As mentioned above, Borrowing Hydrogen reactions are not solely limited to organic 
solvents such as toluene and xylene. Indeed both ionic liquids
34,40
 and water
35,37-40
 
have successfully been used, often giving more advantageous results than toluene, 
either improved selectivity or yield. For examples; Madsen and co-workers use of 
[Cp
*
IrCl2]2 to form piperazines from diols and diamines saw better 
diastereoselectivity in or on water
38
 whilst Williams and co-workers saw faster 
reactions with secondary amines in ionic liquids than water (Scheme 30).
40
 
 
Scheme 31 - N-Alkylation of Indoles via Borrowing Hydrogen 
Another relatively untapped area of C-N bond formation lies in the N-alkylation of 
nitrogen containing heteroaromatic compounds. Two reports are present in the 
literature; the first by Watanabe
45
 uses harsh conditions (200 °C) but has a wide 
substrate tolerance. However, more recently a joint effort by Williams and Beller
46
 
was able to affect N-alkylation of indole under conditions more consistent with 
current borrowing hydrogen methodologies (Scheme 31). 
Borrowing Hydrogen hasn’t been limited to using alcohols as alkylating agents, 
amines can also be used eliminating ammonia as the byproduct instead of water 
(Scheme 32). 
 
Scheme 32 - Alkylation of Amines with Amines via Borrowing Hydrogen 
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The condensation of benzylamine to dibenzylamine is well known, however, 
selective alkylation of other amines is less well known. The first example in the 
literature of this reaction using borrowing hydrogen detailed the self-condensation of 
a variety of amines selectively to the corresponding secondary amine using 
RuCl2(PPh3)3 (Scheme 33).
47 
 
Scheme 33 - Selective Amine Condensation 
This first example only illustrated that self-condensation of amines was possible. 
Another example, also using harsh conditions (180 °C) showed some progress, 
selectively coupling anilines and tetra-substituted ammonium salts in the presence of 
tin chloride.
48
 However, Beller and co-workers have had success in the selective cross 
coupling of amines. By applying Shvo’s catalyst and amines such as anilines49-50 and 
amines with an adjacent tertiary centre
51
 the group were able to selectively alkylate 
with a variety of coupling amines. The amines that could be oxidised and used as 
alkylating agents include; primary amines, symmetric secondary and tertiary amines 
as well as cyclic secondary amines (Scheme 34).
52 
 
Scheme 34 - Selective Cross Coupling of Amines by Beller and Co-Workers 
Williams and co-workers were more successful, obtaining selectivity without the use 
of tertiary centres. Using [Cp
*
IrI2]2 that had previously been shown to racemize chiral 
secondary amines,
53-54
 the group were able to selectively alkylate anilines, benzylic 
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amines and primary alkylamines using diisopropyl and other amines with secondary 
α-centres in good yields (Scheme 35).55 
 
Scheme 35 - Selective Amine Cross Coupling By Williams and Co-Workers 
Madsen and co-workers also published a similar article using [IrCp
*
Cl2]2 however, 
only forming self-condensed secondary amines.
56 
 
1.2 C-C Bond Forming Borrowing Hydrogen Reactions 
Scheme 36 - Alkylation of Carbon Nucleophiles with Amines 
Amines aren’t solely limited to amine-amine cross couplings, similarly to alcohols, 
they can be used as alkylating agents for carbon nucleophiles such as ketones
57
 and 
indoles (Scheme 36).
58 
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The alkylation of carbon nucleophiles with alcohols is well known, with many 
examples in the literature. The first published work was by Grigg and co-workers 
using a rhodium catalyst in the presence of a base to alkylate benzylic nitriles 
(Scheme 37).
59 
 
Scheme 37 - Alkylation of Benzylic Nitriles with Alcohols 
 
Scheme 38 - Alkylation of Benzylic Nitriles with an Iridium Catalyst 
Grigg later revisited this work, applying the [Cp
*
IrCl2]2 catalyst used by Yamaguchi 
and Fujita to effect a more efficient system, reducing the reaction times to less than 
18 hours (Scheme 38).
60 
Grigg and co-workers were then able to apply the [IrCp
*
Cl2]2 
to the alkylation of a wide range of nucleophiles including; 1,3-dimethylbarbituric 
acid,
61
 C3-alkylation of indoles,
62
 4-hydroxycoumarins and 4-hydroxy-2-quinolones 
(Scheme 39).
63 
Scheme 39 - Alkylation of Nucleophiles with Alcohols 
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Scheme 40 - Alkylation of Oxoindole 
The alkylation of oxoindoles was reported by Grigg
64
 and Madsen
65
 within weeks of 
each other. Despite the differences in the metal catalyst, the reports gave very similar 
results and Madsen highlighted the [Cp
*
IrCl2]2 catalyst used by Grigg in his initial 
catalyst screen, discarding it in favour of a cheaper ruthenium-based catalyst (Scheme 
40). 
 
Scheme 41 - Alkylation of Activated Nitriles 
Other C-C bond forming alkylations include a selection of similarly activated nitriles 
which have been reported by Williams using Ru(PPh3)3(CO)(H)2,
66-67
 and Grigg
68
 and 
Ishii
69
 both using iridium based catalysts (Scheme 41). 
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Scheme 42 - Selective Mono- and Di-Alkylation of Diols 
Interestingly, in his report, Ishii demonstrated that a diol could be di-alkylated. The 
dialkylation of ketones with alcohols had been previously reported by Ishii,
70
 
however, further work by Ishii demonstrated that mono- or di-alkylation of diols
71
 
could be achieved selectively by simple control of the stoichiometry (Scheme 42). 
 
Scheme 43 - Self Condensation of Alcohols 
Ishii and co-workers have been very active, developing several C-C bond forming 
borrowing hydrogen reactions. By generating the enolate formed from the aldehyde, 
Ishii was able to show that the alcohol could also be used as a nucleophile to react 
with itself, forming β-alkylated products from the self-condensation of alcohols 
(Scheme 43).
72-73
  
 
Scheme 44 - α-Alkylation of Acetates 
However, one of Ishii’s most interesting pieces of work focused on the α-alkylation 
of acetates, more importantly, avoiding trans-esterification by using a large excess of 
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the acetate (Scheme 44).
74
 Again, it was possible to di-alkylate diols, the product of 
which was hydrolysed and then esterified with ethylene glycol to form ethylene 
brassylate (1.19) a fragrance compound (Musk T) (Scheme 45). 
Williams and co-workers have also looked at the alkylation of esters in the form of 
malonate half esters. Their first attempt suffered from dehydrogenation resulting in a 
mixture of reduced alkylated ester and the α,β-unsaturated ester. This was overcome, 
however, by the use of crotononitrile as an oxidant, isolating only the α,β-unsaturated 
esters (Scheme 46).
75
 Further work screening catalysts led to a more suitable catalyst 
system including the addition of isopropanol, allowing access to the reduced ester as 
well (Scheme 46).
76 
 
Scheme 45 - Application of Acetate Alkylation 
 
Scheme 46 - Applications of Malonate Esters in Borrowing Hydrogen & 
Hydrogen Transfer Methodologies 
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Scheme 47 - Wittig Reagents in Borrowing Hydrogen 
Williams and co-workers have also published work on iridium based C-C bond 
formation using Wittig reagents(Scheme 47).
77-79
  
 
Scheme 48 - Asymmetric Borrowing Hydrogen Methodology 
Furthermore they were able to develop an asymmetric variant,
80
 which is the first 
application of borrowing hydrogen methodology in asymmetric synthesis (Scheme 
48). However, more recent joint efforts from Williams and Whittlesey have shown 
that the combination of the commercially available Ru(PPh3)3(CO)(H)2 with carbenes 
produces very active catalysts for C-C bond formation (Scheme 49).
81
 
 
Scheme 49 - Ruthenium Carbene Catalyst for C-C Bond Formation 
Yamaguchi and Fujita have also published work on C-C bond formation as well as 
the C-N work mentioned previously. They reported the use of their [Cp
*
IrCl2]2 
catalyst for the alkylation of secondary alcohols (Scheme 50).
82
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Scheme 50 - Alkylation of Secondary Alcohols 
 
Scheme 51 - Two Step, One Pot Access to β-Alkylated Chiral Alcohols from 
Ketones 
Whilst there has been some work on the β-alkylation of alcohols,32-33,82-83 there has 
been a significant amount of research and publication on the related β-alkylation of 
ketones.
70-71,84-87 
An interesting variation was published by Nishibayashi, where the 
alkylated ketone was then reduced in a two-step sequence, using asymmetric transfer 
hydrogenation to access the chiral alcohol (Scheme 51).
88 
 
Scheme 52 - Methyl Activation Towards Borrowing Hydrogen 
Almost all the major contributors to the Borrowing Hydrogen literature have 
published work on both C-N and C-C bond formation, and Kempe is no exception. 
Whilst N-alkylating a pyrimidine with a methyl group ortho to a nitrogen, they also 
noticed alkylation of the methyl group well as the expected N-alkylation.
89
 
Investigation showed that C-alkylation still occurred if the nitrogen was benzyl 
protected, although an excess of alcohol was required to drive both N- and C-
alkylation to completion. Further screening demonstrated that this reaction was not 
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reliant on the nitrogen atom directing the alkylation, as seen with some C-H 
activation
90
 as 4-methyl pyridine could also be alkylated, although with a lower yield 
(45%). Considering this result, the authors assumed the reaction to be dictated by the 
electronics of the aromatic ring which was proved by the use of 3-methylpyridine 
which saw no alkylation whatsoever. 
Krische and his group also work in the area of C-C bond forming Borrowing 
Hydrogen, although the mode of action they apply is very different to previous work 
that has been discussed in this chapter. Interested in crotylations and allylations 
avoiding the use stoichiometric metals, the group found that rhodium and iridium 
catalysts in the presence of a hydrogen atmosphere would catalyse the addition of 
alkynes to aldehydes,
91
 ketones
92
 and imines.
93
 Later work demonstrated that 
isopropanol could be used as an alternative hydrogen source,
94
 which led on to the 
finding that in fact the corresponding alcohol could be used instead of the aldehyde 
without the need for a hydrogen source. A mechanism is shown below to illustrate 
how these reactions are believed to occur (Scheme 53). 
 
Scheme 53 - Krische Approach To Borrowing Hydrogen 
The first step involves base-mediated oxidation of the alcohol to the corresponding 
aldehyde, generating a metal hydride. The metal hydride then adds across the alkyne 
to form an organo-metallic species that then adds directly to the aldehyde. 
Protonation then releases the metal catalyst to repeat the cycle whilst forming the 
product. 
Krische and co-workers have expanded on their original work based on allenes
94
 
illustrating that a wide variety of allenes,
94-96
 alkynes,
97-98
 dienes,
99-101
 enynes
102
 and 
activated alkenes
103
 can be used with a range of different iridium and ruthenium based 
catalysts (Scheme 54). What is really unique about the work of Krische and co-
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workers, is the tolerance of double bonds. Previous borrowing hydrogen work has 
seen partial or full reduction of double bonds, but this is not observed with Krische’s 
system. 
 
Scheme 54 -Range of Krische Style Borrowing Hydrogen Reactions 
To conclude, Borrowing Hydrogen has advanced considerably since the first 
publications, particularly over the past 10-15 years. While it is still an expanding 
area, research must focus on new catalysts which are able to run at lower 
temperatures with wide substrate scope. 
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2 RESULTS AND DISCUSSION I 
2.1 Background 
At the start of this work it was known that primary amines and secondary amines 
could be used in borrowing hydrogen methodology to synthesize secondary
1-4
 and 
tertiary
4-6
 amines respectively. Indeed the Williams group had recently published both 
using the [Ru(p-cymene)Cl2]2/diphosphine combination (Scheme 1).
7-8
 However, the 
synthesis of primary amines using ammonia or an ammonia equivalent had not yet 
been realised and our initial work focused on approaches to solving this problem. 
 
Scheme 1 - Known Amine Formation Using Borrowing Hydrogen 
More recently, Milstein,
9
 Vogt
10
 and Beller
11-12
 have been successful in applying 
ammonia gas at elevated pressures to access primary amines selectively. 
 
2.2 Initial Studies 
Initially we considered potential sources of ammonia that would be suitable to access 
primary amines (Scheme 2). 
However, all the ammonium salts
8
 and solutions
13-14
 used, even in large excess, 
showed no indication of the primary amine (2.2) by analysis using mass 
spectrometry. Instead a mixture of secondary (2.3) and tertiary amine (2.4) was 
detected. The only exception to this was when the atmosphere of the reaction was 
changed from nitrogen to ammonia. In this case, the primary amine (2.2) was 
observed by mass spectrometry since analysis of the 
1
H NMR was difficult due to the 
overlapping signals of the secondary (2.3) and tertiary amine (2.4). Further analysis 
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of the product distribution leads to two significant conclusions. The first and most 
important is that the reaction is indeed working and forming the desired primary 
amine (2.2), unfortunately this is then more nucleophilic than the source of ammonia, 
and so goes on to react further giving the observed mixtures of secondary and tertiary 
amines. The second is that the distribution of the mixture between secondary and 
tertiary amine can be determined by the acidity of the counter-ion, which has also 
been noted by Yamaguchi and Fujita.
15
 Since this initial work, urea has also been 
shown to be a useful source of ammonia, although it too leads to over-alkylation.
16 
 
Scheme 2 - Ammonia Source Screening Reaction 
 
Scheme 3 - Masked Amine Approach to Primary Amine Synthesis 
Having established that only the use of high pressures of ammonia could lead to 
selective primary amine formation, an alternative approach was sought that could be 
applied by the large majority of synthetic chemists without the need for specialist 
high pressure apparatus. It was decided to use a masked amine, which would result in  
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Scheme 4 - Synthesis of Benzylic Secondary Amines 
Entry
a 
Amine Conversion (%)
b,c 
Yield (%)
d 
Product 
1  
2.5 
100 -
 
- 
2 
 
2.6 
0 - - 
3 
 
2.7 
100 - - 
4 
 
2.8 
100 - - 
5 
 
2.9 
100 - - 
6  
2.10 
100 85 2.13 
7 
 
2.11 
100 79 2.14 
8 
 
2.12 
60 54 2.15 
aConditions: 3-Phenyl-1-propanol (3 mmol), amine (3.15 mmol), [Ru(p-cymene)Cl2]2 (2.5 
mol%), DPEphos (5 mol%), toluene (3 mL), reflux, 24 h; bConversion determined by 
consumption of alcohol; cDetermined by 1H NMR; dIsolated yield of secondary amine. 
Table 1 - Benzylic Protecting Groups 
the product being a protected primary amine. Once this had been made, a second 
deprotection step could then be carried out in situ to yield the primary amine in a two-
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step one-pot process (Scheme 3). This would avoid the undesirable formation of the 
secondary and tertiary amine previously observed. 
Literature precedent
17-18
 indicated that benzylic amines would provide a readily 
available source of masked amine; being both cheap and widely available. As such a 
screen of known benzylic amine protecting groups (Scheme 4 & Table 1) was run 
with the secondary amines being isolated in each case to prove the intermediate 
structures formed. 
Interestingly, 100% conversion of the alcohol was observed with benzylamine (2.5), 
but analysis of the reaction mixture by mass spectrometry and 
1
H NMR showed a 
mixture of amine products. Isolation by silica column chromatography proved that 
these compounds were not present as traces, but as significant products. Isolation and 
characterisation of each one was conducted in order to prove the structures (Scheme 
5). Further analysis by mass spectrometry and 
1
H NMR also revealed similar 
mixtures for the other benzylic amines tested (Entries 3-5, Table 1). 
Dibenzylamine (2.6) did not react at all (Entry 2, Table 1) which was surprising 
considering that it has been reported to react by the Williams group under identical 
conditions with benzyl alcohol. As mentioned above, other benzylic amines also gave 
similar results (Entries 3-5, Table 1) to benzylamine. However, when the α-position 
was hindered, either with a methyl (2.10) or a phenyl (2.11) the reaction proceeded 
cleanly to the desired secondary amine with good yields (Entries 6 & 7, Table 1). 
Even when the sterically crowded tritylamine (2.12) was used, the reaction still 
proceeded, although with a lower conversion and isolated yield (Entry 8, Table 1). 
Analysis, isolation and characterisation of the products from the benzylamine reaction 
suggested that amine condensation could be a pathway in operation. This was tested 
by attempting the self-condensation of benzylamine under the same reaction 
conditions (Scheme 6). Under these conditions the reaction did not occur, suggesting 
that either the alcohol or the water generated is an important factor in the 
condensation. Indeed the cross coupling of triethylamine and 4-methoxyaniline (2.21) 
does occur at higher temperatures when catalytic water is present (Scheme 7). Thus, 
the amine condensation cannot be ruled out as a possible reaction pathway. 
The desired product (2.16, Scheme 5) is the major product, formed in 57% isolated 
yield, and it is clear to see how the diphenylpropyl tertiary amine (2.18) can be 
formed from this initial product by reaction with another molecule of alcohol. 
Dibenzylamine (2.20) can be assumed to be occurring via amine oxidation; the self-
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condensation of benzylamine by transition metal catalysts is well reported in the 
literature.
19-23
 Only traces of the dibenzyl tertiary amine (2.17) were formed as it is 
only detected by analysis using mass spectrometry and is not observed by TLC. 
Scheme 5 - Products Isolated From the Use of Benzylamine 
 
Scheme 6 - Self Condensation of Benzylamine 
 
Scheme 7 - Cross-coupling of Amines 
This indicates that it is a minor product and fits with the previously observed poor 
reaction of dibenzylamine with 3-phenyl-1-propanol (Entry 2, Table 1). The most 
interesting result is the symmetric tertiary amine (2.19) as this could form by three 
possible routes; oxidation of 2.16, oxidation of 2.18 or isomerisation of the imine 
intermediate (Scheme 8). The oxidation of 2.18 seems to be the least likely, as none 
of the intermediate 2.26 was detected by either 
1
H NMR or mass spectrometry. The 
selective oxidation of 2.16 to 2.23 followed by hydrolysis to the primary amine (2.24) 
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which then reacts with two more molecules of alcohol is possible. However, the 
hydrolysis would require water to be present which would be present only in small 
quantities due to the reaction being run in toluene at reflux. This would account for 
the small amount of this material that was isolated (9%). The final possibility is the 
isomerisation of intermediate imine 2.22 to an alternative imine 2.23 again followed 
by hydrolysis to the primary amine. Isomerisation of imines has been reported 
previously
24
 and in this case would be thermodynamically favourable, setting up an 
extended delocalised system with the aromatic ring. Either of these final two 
mechanisms could be the one in operation, or a combination of both, however, further 
study to determine this was not followed up as this was not the aim of the project. 
Scheme 8 - Possible Routes to 2.19 
Both tert-butylamine (2.27) and tert-octylamine (2.28) gave complete conversion 
with high isolated yields (Entries 1 & 2, Table 2). Both allyl and diallyl amine gave 
mixtures of products including molecules that had the allyl double bond reduced and 
so these two examples were not carried forward. 4-Methoxyaniline (2.31) gave a 
good conversion but lower isolated yield. Analysis of the 
1
H NMR of the crude 
reaction (Entry 5, Table 2) showed three peaks corresponding to the methoxy group, 
suggesting some remaining starting material, product and a by-product. 
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Scheme 8 - Synthesis of Other Secondary Amines 
Entry
a 
Amine Conversion (%)
b,c 
Yield (%)
d 
Product 
1  
2.27 
100 61 2.32 
2  
2.28 
100 89 2.33 
3  
2.29 
N.D. - - 
4 
 
2.30 
N.D. - - 
5 
2.31 
100 60 2.34 
aConditions: 3-Phenyl-1-propanol (3 mmol), amine (3.15 mmol), [Ru(p-cymene)Cl2]2 (2.5 
mol%), DPEphos (5 mol%), toluene (3 mL), reflux, 24 h; bConversion determined by 
consumption of alcohol; cDetermined by 1H NMR; dIsolated yield. 
Table 2 - Other Protecting Groups 
On the basis of the results discussed above the following amines were picked out for 
consideration; 1-phenethylamine (2.10), benzhydrylamine (2.11), tert-butylamine 
(2.27), tert-octylamine (2.28) and 4-methoxyaniline (2.31) (Scheme 9). It is worth 
noting that sulfonamides which might have been good substrates were not considered 
as this work was being done by another member of the group. 
In order to determine which to take forward for further use, the cost and method of 
deprotection for each amine was considered. tert-Butylamine (2.27) and tert-
octylamine (2.28) were discarded due to the strongly acidic conditions required for 
deprotection.
25-33
 4-Methoxyaniline (2.31) was discarded due to the safety concerns of 
combining an oxidising agent, even a mild one, with a transition metal.
34-38
 This left 
two amines, 1-phenethylamine (2.10) and benzhydrylamine (2.11). 
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Both protecting groups can be removed by hydrogenation,
39-40
 however, 
benzhydrylamine offers two other options using acidic
41
 or oxidative
42
 conditions. A 
cost comparison of the two amines shows that benzhydrylamine, at 23 pence per 
mmol, is significantly more expensive than 1-phenethylamine which only costs 1 
pence per mmol. Added to this is the atom economy argument for using 1-
phenethylamine due to its lower molecular weight and number of atoms; so 1-
phenethylamine was chosen as the amine for further studies. A screen of the literature 
for hydrogenation conditions
43-47
 to remove the 1-phenethyl group in situ led to 
conditions that work for the reaction mixture and result in successful deprotection.
48-49 
 
Scheme 9 - Final Amines For Consideration 
 
2.3 Reaction Scope 
Having established a set of conditions (Scheme 10), a series of alcohols was screened 
to determine the tolerance of the reaction to alternative substrates (Table 3). 
 
Scheme 10 - Optimised Conditions 
The first set of results was good (Entries 1-6, Table 3) with yields from 52-85%. 
However, when the substrate range was expanded to phenethyl scaffolds (Entries 7 & 
8, Table 3) problems were encountered (the phenethyl structure is important in 
neurotransmitters). While secondary amine was formed in good conversion (Entries 7 
& 8, Table 3), the deprotection to the primary amine proved problematic. The 
deprotection of the phenethyl compound (Entry 7, Table 3) gave a mixture of 1-
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phenethylamine (2.10) and 2-phenethylamine (2.40) (Scheme 11), indicating that the 
deprotection was not selective. In the case of the naphthyl (Entry 8, Table 3), 
deprotection was unsuccessful, the secondary amine was recovered unchanged 
(Scheme 11). 
Entry
a 
Alcohol Yield (%)
b,c 
Product 
1 
 
85 2.44 
2 
 
52 2.45 
3 
 
75 2.46 
4 
 
54 2.47 
5 
 
65 2.48 
6 
 
67
 
2.49 
7 
 
100
d 
- 
8 
 
79
e 
2.50 
9 
 
0
d 
- 
10 
 
100
d 
- 
aConditions: Alcohol (3 mmol), amine (3.15 mmol), [Ru(p-cymene)Cl2]2 (2.5 
mol%, DPEphos (5 mol%), Toluene (3 mL), reflux, 24 h, then Pd/C (10 wt%, 10 
mol%), EtOH (11 mL), HCl (6 M, 1.1 mL), 65 °C, 14 h; bIsolated Yield; cIsolated 
as the HCl salt; dConversion to the secondary amine product; eIsolated as the 
secondary amine. 
Table 3 - Results of Two-Step Primary Amine Synthesis 
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Problems were also encountered when other functionality was introduced (Entries 9 
& 10, Table 3). No coupling was observed with the amine when an ester group was 
present, suggesting the alcohol and ester (Entry 9, Table 3) were chelating to the 
catalyst. Formation of the secondary amine was more successful in the presence of an 
amide group (Entry 10, Table 3), however, again deprotection was unsuccessful 
returning starting material under the conditions applied. The results of this work 
together with work on the sulfonamides was published.
50 
Scheme 11 - Deprotection Problems with Phenethyl Scaffolds 
 
Scheme 12 - Pheniramines that are APIs 
During the course of this work, it was noticed that one of the intermediates was 
actually an Active Pharmaceutical Ingredient (API). Indeed, the intermediate 
secondary amine produced from the reaction of 3,3-diphenyl-1-propanol (2.36) with 
1-phenethylamine (2.10) is Fendiline (2.52) which has anti-hypertensive and anti-
anginal properties.
51-52
 The 3,3-diphenyl-1-propanamine moiety is present in quite a 
few APIs (Scheme 12) with Fenpiprane (2.53) being spasmolytic and antiallergic and 
Prozapine (2.54) being spasmolytic and choleretic.
53-54
 As such, Fendiline (2.52) was 
isolated in 71% yield. It was also possible to make a single enantiomer of Fendiline 
(2.52) by starting with an enantiopure amine, in this case the (R)-enantiomer (2.55), 
which produced the enantiomerically pure product (2.45) in identical yield to the 
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racemic reaction, and without any racemisation being detected by 
1
H NMR (Scheme 
13) in the presence of (S)-(-)-O-Acetylmandelic acid.
55 
Scheme 13 – Fendiline (2.52) & (R)-Fendiline (2.56) Results 
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2.4 CHAPTER SUMMARY 
 
• A two-step one-pot synthesis of alkyl primary amines from primary alcohols 
was achieved. 
 
• The reaction will tolerate a range of substrates, but not phenethyl scaffolds. 
 
• Other functionality present in a 1,2-substitution pattern can lead to problems 
with either step. 
 
• An intermediate secondary amine which was also an API could be isolated as 
a single enantiomer in good yield. 
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3 RESULTS AND DISCUSSION II 
3.1 Background 
The use of ammonia and its salts in borrowing hydrogen reactions have been shown 
to form symmetric tertiary amines when reacted with an excess of alcohol.
1-5
 Previous 
work (Chapter 2) demonstrated that even when using a large excess of ammonia there 
was little control in the selectivity of product formation between primary, secondary 
and tertiary amines. The formation of symmetric tertiary amines using borrowing 
hydrogen methodology while interesting, has limited synthetic utility. However, non-
symmetric tertiary amines, where one or more groups are different, are present in 
many pharmaceuticals (Figure 1) and are often key to the API’s characteristics. The 
tertiary amine moiety can aid binding in the active site, restrict degrees of rotation in 
the molecule, or modify the log P to improve solubility and/or permeability in vivo. 
 
Figure 1 - Marketed Drugs Containing Non-symmetric Tertiary Amines 
Synthesis of non-symmetric tertiary amines using borrowing hydrogen methodologies 
has focused on the alkylation of secondary amines preventing the problems of over-
alkylation and by-product formation.
6-15
 An alternative approach to this motif would 
take advantage of the reactivity of the nitrogen atom in primary amines and seek to 
alkylate twice with two alcohols tethered together, a diol, thus forming a cyclic 
tertiary amine (Scheme 1). 
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Scheme 1 - Possible Routes to Asymmetric Tertiary Amines 
Examples of this approach were already present in the literature
12,15-18
 with good 
yields and substrate scope, however, there was only one example using the ruthenium 
catalyst system developed by the Williams group
19
 which gave comparatively low 
yields despite using high catalyst loadings (Scheme 2). 
 
Scheme 2 - Previous Example from the Williams Group
19 
 
3.2 Initial Studies 
Initial work focused on screening a range of primary amines and 1,4-butanediol with 
the [Ru(p-cymene)Cl2]2/DPEphos system shown to be active for the synthesis of 
tertiary amines by the Williams group,
10
 using K2CO3 as an activating base
19
 (Scheme 
3). 
 
Scheme 3 - Initial Reaction Conditions 
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Entry
a 
Amine Product 
1
b 
  
2
b 
  
3 
 
Unclear 
4
c 
  
5 
 
Unclear 
6
b 
  
aConditions: [Ru(p-cymene)Cl2] (2.5 mol%), DPEphos (5 mol%), K2CO3 (10 
mol%), amine (1 mmol), diol (1.5 mmol), toluene (1 mL), reflux, 24 h; 
bDetermined by mass spec; cDetermined by 1H NMR. 
Table 1 - Initial Amine Screen 
Analysis of the crude reaction mixtures by 
1
H NMR for all amines showed a large 
number of different compounds present except in the case of aniline (Entry 4, Table 
1) (3.1) where the product was clearly visible by the symmetry of the signals 
observed. This was further confirmed by analysis of mass spectra and comparison of 
the 
1
H NMR with literature references. Further analysis of the other samples by mass 
spectrometry revealed that the major product formed was the amino-alcohol in most 
cases (Entries 1, 2 & 6, Table 1). 
While the initial results were disappointing, the formation of the desired product with 
aniline was encouraging and demonstrated that the reaction did proceed at a lower 
catalyst loading than previously reported.
19 
Previous work in the literature applying borrowing hydrogen methodologies has 
shown that the choice of activating base has an important effect on the reaction. 
Furthermore, the formation of the mono-alkylated product in 50% of the reactions 
illustrated a similarity to the formation of secondary amines previously reported with 
a similar catalyst.
19
 Comparison of the formation of secondary and tertiary amine 
formation reported by the Williams group showed that no base was required for 
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tertiary amine formation.
10
 As such a screen of activating bases was conducted, 
revealing that all gave similar mixtures of products except for triethylamine. Analysis 
of the crude reaction mixture, by 
1
H NMR, in this case showed the presence of the 
desired product and some γ-butyrolactone formed by deydrogenative lactonisation20-23 
of the excess diol. It was then possible to reduce the excess of diol from 1.5 to 1.1 
equivalents while still retaining high conversion. However, it was not possible to 
reduce the catalyst loading below 5 mol% of ruthenium without hampering 
conversion. 
 
3.3 Reaction Scope 
 
Scheme 4 - Optimised Reaction Conditions 
Having established a set of conditions (Scheme 4), a series of anilines was screened 
to determine the tolerance of the reaction to alternative substrates (Table 2). 
The results were generally good with isolated yields >60%. The inclusion of a methyl 
substituent was well tolerated in the ortho (3.6), meta (3.9), and para (3.13) positions. 
Meta substituents were also well tolerated, although a lower yield was recorded for 
the trifluoromethyl compound (3.11) but even with a nitro group (3.12) present on the 
ring the desired product could still be obtained in 50% yield. Substitution at the 2- 
and 4-positions gave varying results dependent on the electronic effect of the 
substitution. Substrates with strong electron withdrawing groups such as cyano (3.19) 
or nitro (3.20) gave no conversion, even on increased heating (155 °C). However, 
weaker electron withdrawing groups such as fluoro (3.4 & 3.14) and chloro (3.5, 3.10 
& 3.15) gave yields determined by the proximity to the nitrogen, with para-
substitution giving higher yields than ortho. In the case of esters (3.18) the yield 
could be improved by increased heating (155 °C) using p-xylene as solvent. Analysis 
of the entire set illustrates that the yield is determined by the nucleophilicity of the 
nitrogen, which is determined by the position and electronic nature of the substituent 
on the aromatic ring with no exceptions. 
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Entry
a 
Substitution Isolated Yield (%) Product 
1 None 78 3.3 
2 2-F 33 3.4 
3 2-Cl 24
b 
3.5 
4 2-Me 76 3.6 
5 2-NO2 0
b 
3.7 
6 3-Me 94 3.9 
7 3-Cl 84 3.10 
8 3-CF3 60 3.11 
9 3-NO2 50
b 
3.12 
10 4-Me 65 3.13 
11 4-F 78 3.14 
12 4-Cl 87 3.15 
13 4-tBu 85 3.16 
14 4-MeO 70 3.17 
15 4-CO2Me 33 (74)
c 
3.18 
16 4-CN 0
b
 (0)
b,c 
- 
17 4-NO2 0
b
 (0)
b,c 
- 
18 3,4-(CH2)3 74 3.19 
aConditions: Aniline (3 mmol), 1,4-butanediol (3.3 mmol), [Ru(p-
cymene)Cl2]2 (2.5 mol%), DPEphos (5 mol%), Et3N (10 mol%), 
toluene (3 mL), reflux, 24 h; bConversion determined by 1H NMR; 
cValue in parentheses run in p-xylene, 155 °C, 24 h. 
Table 2 - Aniline Screen 
Having established that a wide range of aromatic amines could be tolerated, we 
wanted to expand the substrate scope to non-aromatic primary amines and 
heterocycles (Table 3). The results of both benzylamine (Entry 1, Table 3) and 2-
phenethylamine (Entry 2, Table 3) were very similar, however, an increased yield 
was obtained with an α-branched amine (Entry 3, Table 3), again illustrating the 
previous conclusion that the result is driven by the nucleophilicity of the amine. It 
was also pleasing to see that an enantiopure amine (Entry 4, Table 3) could be used 
without racemisation of the chiral centre occurring. The inclusion of heterocycles was 
also tolerated, with furfurylamine (Entry 5, Table 3) resulting in a reasonable yield, 
while the pyridylamines (Entries 6-8, Table 3) conformed to the pattern previously 
seen with the anilines. While this work was underway, the group was successful at 
mono-alkylating sulphonamides
13
; accordingly we applied similar conditions to affect 
dialkylation, without any success (Entry 9, Table 3). 
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Entry
a 
Amine Isolated Yield (%) Product 
1 
 
72 3.20 
2 
 
69 3.21 
3 
 
82 3.22 
4
b 
 
82 3.23 
5 
 
63 3.24 
6 
 
26
c 
3.25 
7 
 
58 3.26 
8 
 
0
c 
- 
9 
 
0
c
 (0)
c,d 
- 
aConditions: Amine (3 mmol), 1,4-butanediol (3.3 mmol), [Ru(p-
cymene)Cl2]2 (2.5 mol%), DPEphos (5 mol%), Et3N (10 mol%), toluene (3 
mL), reflux, 24 h; b>95% e.e. determined by 1H NMR using a chiral shift 
reagent and comparison of specific rotation to literature references24; 
cConversion determined by 1H NMR; dValue in parentheses run in p-xylene, 
155 °C, 24 h. 
Table 3 - Non-Aromatic Primary Amines and Heterocycles 
With a wide range of amines tolerated, we turned our attention to varying the diol 
component of the reaction. A range of diols was screened, with varying chain lengths 
and some containing heteroatoms (Table 4). 
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Entry
a 
Diol Result 
Isolated Yield 
(%) 
1 
 
 
78 
2 
 
 
72 
3
b 
 
 
55 
4
c 
 
 
65 
5
d 
 
 
65 
6 
 
No Reaction 0
e 
7 
 
No Reaction 0
e 
8 
 
No Reaction 0
e 
9 
 
No Reaction 0
e 
a Conditions: Aniline (3 mmol), diol (3.3 mmol), [Ru(p-cymene)Cl2]2 (2.5 mol%), DPEphos (5 mol%), Et3N 
(10 mol%), toluene (3 mL), reflux, 24 h; b Diol (3 mmol), aniline (6.6 mmol); c α-Methylbenzylamine used 
instead of aniline; d Run in p-xylene at 155 °C, 24 h; e Conversion determined by 1H NMR. 
Table 4 - Diol Tolerance 
The reaction of 1,4-pentanediol (3.30) proceeded smoothly at a higher temperature 
(155 °C) using p-xylene as the solvent, showing complete consumption of the aniline. 
The increase in temperature corresponds to the conditions used for the coupling of 
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secondary amines with secondary alcohols
13
 which had been reported. When 
purifying the product, two chromophores were detected by UV analysis of the TLC, 
both were isolated and analysed. The major product was the desired cyclic pyrrolidine 
(3.37), the minor product was N-ethylaniline (3.38) (Scheme 5). 
 
Scheme 5 - Reaction of 1,4-Pentanediol at 155 °C 
Formation of the by-product can be attributed to transfer of an ethyl group from the 
catalytic triethylamine present in the reaction mixture. At the increased temperature, 
the catalyst is able to perform borrowing hydrogen reactions on tougher substrates 
such as sulphonamides and secondary alcohols.
13
 We reasoned that at the higher 
temperature oxidation of the triethylamine was occurring, followed by nucleophilic 
addition of the aniline to form an aminal. Protonation and elimination would lead to 
the imine intermediate which could then be reduced using the hydrogen removed by 
the initial oxidation (Scheme 6). 
 
Scheme 6 - Formation of N-Ethylaniline By-product 
This is not the first example of this reaction; indeed both the Williams group
25
 and 
others
26-30
 have manipulated this pathway to use amines as alkylating agents. 
Finally, the inclusion of a heteroatom (Entries 6-9, Table 4) in the backbone of the 
diol led to no product in any case, analysis of the crude reaction mixtures by 
1
H NMR 
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showed only starting material. The return of starting materials in these cases suggests 
that the active catalyst was not formed. This could be due to competitive ligand 
binding by the diol substrates themselves, all of which have a 1,4,7-substitution 
pattern of heteroatoms which can act as bi- or tri-dentate ligands, as illustrated in the 
literature.
31-32 
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3.4 CHAPTER SUMMARY 
 
• An improved catalytic system has been developed for the formation of cyclic 
tertiary amines using a previously known catalyst. 
 
• The reaction will tolerate a wide range of substrates and the results can be 
predicted by consideration of the electron density at the nitrogen lone pair. 
 
• The reaction will tolerate α-stereocentres on the amine without erosion of the 
enantiomeric excess. 
 
• The reaction is unsuccessful at forming 6-membered cyclic rings containing 
more than one heteroatom. 
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4 RESULTS AND DISCUSSION III 
4.1 Background 
The combination of [Ru(p-cymene)Cl2]2 and DPEphos has been proven to be a 
versatile catalyst able to form a wide variety of C-N bonds via the borrowing 
hydrogen approach and the Williams group has exploited this reactivity.
1
 However, 
most of the reactions require long reaction times and high temperatures. Kempe and 
co-workers have developed a P-N ligand that when combined with a suitable iridium 
source facilitated C-N bond formation under milder conditions.
2-3
 We wished to 
develop a catalyst or suitable reaction conditions to allow C-N bond formation to 
occur more quickly than previously reported. 
 
4.2 Initial Studies 
Initial work focused on developing a stable preformed catalyst that could become 
commercially available. 
 
Figure 1 - Ruthenium Based Catalysts & Ligands 
The combination of [Ru(p-cymene)Cl2]2 (4.1) and DPEphos (4.2) has been already 
been shown by the Williams group to be an active system as mentioned above, in 
addition the combination of [Ru(p-cymene)Cl2]2 (4.1) and triphenylphosphine has 
been shown to be active for C-N bond formation with sulfonamides at higher 
Chapter 4 
62 
 
temperatures.
4
 A search of the literature revealed several complexes containing 
ruthenium/DPEphos combinations.
5
 These were all synthesized successfully 
following the literature procedures except [RuCl2(DPEphos)(CH3CN)(H2O)] (4.6) 
which despite repeated attempts was unsuccessful. These were then tested under 
standard reaction conditions (Scheme 1). 
 
Scheme 1 - Standard Reaction Conditions 
Entry
a 
Catalyst Conversion (%)
b 
1 4.1/4.2 100 
2
 
4.1/4.2/PPh3 98
c 
3 4.3 96 
4 4.4 94 
5 4.5 97 
aConditions: Benzyl alcohol (1 mmol), morpholine (1 
mmol), [Ru] (5 mol% with respect to ruthenium), 
ligand (5 mol%), toluene (1 mL), reflux, 24 h; 
bConversion determined by 1H NMR; c5 mol% PPh3 
Table 1 - Tertiary Amine Formation Catalyst Screen 
Analysis of the crude reaction mixtures by 
1
H NMR showed good conversions for all 
catalyst combinations. However, the catalyst loading for this reaction was double the 
reported loading,
6
 but despite this, these results were encouraging. 
 
Scheme 2 - Secondary Amine Reaction Conditions 
Having established that a range of ruthenium/DPEphos combinations was active for 
the synthesis of tertiary amines from secondary amines, we next wanted to test them 
in the more challenging synthesis of secondary amines using primary amines 
(Scheme 2, Table 2). 
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Entry
a 
Catalyst Conversion (%)
b 
1 4.1/4.2 100 
2
 
4.1/4.2/PPh3 100
c 
3 4.3 49 
4 4.4 100 
5 4.5 0 
aConditions: Benzyl alcohol (1 mmol), (+/-)-1-
phenethylamine (1 mmol), [Ru] (5 mol% with 
respect to ruthenium), toluene (1 mL), reflux, 24 h; 
bConversion determined by 1H NMR; c5 mol% PPh3 
Table 2 - Secondary Amine Formation Catalyst Screen 
The results of this screen were more interesting. The inclusion of triphenylphosphine 
into the reaction mixture (Entry 2, Table 2) showed little or no difference in 
conversion compared to the reaction without triphenylphosphine (Entry 1, Table 2). 
However, when the pre-formed catalyst with the triphenylphosphine already bound 
[RuCl2(DPEphos)(PPh3)] (4.5) (Entry 5, Table 2) was used there was no conversion 
to product. Comparison of these results with the reaction of [RuCl2(dmso)(DPEphos)] 
(4.4) (Entry 4, Table 2) and RuCl2(PPh3)3 (4.3) (Entry 3, Table 2) can start to shed 
some light on the active species. 
Both RuCl2(PPh3)3 (4.3) and [RuCl2(DPEphos)(PPh3)] (4.5) have triphenylphosphine 
bound, however, only reactions using RuCl2(PPh3)3 (4.3) showed any conversion. The 
difference between the two catalysts is the latter has the triphenylphosphine bound in 
the axial position, although it is unlikely that this will have any affect as it is well 
known that triphenylphosphine can dissociate from the metal, and this is required for 
RuCl2(PPh3)3 (4.3) to form an active catalyst and facilitate the reaction. 
Comparison of [RuCl2(dmso)(DPEphos)] (4.4) and [RuCl2(DPEphos)(PPh3)] (4.5) 
again shows that the latter catalyst shows no activity while the first shows excellent 
activity. As mentioned previously, dissociation of the triphenylphosphine is likely, so 
the difference in reactivity can be attributed to the binding of the DPEphos ligand. In 
the [RuCl2(dmso)(DPEphos)] (4.4) complex, the two phosphines are bound in cis 
equatorial positions with the oxygen binding through an axial position. Alternatively, 
[RuCl2(DPEphos)(PPh3)] (4.5) has the DPEphos bound in a plain with 180° between 
the two phosphines and 90° between each phosphine and the oxygen. The resulting 
difference between the two catalysts is that [RuCl2(dmso)(DPEphos)] (4.4) can form 
two free equatorial sites with loss of the chlorines, while [RuCl2(DPEphos)(PPh3)] 
cannot. It is worth noting that both catalysts can form two free sites in an axial-
Chapter 4 
64 
 
equatorial relationship. This implies that the active species for secondary amine 
formation requires two free equatorial sites, whilst the active species for tertiary 
amine only requires one. 
From the screen it is clear that in our pursuit for a stable preformed catalyst that the 
[RuCl2(dmso)(DPEphos)] (4.4) is the lead candidate. However, analysis of the 
synthesis
5
 of this catalyst starts from RuCl2(dmso)4 (4.11) which is far more 
expensive than [Ru(p-cymene)Cl2]2 (4.1), nor is the synthesis of this precursor from 
RuCl3 particularly appealing.
7
 Added to this is the long-term stability of the dmso 
remaining bound to the catalyst on storage means that this route to an improved 
catalytic system is unlikely. 
 
Scheme 3 - Model Reaction Conditions for Ionic Liquid Screen 
Entry
a 
Solvent Conversion (%)
b 
1 Toluene 18 
2 [BMIM][PF6] 34 
3 [BMIM][Cl] 4 
4 [BMIM][OTf] 14 
5 [BMIM][BF4] 31 
6 [BMIM][SbF6] 18 
7 [BDMIM][PF6] 24 
8
 
[BMIM][PF6] 61
c 
aConditions: Benzyl alcohol (1 mmol), morpholine (1 
mmol), [Ru(p-cymene)Cl2]2 (1.25 mol%), DPEphos (2.5 
mol%), solvent (1 mL), 115 °C, 90 min; bConversion 
determined by 1H NMR; cReaction heated for 6 h. 
Table 3 - Ionic Liquid Screen 
The choice of solvent can have a large impact on the course of a reaction.
8
 The 
Williams group,
9
 Yamaguchi and co-workers
10-11
 and the Madsen group
12
 have all 
shown that iridium catalysed borrowing hydrogen reactions can occur on or in water, 
whilst Milstein and Gunanathan
13
 have demonstrated that ruthenium can also catalyse 
reactions on or in water. Further work by the Williams group has also shown unique 
reactivity of iridium catalysed borrowing hydrogen reactions in ionic liquids.
14
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However, there were no published reports of ruthenium catalysed borrowing 
hydrogen reactions in ionic liquids and considering the published work with iridium, 
we hoped to see similar acceleration of the reaction to shorten reaction times (Scheme 
3). 
Initial work focused on a screen of ionic liquids with comparison to toluene over 90 
min (Table 3). 
Initial results from the screen looked very promising, showing that [BMIM][PF6] 
(Entry 2, Table 3) had almost doubled the conversion compared with toluene (Entry 
1, Table 3). Furthermore, the ionic liquid acting as a carbene ligand can also be ruled 
out due to the increased conversion also illustrated by [BDMIM][PF6] (Entry 7, Table 
7) which is unable to form a carbene due to the blocking methyl group. However, on 
extended heating, the rate of reaction was not maintained (Entry 8, Table 3). The 
effect of catalyst loading and reaction time were then investigated (Table 4). 
Entry
a 
Solvent 
Catalyst Loading 
(Mol%)
b 
Time (h) Conversion
c 
1 [BMIM][PF6] 5 6 94 
2 [BMIM][PF6] 4 6 99 
3 [BMIM][PF6] 3 6 90 
4 [BMIM][PF6] 4 5 94 
5 [BMIM][PF6] 4 4 91 
6 Toluene 4 4 99 
aConditions: Benzyl alcohol (1 mmol), morpholine (1 mmol), [Ru(p-cymene)Cl2]2, DPEphos, solvent (1 
mL), 115 °C; bWith respect to [Ru]; cConversion determined by 1H NMR. 
Table 4 - Time and Catalyst Loading Screen 
Further analysis of the use of ionic liquids was disappointing, demonstrating that a 
higher catalyst loading of 4 mol% was required to reach full conversion in 6 hours 
(Entry 2, Table 4). Decreasing the reaction time whilst maintaining the high 
conversion was possible at the higher catalyst loading (Entry 4 & 5, Table 4) 
however, the results were not as good when compared with toluene (Entry 6, Table 
4). Furthermore, other C-N bond forming reactions either stalled or were not active in 
the ionic liquid, illustrating poor reaction scope and ending this line of investigation. 
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Scheme 4 - Initial Microwave Screening Conditions 
Entry
a 
Solvent Conversion (%)
b 
1 Toluene 0 
2 Dioxane >5 
3 DME >5 
4 t-BuOH >5 
5 MeOH 0 
6 H2O 0 
aConditions: Benzyl alcohol (1 mmol), aniline (1 mmol), 
[Ru(p-cymene)Cl2]2 (2.5 mol%), DPEphos (5 mol%), 
solvent (1 mL), 115 °C, 60 min; bConversion determined 
by 1H NMR. 
Table 5 - Microwave Solvent Screen 
Grigg and co-workers have shown that the use of microwaves can accelerate iridium 
catalysed borrowing hydrogen reactions
15-17
 however; there was no precedent for the 
use of ruthenium under these conditions, nor the application to C-N bond formation. 
As such, a set of standard conditions were chosen (Scheme 4) and the three major 
catalyst systems published by Yamaguchi,
18
 Beller
19
 and Williams
1
 were tested at 
their reported loadings. 
 
Scheme 5 - Revised Microwave Conditions 
Under the conditions chosen, only the iridium system published by Yamaguchi 
showed any activity (7% conversion by 
1
H NMR). Continuing to work with the 
catalyst system published by the Williams group, a screen of oxygen containing 
solvents was conducted to see if altering the solvent would have any beneficial effects 
on the reaction (Table 5). 
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The results did not show any increase in conversion. A review of the conditions used 
by Grigg and co-workers revealed that they used no solvent in their reactions, but an 
excess of alcohol instead. With this information, a modified set of conditions was 
screened (Scheme 5). 
Using the revised conditions both the catalyst systems used by Yamaguchi and the 
Williams group were successful giving 100% and 52% conversions respectively. The 
catalyst system used by Beller and co-workers
16
 gave no conversion. Despite the full 
conversion with the [IrCp*Cl2]2 catalyst, we chose to continue our work with the 
[Ru(p-cymene)Cl2]2/DPEphos system as it has been successfully used previously by 
the Williams group.
1
 Further optimisation was conducted to find the optimal reaction 
conditions. 
Entry
a 
Equivalents of Alcohol Time (min) Conversion (%)
b 
1 3 60 52 
2 3 120 100 
3 2 120 88 
4 1 120 71 
5 3
c 
120 60 
6 3
c 
240 100 
aConditions: Benzyl alcohol, aniline (1 mmol), [Ru(p-cymene)Cl2]2 (2.5 mol%), 
DPEphos (5 mol%), solvent (1 mL), 115 °C, 60 min; bConversion determined by 1H 
NMR; cEquivalents of amine. 
Table 6 - Optimisation of Conditions 
By increasing the reaction time (Entry 2, Table 6) it was possible to push the reaction 
to full conversion. However, decreasing the amount of alcohol led to a decrease in 
conversion (Entry 3 & 4, Table 6), even on extended heating the conversion did not 
increase. It was also possible to use an excess of amine (Entry 5, Table 6), although 
this required doubling the reaction time (240 min, Entry 6, Table 6). 
Having established suitable reaction conditions for the reaction of aniline (4.9), the 
reaction of morpholine (4.11) with benzyl alcohol (Scheme 6) was evaluated. 
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Scheme 6 - Reaction of Morpholine with Benzyl Alcohol 
Entry
a 
Equivalents of Alcohol Time (min) Conversion (%)
b 
1 3 60 100 
2 2 60 100 
3 1.6 90 100 
4 1.2 90 94 
5 1.2 120 94 
6
 
1.6 90 100
c 
aConditions: Benzyl alcohol (1 mmol), morpholine (1 mmol), [Ru(p-cymene)Cl2]2 (2.5 
mol%), DPEphos (5 mol%), 115 °C; bConversion determined by 1H NMR; cReaction 
scaled to 3 mmol. 
Table 7 - Reaction with Morpholine 
The initial test (Entry 1, Table 7) gave full conversion to the product and it was then 
possible to reduce the excess of alcohol down to 1.6 equivalents (Entry 3, Table 7) 
without hampering the conversion. However, on reducing the excess further (Entry 4, 
Table 7), it was not possible to drive the reaction to completion even on extended 
heating (Entry 5, Table 7). It was also possible to increase the reaction scale whilst 
still maintaining the short reaction time (Entry 6, Table 7). 
 
3.3 Reaction Scope 
Having established a set of conditions, a variety of secondary amines and primary 
alcohols were coupled to evaluate the scope of the reaction (Scheme 7 & Table 8).  
We were pleased to see that all the products could be isolated in high yields 
comparable with thermal heating
1
 but with the desired shorter reaction times. The use 
of excess amine instead of alcohol (Entry 2, Table 8) was also possible and added 
value to the reaction as this meant the least expensive coupling partner, whichever it 
may be, could be used in excess while still giving good yields. Although the reactions 
proceeded well, an increase in temperature (125 °C) was required for the acyclic 
substrate (4.13) to couple in high yield. 
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Scheme 7 - Tertiary Amine Synthesis 
Entry
a 
Product 
Equivalents 
of Alcohol 
Time 
(min) 
Isolated 
Yield (%) 
1 
 
1.6 90 79 
2
 
 
2.0
b 
90 94
c 
3 
 
1.6 120 79 
4 
 
1.6 90 83 
5 
 
1.6 90 81 
aConditions: Amine (3 mmol), alcohol, [Ru(p-cymene)Cl2]2 (2.5 mol%), DPEphos (5 mol%), 
115 °C; bEquivalents of amine; c125 °C. 
Table 8 - Tertiary Amine Results 
Thermal C-N bond formation via borrowing hydrogen has been shown to react 
selectively at the primary
1
 or least hindered alcohol.
20
 We wished to determine if this 
was still the case with microwave heating. To test this, morpholine was then reacted 
with a series of 1,2-diols, however, only diols with a benzylic secondary alcohol were 
active towards coupling. The use of alkyl 1,2-diols led to the oxidation of the 
secondary alcohol to the corresponding hydroxy ketone. This is in contrast to 
previously reported thermal coupling reactions, suggesting that there may be 
limitations to the use of microwave heating in specific cases. With the limitation of 
the 1,2-diol substrate evaluated, various secondary amines were screened against 1-
phenyl-1,2-ethanediol
20
 (Scheme 8, Table 9). 
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Scheme 8 - Amino-alcohol Synthesis 
Entry
a 
Product 
Equivalents 
of Amine 
Time 
(min) 
Isolated 
Yield (%) 
1 
 
2.0 90 75 
2 
 
2.0 90 90 
3 
 
2.0 90 65 
4 
 
2.0 120 79 
5 
 
2.0 90 61 
aConditions: Diol (1 mmol), amine (2 mmol), [Ru(p-cymene)Cl2]2 (2.5 mol%), DPEphos 
(5 mol%), 115 °C. 
Table 9 - Amino-alcohol Results 
Again the yields for most substrates were good (Entries 1, 2 & 4, Table 9), however, 
the introduction of acyclic amine (4.20) or a larger cyclic amine (4.18) gave full 
conversion by 
1
H NMR despite the lower isolated yield. 
We then turned our attention to the coupling of primary amines, which under the 
previous conditions gave poor conversion. We assumed this was due to the 
deactivation of the catalyst as a result of the amine binding more tightly to the 
catalyst under the concentrated conditions.
21
 Assuming this to be the case, the 
reaction temperature was increased by 10 °C, and the reaction progressed to full 
conversion. With the new conditions established, a series of primary amines was 
coupled to evaluate the scope of the reaction (Scheme 9 & Table 10). 
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Scheme 9 - Secondary Amine Synthesis 
Entry
a 
Product 
Equivalents 
of Alcohol 
Time 
(min) 
Isolated 
Yield (%) 
1
 
 
3.0 120 91
b 
2
 
 
2.1 120 73
b 
3 
 
1.6 60 94 
4 
 
2.0 90 82 
5 
 
1.6 60 80 
aConditions: Amine (1 mmol), alcohol, [Ru(p-cymene)Cl2]2 (2.5 mol%), DPEphos (5 mol%), 125 
°C; b115 °C. 
Table 10 - Secondary Amine Results 
As expected, the results were good, with a range of alcohols and amines coupling in 
high yields. Anilines (Entries 1 & 2, Table 10) also gave good results at lower 
temperatures (115 °C) as shown in the initial work. The lower temperature of these 
reactions can be attributed to the lone pair on the nitrogen being less nucleophilic due 
to the orbital overlap with the aromatic ring. As a result the nitrogen will bind less 
tightly to the catalyst, reducing the amount of deactivation. Bulky amines (Entries 3-
5, Table 10) also coupled well and again gave yields comparable with thermal 
heating. 
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Scheme 10 - Cyclic Tertiary Amine Synthesis 
Entry
a 
Product 
Equivalents 
of Alcohol 
Time 
(min) 
Isolated 
Yield (%) 
1 
 
1.6 90 88 
2 
 
1.6 90 81 
3 
 
1.6 90 77 
4 
 
1.6 90 82 
5 
 
1.6 90 54 
aConditions: Amine (1 mmol), diol (1.6 mmol), [Ru(p-cymene)Cl2]2 (2.5 mol%), 
DPEphos (5 mol%), 135 °C. 
Table 11 - Cyclic Tertiary Amine Results 
Having determined that mono-alkylation of primary amines was possible, we wanted 
to see if we could repeat some of our earlier work (Chapter 3) and di-alkylate using 
symmetric diols (Scheme 10).
1, 22-23 
Again, a slight increase in temperature (135 °C) was required for the reaction to 
proceed to completion. With the conditions established, a range of substrates were 
screened (Table 11) giving generally good yields, comparable with our previously 
reported results. The only exception was furfurylamine (4.30), which gave a lower 
yield. When an enantiomerically enriched amine (4.29) was alkylated, again, no 
racemisation was observed, proven by 
1
H NMR using a chiral shift reagent
24-25
 and 
comparison of the specific rotation with a literature reference.
26 
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Scheme 11 - Sulfonamide Alkylation 
Entry
a 
Product 
Equivalents 
of Alcohol 
Time 
(min) 
Isolated 
Yield (%) 
1 
 
3.0 120 91 
2 
 
3.0 180 96 
3 
 
3.0 180 74 
4 
 
3.0 180 91 
5 
 
3.0 180 86 
aConditions: Amide (1 mmol), alcohol (3 mmol), [Ru(p-cymene)Cl2]2 (2.5 mol%), DPEphos (5 
mol%), 165 °C. 
Table 12 - Sulfonamide Alkylation Results 
Having screened a series of different amine and alcohol couplings, we turned our 
attention towards the alkylation of sulfonamides.
1,4,27
 An increase in temperature (165 
°C) and reaction time (180 min) was required to drive the reaction to completion. An 
increased amount of alcohol was also necessary; we assumed this was required to 
dissolve the sulfonamide. However, contrary to previous reports, the inclusion of an 
inorganic base to deprotonate the sulfonamide was not required. The results of the 
sulfonamide couplings (Table 12) were good, with high yields except for 
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cyclopropylmethanol (4.33). In this case the yield was low due to the alcohol 
undergoing oxidative dimerization to form the symmetric ester.
28-32 
 
Scheme 12 - Alkylation of Primary Amides 
Entry
a 
Product 
Equivalents 
of Alcohol 
Time 
(min) 
Isolated 
Yield (%) 
1 
 
3.0 120 66 
2 
 
3.0 120 72 
3 
 
3.0 180 54
b 
4 
 
3.0 120 74 
5 
 
3.0 120 79 
aConditions: Amide (1 mmol), alcohol (3 mmol), [Ru(p-cymene)Cl2]2 (2.5 mol%), 
DPEphos (5 mol%), 175 °C; bConversion determined by 1H NMR was 84%, the low yield 
is due to difficulties in isolation. 
Table 13 - Alkylation of Primary Amides Results 
Satisfied that we could replicate the previous results and couplings, we wanted to 
extend the scope of the catalyst and alkylate primary amides in the same way. This 
catalyst system has previously been unsuccessful in this area although there are at 
least three reports in the literature
33-35
 of this coupling being achieved with both 
ruthenium and iridium, but with high reaction temperatures. By starting with the 
sulfonamide conditions, it was quickly determined that the coupling of primary 
Chapter 4 
75 
 
amides and alcohols was possible, although to reach full conversion the reaction 
temperature had to be increased to 175 °C. 
Despite the high reaction temperature, the reaction time was shorter than the coupling 
of sulfonamides (120 vs 180 min) and once again the coupling proceeded without the 
need for a base. The reaction scope was then evaluated and compared with the system 
reported by Yamaguchi et al.
35 
Both aromatic (Entries 1 & 2, Table 13) and alkyl amides (Entries 4 & 5, Table 13) 
were coupled with aliphatic and benzylic alcohols with reasonable yields. The 
coupling of alkyl amides in particular was interesting as the yields were better than 
those reported by Yamaguchi, even though the reaction temperature was significantly 
higher. Finally, we were very pleased to isolate N-hexylnicotinamide in reasonable 
yield (4.38), demonstrating that the reaction was also applicable to biologically 
relevant molecules. 
Scheme 13 - Drug Molecule Synthesis 
With a range of reaction conditions established, we were keen to apply our chemistry 
to two pharmaceutical compounds, Piribedil (4.41) and Fentanyl (4.42), both of 
which were isolated in good yield (Scheme 13). 
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4.4 CHAPTER SUMMARY 
 
• The combination of [Ru(p-cymene)Cl2]2 and DPEphos has proven to be the 
best catalyst system for the formation of secondary and tertiary amines over 
the preformed combinations present in the literature. 
 
• The use of toluene as a reaction solvent is superior to ionic liquids. 
 
• Microwave heating can be applied to C-N bond formation via borrowing 
hydrogen methodology under solvent free conditions. 
 
• The use of microwave heating can be applied to a wide range of amine and 
amide syntheses. 
 
• The alkylation of primary amides has been achieved using the catalyst system 
published by the Williams group for the first time. 
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5 RESULTS AND DISCUSSION IV 
5.1 Background 
In 1993 Murai reported the first catalytic applications of C-H activation of 
acetophenones using a ruthenium catalyst.
1
 Since then, Murai and co-workers
2-10
 have 
fully evaluated the area providing a wealth of information which has been reviewed 
several times.
11-13
 More recently Murai has been able to run the reaction at room 
temperature by isolating the catalytically active species.
14
 However, our interest 
focused on the recent success of using vinylic alcohols
15
 as starting materials. The 
alcohols are isomerised to the corresponding ketones which then undergo the C-H 
activation chemistry that has been so well reported (Scheme 1). 
 
Scheme 1 - Tandem Isomerisation/C-H Activation Process 
We wanted to apply a similar approach, starting from a benzyl alcohol, where the 
alkene would act as an oxidant and alkylating agent in a tandem oxidation/C-H 
activation (Scheme 2). 
 
Scheme 2 - Proposed Work 
 
5.2 Initial Studies 
Initial work focused on applying 1-m-tolylethanol (5.1) under the reaction conditions 
reported by Murai.
1
 We were very pleased to see that under these conditions the 
oxidation and alkylation proceeded. Furthermore, the alkylation occurred para to the 
methyl group, as expected (Scheme 3).
10
 It was then possible to reduce the amount of 
alkene from 5 equivalents down to 2.5 without hampering conversion (Entry 3, Table 
1). Further reduction in the number of equivalents of alkene was possible but required 
an increase in the reaction time from 2 to 3 hours (Entries 5 & 6, Table 1). 
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Scheme 3 - Optimisation of Equivalents of Alkene 
Entry
a 
Equivalents of Alkene Conversion (%)
b 
1 5 100 
2 3 100 
3 2.5 100 
4 2.2 94
c,d 
5 2.2 100
e 
6 2.1 96
e 
aConditions: 1-m-Tolylethanol (1 mmol), 3,3-dimethylbut-1-ene, 
Ru(PPh3)3(CO)(H)2 (5 mol%), toluene (1 mL), 135 °C, 2 h; 
bConversion 
determined by 1H NMR; cReaction run for 2.5 h; dRemaining 6% was 
the corresponding acetophenone; eReaction run for 3 hours. 
Table 1 - Optimisation of Equivalents of Alkene 
Having optimised the tandem oxidation/C-H activation we were keen to see whether 
the alkylated ketone could then be reduced back to the alcohol, again using ruthenium 
catalysed transfer hydrogenation.
16
 In order to test this, the tandem oxidation/C-H 
activation was run at 135 °C, the reaction allowed to cool to room temperature before 
a hydrogen source was added under nitrogen. The reaction was then re-sealed and re-
heated back to 135 °C, the results are summarised below (Scheme 4). 
The use of isopropanol gave a favourable result (94% conversion after 4 hours), 
however, the use of a similar irreversible hydrogen source, 1,4-butanediol
17-18
 was 
poor in comparison (19% conversion after 1 hour). While the reaction times are 
different, extrapolation of the conversion after 1 hour would imply 76% conversion 
after 4 hours. The best result was obtained with formic acid (98% conversion in 3 
hours), which is also an irreversible hydrogen source (the ruthenium-catalysed 
decomposition of formic acid is well reported
19-21
) generating hydrogen and carbon 
dioxide. Comparison of the two best results, isopropanol and formic acid, revealed 
formic acid as the superior hydrogen source. While isopropanol gave an excellent 
result under the reaction conditions, the reaction is at equilibrium (Scheme 5), as the 
acetone by-product formed can act as an oxidant
22-30
 to convert the alkylated alcohol 
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(5.3) back to the alkylated ketone (5.2). The use of a formic acid/triethylamine (5:2) 
mixture, previously used in reduction
16,31-33
 as an alternative to formic acid, was also 
tested, however, the results were not as good as those obtained with formic acid. 
 
Scheme 4 - Hydrogen Source Screen 
 
Scheme 5 - Oxidation/Reduction Equilibrium 
It was at this point, a question was raised about the nature of the reaction. Was the 
reaction sequence occurring as we had conceived? Despite the literature precedent for 
the ruthenium-catalysed C-H activation of acetophenones, we wanted to prove that 
the C-H activation was happening at the ketone oxidation state, and not at the alcohol 
level, which would provide evidence that our reaction was indeed occurring via 
oxidation first and C-H activation occurring second, not vice versa or a mixture of 
both pathways. 
Three test substrates were devised (Figure 1). The methyl ether of 1-phenylethanol 
(5.4) and a similar tertiary alcohol (5.5) would offer the same oxidation level as the 
alcohol, whilst not being open to oxidation. The final example, α-trifluoromethyl 
alcohol (5.6), makes the oxidation thermodynamically unfavourable. Each substrate 
was submitted to the C-H activation reaction for 24 hours using 5 equivalents of 
alkene. In each case, no C-H activation was observed. This supports our reaction 
pathway of alcohol oxidation and then C-H activation of the acetophenone. 
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Figure 1 - Test Substrates 
We were very pleased with the results obtained, as we had demonstrated not only that 
a tandem oxidation/C-H activation process was possible and successful, but 
furthermore, a third step could be added to the reaction sequence, providing three 
consecutive ruthenium-catalysed transformations in one pot. Whilst this is well 
known with other metals such as palladium,
34-36
 to the best of our knowledge this is 
the only ruthenium-catalysed example. In comparison, our example involves 
hydrogen transfer (oxidation), C-H activation and then transfer hydrogenation 
(reduction) requiring the catalyst to act in three different modes, rather than one mode 
for the same transformation three times. 
 
5.3 Reaction Scope 
 
Scheme 4 - Sequential Oxidation/Alkylation/Reduction Conditions 
Having established an effective protocol for tandem oxidation/C-H activation 
followed by carbonyl reduction, a range of secondary benzylic alcohols was screened 
(Tables 2, 3 & 4). 
By tuning the number of equivalents of alkene and the reaction time it was possible to 
obtain a good ratio of mono-alkylated ketone with 1-phenethyl alcohol (5.7) and other 
para substituted alcohols. Furthermore, on addition of formic acid, only the mono-
alkylated product was reduced to the alcohol, allowing easy separation and 
purification of the alcohols by silica column chromatography. 
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Entry
a 
Alcohol
b 
Time (h)
c 
Equivalents 
of Alkene 
Isolated 
Yield (%) 
Product 
1 
 
3 2.7 76 5.10 
2 
 
3 2.1 56 5.11 
3 
 
3.5 2.7 62 5.12 
a Conditions: Alcohol (1 mmol), 3,3-dimethylbut-1-ene, Ru(PPh3)3(CO)(H)2 (5 mol%), toluene (1 mL), 
135 °C, then formic acid (0.19 mL, 5 mmol), 135 °C, 3 h; b Arrow indicates position of substitution; c 
Time indicates the time for tandem oxidation/C-H activation. 
Table 2 - Alkylated Alcohol Results 
The results from Table 2 show that the reaction of 1-phenylethanol (5.7) gave good 
selectivity to the mono-alkylated product (Entry 1, Table 2). Despite the low 
equivalents of alkene, a large amount of disubstituted product was obtained when 1-
p-tolylethanol was used as a substrate and thus resulted in a lower isolated yield. In 
comparison, no mono-substituted product could be isolated from the reaction of the 
para methoxy equivalent (Entry 7, Table 5), suggesting that the rate of the second 
alkylation is significantly faster than that of the first. The use of 1-o-tolylethanol 
(5.13) (Entry 1, Table 3) led to complete conversion of the alcohol; however, the 
reduction of the alkylated ketone to the product (5.17) was low yielding. This is 
probably due to the steric crowding around the carbonyl. 
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Entry
a 
Alcohol
b 
Time (h)
c 
Equivalents 
of Alkene 
Isolated 
Yield (%) 
Product 
1 
 
3 2.3 41 5.17 
2 
 
3 2.3 72 5.3 
3 
 
3 2.3 87 5.18 
4 
 
3 2.3 62 5.19 
5 
 
4 2.3 
70
d 
(79:21) 
5.20 
a Conditions: Alcohol (1 mmol), 3,3-dimethylbut-1-ene, Ru(PPh3)3(CO)(H)2 (5 mol%), toluene (1 mL), 
135 °C, then formic acid (0.19 mL, 5 mmol), 135 °C, 3 h; b Arrow indicates position of substitution; c 
Time indicates the time for tandem oxidation/C-H activation; d Mixture of regioisomers, major isomer 
shown. 
Table 3 - Meta-Substituted Alkylated Alcohol Results 
The use of meta substituted alcohols led to similar substitution patterns to those 
obtained by Murai with the alkylation of ketone.
4,10
 Both meta methyl (5.1) and meta 
trifluoromethyl (5.14) led to alkylation para to the substituent (Entries 2 & 3, Table 
3). This suggests that the insertion of the ruthenium into the C-H bond is dictated by 
steric effects, however, when the meta fluoro alcohol (5.15) was used, the alkylation 
still occurred para to the substituent. In this case the difference in size of the fluorine 
and hydrogen atoms is negligible; indicating that the electronic nature of the aromatic 
ring also has a substantial effect. 
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Entry
a 
Alcohol
b 
Time (h)
c 
Equivalents 
of Alkene 
Isolated 
Yield (%) 
Product 
1 
 
4 2.3 53 5.25 
2 
 
3 2.3 89 5.26 
3 
 
4 3 55 5.27 
4 
 
24 3 55 5.28 
a Conditions: Alcohol (1 mmol), 3,3-dimethylbut-1-ene, Ru(PPh3)3(CO)(H)2 (5 mol%), toluene (1 mL), 
135 °C, then formic acid (0.19 mL, 5 mmol.), 135 °C, 3 h; b Arrow indicates position of substitution; c 
Time indicates the time for tandem oxidation/C-H activation. 
Table 4 - Other Alkylated Alcohols 
The importance of electronic effects on the aryl ring was re-enforced by the result 
obtained with the meta methoxy alcohol (5.16) (Entry 5, Table 3) which gave a 
mixture of regioisomers (79:21). The major isomer had been alkylated at the most 
sterically hindered position, whilst the minor isomer was alkylated para to the 
methoxy group. This mixture confirms that both steric and electronic factors play an 
important role in determining which ortho C-H bond the ruthenium inserts 
into.
4,10,14,37 
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Entry
a 
Product Time (h)
b 
Equivalents of Alkene Isolated Yield (%) 
1 
 
5 5 98 
2 
 
3 2.3 97 
3 
 
3 2.3 96 
4 
 
6 2.3 81 
5 
 
8 2.3 99 
6 
 
24 3 76 
7 
 
4 4 85 
a Conditions: Alcohol (1 mmol), 3,3-dimethylbut-1-ene, Ru(PPh3)3(CO)(H)2 (5 mol%), toluene (1 mL), 135 °C; 
b Time 
indicates the time for tandem oxidation/C-H activation. 
Table 5 - Tandem Oxidation/C-H Activation Products 
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Entry
a,b 
Product Time (h)
c 
Equivalents 
of Alkene
 
Isolated 
Yield (%) 
1 
 
3 2.3 72 
2 
 
24 2.5 12
d 
3 
 
24 4.5 67 
4 
 
5 3 
59
e 
(79:21) 
5 
 
24 4.5 68 
6 
 
3 2.3 84 
a Conditions: 1-m-Tolylethanol (1 mmol), alkene, Ru(PPh3)3(CO)(H)2 (5 mol%), toluene (1 mL), 135 °C, 
then formic acid (0.19 mL, 5 mmol), 135 °C, 3 h; b Conditions: 1-m-Tolylethanol (1 mmol), alkene, 
Ru(PPh3)3(CO)(H)2 (5 mol%), toluene (1 mL), 135 °C; 
c Time indicates time for tandem oxidation/C-H 
activation only; d Conversion determined by 1H NMR; e The product was isolated as a mixture of mono- 
and di-alkylated product, the ratio is given in parentheses. 
Table 6 - Alkene Scope 
The alkylation of other alcohols using the optimised protocol was also successful 
(Table 4). Piperonyl alcohol (5.21) (Entry 1, Table 4) showed similar regioselectivity 
to that observed with the meta methoxy substrate (Entry 5, Table 3). Naphthalene 
derivatives also worked well (5.22) (Entry 2, Table 4), again alkylation occurred at 
the most hindered, but electronically activated position. It was also possible to use 
Chapter 5 
89 
 
heterocyclic alcohols (Entries 3 & 4, Table 4), although with slightly lower isolated 
yields. 
Alkylated ketones from the tandem oxidation/alkylation could also be isolated (Table 
5). Entries 1-3, Table 5 were isolated in good yield to illustrate that ketones could be 
isolated as ketones from the reaction mixture as well as alcohols. The use of both 
1,2,3,4-tetrahydronaphthalen-1-ol and 1-(naphthalen-1-yl)ethanol gave good 
conversion through to the alkylated ketones (Entry 4 & 5, Table 5), but the reduction 
steps were poor. Interestingly, the use of a similar alcohol, 2,3-dihydro-1H-inden-1-ol 
resulted only in oxidation and no C-H activation. Murai also observed that no C-H 
activation occurred with this ketone, and proposed that the carbonyl was too far away 
from the ortho-aromatic protons to direct the insertion.
5
 The thienyl alcohol (Entry 6, 
Table 5) could be isolated as either the alcohol (Entry 4, Table 4) or the ketone, the 
latter in better yields. Finally, the 1-(4-methoxyphenyl)ethanol was isolated as the di-
alkylated product (Entry 7, Table 5), as the mono-alkylated product was only 
observed as the minor product by 
1
H NMR analysis. 
A screen of alkenes was undertaken, with 1-hexene (Entry 2, Table 6) giving a 
similarly poor result to the one obtained by Murai.
10
 The alkylation with styrene 
(Entry 3, Table 6) required a longer reaction time to drive the reaction to completion. 
The use of a silylated alkene (Entries 4 & 5, Table 6) gave good results when an allyl 
group was used; however, when the vinyl silane was used, a mixture of mono- and di-
alkylated product was isolated. This was attributed to the longer C-Si bond resulting 
in the steric bulk of the trimethylsilyl group being far enough away to allow di-
substitution with the vinyl silane. It was also possible to use norbornene (Entry 6, 
Table 6) with the alkylation product being isolated as a mixture of diastereomers, in 
good yield. 
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5.4 CHAPTER SUMMARY 
 
• A tandem oxidation/C-H activation of alcohols was developed. 
 
• It was then possible to add a further reduction step, generating a one-pot, 
three step process to go from alcohol to alkylated alcohol. 
 
• Various substituted alcohols, including heterocyclic examples, were isolated. 
 
• Substrates that were difficult to reduce could be isolated as the alkylated 
ketones in good yields. 
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6 RESULTS AND DISCUSSION V 
6.1 Background 
The previous chapter demonstrated how hydrogen transfer methodology could be 
used to modify alcohols at positions remote to the hydroxy group by utilising C-H 
activation. Having succeeded in activating the ortho position of benzylic alcohols,
1
 
the potential to apply the idea of remote electronic activation to other functionalities 
was followed. Previous work from the Williams group has demonstrated that allylic 
alcohols can be activated towards nucleophilic additions of malonates
2
 and stabilised 
nucleophiles
2-3 
via a borrowing hydrogen approach (Scheme 1). 
 
Scheme 1 - Remote Electronic Activation of Allylic Alcohols 
 
Scheme 2 - Nucleophilic Substitution of Fluoroacetophenone 
The nucleophilic aromatic substitution of activated fluorides in acetophenones is well 
reported (Scheme 2).
4-6 
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Scheme 3 - Proposed Application of the Borrowing Hydrogen Methodology to 
Activate Fluorine to Nucleophilic Aromatic Substitution 
Modifying this reaction so that alcohols could be used (Scheme 3), via a borrowing 
hydrogen mechanism, would provide a new approach to borrowing hydrogen. This 
would demonstrate that borrowing hydrogen reactions can be performed that do not 
occur at the carbonyl centre, whilst adding a further example to the area of remote 
electronic activation. 
 
6.2 Initial Studies 
Initial work focused on applying a borrowing hydrogen methodology to the 
substitution of 4-fluoro-substituted secondary alcohols (Scheme 3). In order for this 
process to be viable, the conversion of the alcohol (6.1) into the product alcohol (6.4) 
must not happen without the need for the catalysis. Accordingly, this reaction was the 
first tested (Scheme 4). As expected, this reaction did not proceed and no product or 
other by-products were observed in the analysis of the 
1
H NMR, only return of the 
starting materials. 
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Scheme 4 - Test for Aromatic Substitution 
Having established that the alcohol would not undergo the reaction, the 4-fluoro 
ketone (6.2) was also tested under the same reaction conditions, to ensure the desired 
reaction would proceed as reported in the literature. As expected the reaction went to 
100% conversion by analysis of the 
1
H NMR (Scheme 4). Interestingly, attempts to 
use 4-bromo or 4-chloro acetophenone under these conditions were unsuccessful. 
A review of the literature revealed that DMF and DMSO were the two solvents of 
choice for the substitution reaction, a screen of other solvents confirmed that indeed 
the reaction did not occur or did so with a lower conversion. Contrary to literature 
reports, a better conversion was observed in DMSO compared with DMF, and so 
DMSO was chosen as the reaction solvent. A variety of bases have been reported in 
the literature for the substitution reaction and a screen of inorganic and organic bases 
was conducted to determine which would be most suitable (Table 1). 
Analysis of the results showed that several of the bases led to by-product formation, 
clearly visible by a new set of doublets in the aromatic region of the 
1
H NMR spectra, 
which were not associated with the desired product. These bases were therefore 
discounted and further work concentrated on the bases that gave the highest 
conversion without by-product formation. The best result was obtained with 
triethylamine (Entry 11, Table 1) which gave 34% conversion after 3 hours. A linear 
extrapolation of this result, would give full conversion after 9 hours, however in 
practice the reaction had only reached 71% conversion after 12 hours (Table 1, Entry 
12), suggesting a tail off in the rate of reaction. 
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Entry
a 
Base Conversion (%)
b 
1 No Base
c 
33 
2 NaOH N. D.
d 
3 KOH N. D.
d 
4 NaHCO3 0 
5 KHCO3 0 
6 Na2CO3 21 
7 K2CO3 22 
8 Cs2CO3 N. D.
d 
9 KOt-Bu N. D.
d 
10 K3PO4 23 
11 Et3N 34 
12 Et3N
e 
71 
aConditions: 4-Fluoroacetophenone (1 mmol), morpholine 
(1.1 mmol), base (1.2 mmol), DMSO (1 mL), 115 °C, 3 h; 
bConversion determined by 1H NMR; c2.2 mmol of 
morpholine used in this case; dBy-products were visible by 
1H NMR so the conversion was not determined; e12 h. 
Table 1 - Base Screen 
Entry
a 
Base 
Equivalents 
of Base
b 
Conversion (%)
c 
1 Et3N 1.2 77 
2 DABCO 1.2 65 
3 Hünig’s Base 1.2 66 
4 Tripropylamine 1.2 63 
5 N-Ethyl morpholine 1.2 57 
6 K2CO3 1.2 38 
7 Et3N 1.5 80 
8 Et3N 2.0 65 
9 No Base
d 
- 100 
aConditions: 4-Fluoroacetophenone (1 mmol), morpholine (1.1 mmol), base, 
DMSO (1 mL), 115 °C, 24 h; bRelative to the amount of ketone; cConversion 
determined by 1H NMR; d2.2 mmol of morpholine used. 
Table 2 - Further Base Screen 
From all the results, triethylamine had consistently been the superior base; however, 
the reaction had not gone to completion which is necessary to obtain a good yield of 
the final amino alcohol. The number of equivalents of base was examined, to see if 
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the reaction could be driven to completion. Initial results looked good, with an 
increase to 1.5 equivalents of triethylamine giving a conversion of 80% after 24 hours 
(Table 2, Entry 7), however, a further increase to 2 equivalents led to a drop in 
conversion to 65% (Table 2, Entry 8). A return to the use of an excess of morpholine 
(Table 2, Entry 9) gave full conversion after 24 hours (Table 2, Entry 9). While this 
provides a solution, driving the substitution to 100% conversion, it is not ideal as an 
excess of amine is required. It is also not possible to use a sacrificial primary or 
secondary amine as this would lead to competitive substitution, leading to a mixture 
of products. 
 
Scheme 5 - Hydrogen Transfer Test in DMSO 
Having established that an excess of secondary amine gave the best results rather than 
the addition of a base it was necessary to focus on the catalyst options. A range of 
catalysts was screened in a simple irreversible hydrogen transfer reaction (Scheme 5) 
previously reported by the Williams group
7
 to determine which catalysts were active 
in DMSO (Table 3). 
The results showed that only half the catalysts screened were active for hydrogen 
transfer in DMSO. While some catalyst deactivation was expected, the large number 
of catalysts that showed no activity was surprising. However, three commerically 
available catalysts did show activity (Table 3, Entries 4-6). Of these, 
Ru(PPh3)3(CO)(H)2 (Table 3, Entry 5) was the most active, whilst the hydrochloride 
variant Ru(PPh3)3(CO)(H)(Cl) (Table 3, Entry 6) showed significantly less activity. 
Accordingly the dihydride catalyst was chosen for further work. 
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Entry
a 
Catalyst Conversion (%)
b 
1 [Ru(p-cymene)Cl2]2 0 
2 RuCl2(PPh3)3 0 
3 Ru3(CO)12
c 
0 
4 Shvo’s Catalyst 23 
5 Ru(PPh3)3(CO)(H)2 93 
6 Ru(PPh3)3(CO)(H)(Cl) 28 
aConditions: Acetophenone (1 mmol), 1,4-Butanediol (1.5 mmol), 
[Ru] (5 mol%), DMSO (1 mL), 115 °C, 24 h; bDetermined by 1H 
NMR; c2 mol% catalyst used, meaning 6 mol% [Ru]. 
Table 3 - Catalyst Screen 
 
Scheme 6 - Amine Formation Using Borrowing Hydrogen 
In a borrowing hydrogen reaction, one or two of the reaction steps can be reversible 
or at equilibrium, provided one is irreversible to drive the reaction to completion. For 
example, in amine formation (Scheme 6), the oxidation of the alcohol (6.7) to the 
aldehyde (6.8) is reversible, as is the formation of the imine (6.9) from the aldehyde 
(6.8). However, due to the conditions used, the reduction of the imine (6.9) to the 
secondary amine (6.10) is not reversible which drives the formation of the amine to 
completion. 
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Scheme 7 - Proposed Application of the Borrowing Hydrogen Methodology to 
Activate Fluorine to Nucleophilic Aromatic Substitution 
In order for the proposed reaction to proceed (Scheme 7), there must be a transfer of 
hydrogen atoms between the starting alcohol (6.1) and the product ketone (6.3). 
Without this, the reaction may stall as the active sites on the catalyst would be 
blocked by the hydrogen atoms removed in the initial oxidation, or give an undesired 
result by eliminating molecular hydrogen
8-11
 resulting in formation of the aminated 
ketone (6.3) only and not the desired amino alcohol (6.4). 
With this in mind, it was decided to test this key crossover reaction to ensure that the 
reaction would indeed proceed as desired (Scheme 8). Analysis of the reaction by 
1
H 
NMR showed no indication of either 6.2 or 6.4 meaning that the crossover reaction 
necessary for the borrowing hydrogen strategy to work was not occurring. 
Nevertheless, a test of the actual reaction was run (Scheme 9). 
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Scheme 8 - Crossover Reaction 
Scheme 9 - Full Test of Borrowing Hydrogen Reaction 
Analysis of the reaction mixture by 
1
H NMR showed that the reaction had indeed 
proceeded to yield some of the desired product (6.4), although only in small amounts 
(3% conversion). An overall assessment of the reaction demonstrated that while the 
desired pathway was operating, the majority of the reaction mixture was still starting 
material (6.1). This agrees with the result obtained in the crossover reaction (Scheme 
8) and strongly suggests that the equilibrium lies in a disfavoured position. 
At this point, it was decided to approach the problem in a similar manner to that 
described in chapter 6; have a tandem oxidation and substitution and then add a 
reducing agent. As the reduction of the aminoketone (6.3) was known to be difficult, 
this was screened first (Scheme 10, Table 4). 
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Scheme 10 - Reduction Screen of Aminoketone 6.3 
Entry
a 
Reducing Agent Conversion (%)
b 
1 Formic Acid 45 
2 1,4-Butanediol 63 
3 Isopropanol 25
c 
4 6.1 0 
aConditions: 6.3 (1 mmol), reducing agent (1.5 mmol), 
Ru(PPh3)3(CO)(H)2 (5 mol%), DMSO (1 mL), 115 °C, 24 h; 
bConversion determined by 1H NMR; c 13 mmol of 
isopropanol (1 mL) were used. 
Table 4 - Reduction Screen 
A short screen of reducing agents quickly demonstrated that 1,4-butanediol was a 
good source of hydrogen to reduce the aminoketone (Entry 2, Table 4). When 
compared to isopropanol (Entry 3, Table 4), it can be seen why the 1,4-butanediol is a 
useful source of hydrogen as the lactone generated when 1,4-butanediol is oxidised 
makes the reaction irreversible (Scheme 11).
7
 It should also be noted that again 6.1 
(Entry 4, Table 4) was unsuccessful as a reducing agent for the aminoketone (6.3). 
 
Scheme 11 - Irreversible Hydrogen Generation from 1,4-Butanediol 
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Having established that the reduction could be achieved, and with further 
modifications to improve the yield, attention was turned to the tandem 
oxidation/substitution reaction (Scheme 12). 
 
Scheme 12 - Tandem Oxidation/Substitution Process 
Based on the results obtained earlier, it was then necessary to screen a series of 
oxidants for the reaction. Alkenes were chosen over the use of other organic 
hydrogen acceptors such as ketones
12-15
 or crotononitrile
16-18
 due to their relatively 
inert nature with respect to the other reaction components. The secondary amine 
could react with a ketone to form an enamine or iminium species, while amines have 
been shown to react with crotononitrile itself irreversibly. A screen of the readily 
available alkenes was conducted and the results are shown below (Table 5). 
Entry
a 
Oxidant Conversion (%)
b 
1 
 
24 
2 
 
6 
3  22 
4  34 
5 
 
28 
aConditions: 1-(4-Fluorophenyl)ethanol (1 mmol), morpholine 
(2.2 mmol), oxidant (1.5 mmol), Ru(PPh3)3(CO)(H)2 (5 mol%), 
DMSO (1 mL), 115 °C, 24 h; bDetermined by analysis of the 1H 
NMR spectra. 
Table 5 - Oxidant Screen 
Terminal alkenes tend to give better results; the only example of a non-terminal 
alkene was cyclohexene (Table 5, Entry 2) which only resulted in 6% conversion. 
The two best alkenes were 3,3-dimethyl-1-butene (Entry 5, Table 5) and 1-octene 
(Entry 4, Table 5). Of these, 1-octene was chosen due to its higher boiling point, 
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despite the slightly lower atom economy. A series of ligands was then studied to see 
if the extent of the oxidation could be improved (Table 6). 
Entry
a 
Ligand Conversion (%)
b
 
1 dppm 48 
2 dppe 47 
3 dppp 34 
4 dppb 24 
5 dpppent 15 
6 Triphos 10 
7 Xantphos 41 
8 DPEphos 17 
9 (+/-)-BINAP 33 
10 dppbe 41 
11 1,2-Bis(dicyclohexylphosphino)ethane 60 
12 cis-1,2-Bis(diphenylphosphino)ethylene 30 
aConditions: 1-(4-Fluorophenyl)ethanol (1 mmol), 1-octene (1.5 mmol), 
Ru(PPh3)3(CO)(H)2 (5 mol%), ligand (5 mol%), DMSO (1 mL), 115 °C, 24 h; 
bDetermined by analysis of the 1H NMR spectra. 
Table 6 - Ligand Screen 
Analysis of the ligand screen revealed 4 ligands with similar activity; dppm, dppe, 
Xantphos and dppbe all giving 40-50% conversion (Entries 1, 2, 7 & 10, Table 6). 
However, the best ligand was 1,2-bis(dicyclohexylphosphino)ethane (Entry 11, Table 
6). Due to the increased conversion afforded by this ligand (~10-15% better than any 
other ligand) it was taken forward for further optimisation. 
In order to increase the conversion, an increase in reaction temperature was 
necessary. However, on increasing the reaction temperature the reaction conversion 
decreased, indicating that 115 °C was optimal, although this only resulted in a 60% 
conversion after 24 hours. We did not want to increase the reaction time to 48 hours 
and so, work on the tandem oxidation/substitution followed by reduction was halted. 
The idea of combining the aromatic nucleophilic substitution with another step was 
very appealing, and with the amount of work already done on the application, it was 
disappointing that the tandem oxidation/substitution could not be implemented. The 
aromatic substitution reaction requires an aromatic ketone as the substrate, we chose 
to generate this via an oxidation of the alcohol, however, a redox neutral approach 
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would work with a vinylic alcohol (6.11) that could be isomerised into the ketone 
(6.12) (Scheme 13). 
Scheme 13 - Redox Neutral Isomerisation 
Transition metal catalysed isomerisations of allylic alcohols to carbonyl compounds 
have well reported.
19-20
 The use of ruthenium to isomerise vinylic alcohols to ketones 
is also well reported
21
 and applications of this chemistry in tandem processes have 
also been reported.
22-25
 So this appeared to be an approach worth evaluating. 
Based on the work described above, DMSO was still the solvent of choice and 
similarly Ru(PPh)3(CO)(H)2 was chosen as catalyst. With the catalyst and solvent 
established a ligand screen was run to determine which ligands might be suitable 
(Scheme 14 & Table 7). 
Analysis of the ligand screen showed that most of the ligands used gave little 
improvement in conversion over the use of no ligand at all (Entry 1, Table 7). The 
two ligands that stood out were DPEphos (Entry 9, Table 7) and 1,4-
bis(dicyclohexylphosphino)butane (Entry 13, Table 7). A cost analysis of these two 
ligands shows that DPEphos is the cheaper at £2.10 per mmol while 1,4-
bis(dicyclohexylphosphino)butane is at least 10 times more expensive at £29.10 per 
mmol. We therefore chose to carry out further optimisation of the reaction with 
DPEphos as the ligand of choice. Extension of the reaction time from 90 minutes to 3 
hours (Entry 15, Table 7) resulted in 71% conversion, suggesting either an activation 
period or tailing off of reactivity. However, a further increase in reaction time to 5 
hours led to 81% conversion by 
1
H NMR analysis (Entry 16, Table 7). 
A test of the tandem isomerisation and addition did not give the same conversion 
after 5 hours, suggesting that the effectiveness of the catalyst was reduced by the 
addition of the amine. However, when left for 24 hours the reaction proceeded to 
complete conversion. It was also possible to reduce the catalyst loading to 4 mol% 
without further reducing the conversion with a reaction time of 24 hours. 
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Scheme 14 - Isomerisation Ligand Screen 
Entry
a 
Ligand Conversion (%)
b 
1 No Ligand 13 
2 dppm 16 
3 dppe 19 
4 dppp 35 
5 dppb 20 
6 dpppent 13 
7 Triphos 15 
8 Xantphos 27 
9 DPEphos 50 
10 (+/-)-BINAP 12 
11 dppbe 16 
12 1,2-Bis(dicyclohexylphosphino)ethane 27 
13 1,4-Bis(dicyclohexylphosphino)butane 58 
14 cis-1,2-Bis(diphenylphosphino)ethylene 17 
15 DPEphos 71
c 
16 DPEphos 81
d 
aConditions: 1-(4-Fluorophenyl)prop-2-en-1-ol (1 mmol), Ru(PPh3)3(CO)(H)2 (5 mol%), 
ligand (5 mol%), DMSO (1 mL), 115 °C, 90 min; bConversion determined by 1H NMR; 
cReaction run for 3 h; dReaction run for 5 h. 
Table 7 - Isomerisation Ligand Screen 
To this point, only morpholine had been used as a nucleophile, but to demonstrate the 
generality of the process, it was important to determine which other amines and 
nitrogen containing nucleophiles could be used (Scheme 15 & Table 8). As our model 
substrate (1-(4-fluorophenyl)prop-1-en-2-ol) was not commercially available, we 
chose to test the nucleophiles on 4-fluoroacetophenone (6.2) initially. Malonates, 
sulfonamides and amides were all found not to react. 
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Scheme 15 - Nucleophile Screen 
Entry
a 
Nucleophile Conversion (%)
b 
1 
 
23 
2 
 
0 
3 
 
0 
4 
 
0 
5 
 
18
c 
6 
 
0
d 
7 
 
100 
a Conditions: 4-Fluoroacetophenone (1 mmol), amine (2.2 
mmol), DMSO (1 mL), 115 °C, 24 h; b Conversion 
determined by 1H NMR; c1.1 mmol of pyrrole and 1.1 mmol 
of K2CO3 used instead of 2.2 mmol amine; 
d Conditions as 
per entry 5 but using DMF as the reaction solvent. 
Table 8 - Nucleophile Screen 
The results of the nucleophile screen were disappointing. The use of other acyclic 
secondary amines such as dipropylamine (6.13) (Entry 1, Table 8) and 
diisopropylamine (6.14) (Entry 2, Table 8) gave low or no conversion returning only 
starting materials. The use of primary amines such as tert-octylamine (6.15) (Entry 3, 
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Table 8) or aniline (6.16) (Entry 4, Table 8) gave no conversion either. Despite a 
report in the literature using pyrrole
26
 (6.17), this also gave no conversion (Entry 5, 
Table 8) even under the reported conditions using DMF as a solvent (Entry 6, Table 
8). 
 
6.3 Reaction Scope 
Having established that only secondary cyclic amines worked particularly well in the 
reaction, a screen of other substrates of this type was run (Table 9). Analysis of all the 
results showed the reaction to be working well with < 70% isolated yield in every 
case. 5, 6 and 7 membered rings were all tolerated well (Entries 1-3, Table 9) and the 
inclusion of heteroatoms in the 4-position on six membered rings also caused no 
difficulties (Entries 4 & 5, Table 9). 
The effect of substitution on the double bond was then examined (Table 10). 
Inclusion of a methyl group on the most substituted carbon (6.28) led to a lower 
isolated yield (Entry 2, Table 10). A similar result was obtained when the substrate 
possessed two methyl groups on the least substituted carbon (6.29) (Entry 3, Table 
10). Furthermore, inclusion of a methyl group in the most substituted and least 
substituted position (6.30) (Entry 4, Table 10) gave no product at all and instead led 
to isomerisation to give the cis-isomer. Although in all cases a higher catalyst loading 
(5 mol%) and longer reaction time (48 hours) was required to drive the reaction 
further. This indicates that steric bulk around the double bond has a large influence on 
the rate of reaction. The inclusion of a phenyl group (6.31) (Entry 5, Table 10) also 
has a dramatic effect on the course of the reaction (37% isolated yield), indicating 
that electronic as well as steric effects dictate the rate of isomerisation. Finally, the 
use of an allyl alcohol (6.32) (Entry 5, Table 10) returned a good yield demonstrating 
that the reaction is not only limited to vinyl alcohols, but other longer chain alcohols 
can also be transformed under the same conditions. 
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Scheme 16 - Optimised Reaction Conditions 
Entry
a 
Amine Isolated Yield (%) Product 
1 
 
77 
 
2 
 
87 
 
3 
 
81 
 
4 
 
86 
 
5 
 
71 
 
aConditions: 1-(4-Fluorophenyl)prop-2-en-1-ol (3 mmol), amine (2.2 mmol), 
Ru(PPh3)3(CO)(H)2 (4 mol%), DPEphos (4 mol%), DMSO (3 mL), 115 °C, 24 h. 
Table 9 - Cyclic Amine Screen 
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Entry
a 
Alcohol 
Isolated Yield 
(%) 
Product 
1 
 
86 
 
2 
 
52
b,c 
 
3 
 
57
b,c 
 
4 
 
0
b,c 
 
5 
 
37
b,c 
 
6 
 
85 
 
aConditions: Alcohol (3 mmol), morpholine (2.2 mmol), Ru(PPh3)3(CO)(H)2 (4 mol%), DPEphos (5 
mol%), DMSO (3 mL), 115 °C, 24 h; b5 mol% catalyst; c48 h. 
Table 10 - Double Bond Substitution 
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Entry
a 
Alcohol Isolated Yield (%) Product 
1 
 
51 
 
2 
 
6
d
 (74)
e 
 
3 
 
58 
 
4 
 
67 
 
5 
 
61 
 
6 
 
35
b,c 
 
aConditions: Alcohol (3 mmol), morpholine (2.2 mmol), Ru(PPh3)3(CO)(H)2 (4 mol%), DPEphos 
(4 mol%), DMSO (3 mL), 115 °C, 24 h; b5 mol% catalyst; c48 h; dConversion determined by 1H 
NMR; eIsolated yield of ketone. 
Table 11 - Ring Substitution 
Substitution around the aromatic ring was examined, as this would be likely to affect 
the rate of aromatic substitution. The inclusion of a methyl group meta to the fluorine 
(6.38) (Entry 1, Table 11) did reduce the yield to 51%, however, inclusion of the 
methyl ortho to the fluorine (6.39) (Entry 2, Table 11) had a more dramatic effect 
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resulting in only 6% substitution. This could be the result of either steric or electronic 
effects, in this case it would seem reasonable that this is mainly due to the electron 
donating nature of the methyl group since substitution with both ortho chloro (6.40) 
(Entry 3, Table 11) and ortho trifluoromethyl (6.42) (Entry 5, Table 11) result in 58% 
and 61% yields. If this were due to steric effects, then the results of these other two 
reactions would also be expected to be lower, but not in this case. It was also possible 
to see selective substitution of the fluorine para to the ketone, as expected, when the 
3,4-difluoro alcohol was used (6.41) (Entry 4, Table 11). The reaction also tolerated 
fluorine ortho to the ketone (6.43) (Entry 6, Table 11) although yields were lower. 
It is worth noting that at no point during any of this work was a product from C-N 
bond formation observed via the borrowing hydrogen reaction of an amine and 
alcohol. 
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6.4 CHAPTER SUMMARY 
 
• A borrowing hydrogen approach to aromatic substitution of ketones was 
explored. 
 
• A tandem oxidation/substitution approach to aromatic substitution of ketones 
was also explored. 
 
• A tandem isomerisation/substitution was explored and proved to be 
successful and was optimised. 
 
• A wide range of substrates was evaluated illustrating the scope of the 
reaction, including substitution on the alkene, aromatic ring and choice of 
nucleophiles available.  
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7 EXPERIMENTAL DATA 
7.1 General Experimental Methods 
Reactions which required the use of anhydrous, inert atmosphere techniques were 
carried out under an atmosphere of nitrogen. In all cases, solvents were distilled or 
obtained by passing through anhydrous alumina columns using an Innovative 
Technology Inc. PS-400-7 solvent purification system or by distillation. Where 
stated, apparatus was oven dried and purged with nitrogen. Tetrahydrofuran, toluene 
and tert-butanol were dispensed using inert atmosphere techniques. 
TLC using polythene or aluminium backed plates pre-coated with Macherey-Nagel 
Sil G/UV254 nm neutral silica were used to monitor reactions where appropriate. 
Visualisation of these plates was by 254 nm UV light and/or KMnO4, ninhydrin or 
PMA dips followed by gentle warming. TLC data quoted for specific compounds 
indicate the most suitable method of visualisation. Organic layers were routinely 
dried with anhydrous MgSO4 or Na2SO4 and concentrated in vacuo using a Büchi 
rotary evaporator. Where necessary, further drying was facilitated by high vacuum. 
Flash column chromatography was carried out using Davisil LC 60 Å silica gel (35-
70 micron) purchased from Fisher or Sigma-Aldrich. 
NMR spectra were run in CDCl3 or d6-DMSO on either a Bruker Avance 250 (250 
MHz), Bruker Avance 300 (300 MHz) or Bruker Avance 400 (400 MHz) instrument 
and recorded at the following frequencies: proton (
1
H - 250/300/400 MHz), carbon 
(
13
C – 75.5 MHz), fluorine (19F - 376.5 MHz), phosphorus (31P - 121.5 MHz). 
Chemical shifts are reported relative to the residual solvent peak where possible or 
alternatively to SiMe4 (δ = 0.00 ppm) as the internal standard. Coupling constants (J) 
are given in Hz and multiplicities denoted as singlet (s), doublet (d), triplet (t), quartet 
(q), pentet (pent), septet (sep), unresolved multiplet (m), broad (br.) or apparent 
(app.). All structural assignments were achieved with comparisons from analogous 
literature compounds where possible. Protons that possess chemical but not magnetic 
equivalence (AA’BB’ systems) as in the case of 1,4-disubstituted aromatics are 
reported as multiplets or doublets, depending on their appearance in spectra. 
Melting points were carried out on a Gallenkamp MF-370 hot stage melting point 
apparatus and are uncorrected. 
IR spectra were recorded neat using a Perkin Elmer Spectrum 100 FT-IR 
spectrometer (with internal background scan). Absorption maxima (νmax) are 
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recorded in wavenumbers (cm
-1
). 
Mass spectra, including high resolution spectra, were recorded using electron impact 
(EI
+
) ionisation at the University of Bath using a micrOTOF electrospray time-of-
flight (ESI-TOF) mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany); 
this was coupled to an Agilent 1200 LC system (Agilent Technologies, Waldbronn, 
Germany). The LC system was used as an autosampler only. 10 µL of sample were 
injected into a 30:70 flow of water:acetonitrile at 0.3 mL/min to the mass 
spectrometer. For each acquisition 10 µL of a calibrant of 5mM sodium formate were 
injected after the sample. 
Unless preparative details are provided, all reagents were commercially available and 
purchased from Acros Organics, Sigma-Aldrich, Alfa Aesar, Avocado, Fluka, 
Lancaster, Maybridge or Strem chemical companies. 
 
7.2 Experimental procedures: Chapter 2 
7.2.1  Representative Procedure for the Synthesis of Secondary Amines 
To an oven-dried, nitrogen purged Young’s tube containing [Ru(p-cymene)Cl2]2 
(45.9 mg, 0.075 mmol) and DPEphos (80.8 mg, 0.15 mmol) were added 3-phenyl-1-
propanol (408 µL, 3 mmol), amine (3.15 mmol) and toluene (3 mL). The reaction 
vessel was then sealed and heated to reflux for 24 hours. On completion the reaction 
was allowed to cool to room temperature and the solvent removed in vacuo. 
Conversion was determined by the disappearance of the characteristic CH2OH triplet 
at 3.63 ppm in the 
1
H NMR spectra.  The crude product was then purified by silica 
column chromatography. 
 
7.2.2 Representative Procedure for the Synthesis of Primary Amines 
To an oven-dried, nitrogen purged Young’s tube containing [Ru(p-cymene)Cl2]2 
(45.9 mg, 0.075 mmol) and DPEphos (80.8 mg, 0.15 mmol) were added the alcohol 
(3 mmol), 1-phenethylamine (0.41 mL, 3.15 mmol) and toluene (3 mL). The reaction 
vessel was then sealed and heated to reflux for 24 hours. On completion the reaction 
was allowed to cool to room temperature before Pd/C (10 wt%, 10 mol% in Pd), 
EtOH (11 mL), HCl (6M, 1.1 mL) were added. The atmosphere was then purged with 
H2 before the reaction vessel was sealed. The reaction was then heated to 65 °C for 14 
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hours. On completion the reaction was allowed to cool to room temperature and 
filtered through Whatman filter paper grade GF/C before the solvent was removed in 
vacuo. The solid was then recrystallized by dissolving in a minimum of hot EtOH 
before precipitating with EtOAc. 
 
7.2.3 Ruthenium-Catalysed Synthesis of Secondary Amines 
3-Phenyl-N-(1-phenethyl)propan-1-amine 2.13 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; EtOAc/hexanes, 2:1, Rf = 0.30, det: KMnO4) and 
isolated as a yellow oil (610 mg, 85%). 
1
H NMR (300 MHz, CDCl3, 25 °C): δ = 7.16-
7.36 (10H, m, arom. H), 3.77 (1H, q, J = 6.60 Hz, H4), 2.45-2.72 (4H, m, H3 & H1), 
1.76-1.86 (2H, m, H2), 1.37 (3H, d, J = 6.60 Hz, H5); 
13
C NMR (75.4 MHz, CDCl3, 
25 °C): δ = 145.9 (C6), 142.3 (C10), 128.5 (C12), 128.5 (C8), 128.4 (C11), 126.9 (C9), 
126.7 (C7), 125.8 (C13), 58.4 (C4), 47.5 (C3), 33.8 (C1), 32.0 (C2), 24.5 (C5); 
HRMS(ESI-TOF): calcd. for C17H21NH
+
: 240.1752. Found: 240.1750 (MH
+
). This is 
consistent with literature data.
1 
 
N-Benzhydryl-3-phenylpropan-1-amine 2.14 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 9:1, Rf = 0.29, det: KMnO4) and 
isolated as a yellow oil (714 mg, 79%). IR: νmax/cm
-1
 (neat) 3060, 3024, 2930, 2855, 
1492, 1452, 742, 694; 
1
H NMR (300 MHz, CDCl3, 25 °C): δ = 7.15-7.41 (15H, m, 
arom. H), 4.80 (1H, s, H4), 2.60-2.69 (4H, m, H3 & H1), 1.80-1.89 (2H, m, H2), 1.51 
(1H, br s, NH); 
13
C NMR (75.4 MHz, CDCl3, 25 °C): δ = 144.4 (C5), 142.4 (C9), 
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128.6 (C7), 128.5 (C11), 128.4 (C10), 127.4 (C6), 127.1 (C8), 125.8 (C12), 67.6 (C4), 
47.9 (C3), 33.8 (C1), 32.1 (C2); HRMS(ESI-TOF): calcd. for C22H23NH
+
: 302.1909. 
Found: 302.1897 (MH
+
); CHN: Anal. Calc. for C22H23N: C, 87.66%, H, 7.69%, N, 
4.65%; Found: C, 87.70%, H, 7.63%, N, 4.66%. 
 
3-Phenyl-N-tritylpropan-1-amine 2.15 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; CH2Cl2/hexanes, 1:1, Rf = 0.25, det: KMnO4) and 
isolated as a colourless solid (680 mg, 60%).  M. p. = 88-90 °C; IR: νmax/cm
-1
 (neat) 
3057, 3019, 2938, 2844, 1594, 1488, 1453, 1211, 1184, 1150, 1030; 
1
H NMR (300 
MHz, CDCl3, 25 °C): δ = 7.45-7.49 (6H, m, H11), 7.14-7.30 (14H, m, arom. H), 2.66 
(2H, t, J = 7.95 Hz, H3), 2.21 (2H, t, J = 6.75 Hz, H1), 1.77-1.86 (2H, m, H2), 1.53 
(1H, br s, NH); 
13
C NMR (75.4 MHz, CDCl3, 25 °C): δ = 146.4 (C9), 142.5 (C5), 
128.8 (C11), 128.4 (C6 & C7), 127.9 (C10), 126.3 (C12), 125.8 (C8), 71.0 (C4), 43.4 
(C1), 33.9 (C3), 32.7 (C2); HRMS(ESI-TOF): calcd. for C27H27NH
+
: 378.2216. Found: 
378.2193 (MH
+
), 400.2021 (MNa
+
); CHN: Anal. Calc. for C27H27N: C, 89.08%, H, 
7.21%, N, 3.71%; Found: C, 89.20%, H, 7.25%, N, 3.66%. 
 
N-Benzyl-3-phenylpropan-1-amine 2.16 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; Et2O/petroleum ether b. p. 40-60 °C, 3:2, Rf = 0.22, 
det: KMnO4) and isolated as a brown oil (385 mg, 57%). 
1
H NMR (300 MHz, CDCl3, 
25 °C): δ = 7.23-7.33 (7H, m, arom. H), 7.16-7.20 (3H, m, arom. H), 3.79 (2H, s, H4), 
2.64-2.71 (4H, m, H1 & H3), 1.81-1.91 (2H, m, H2); 
13
C NMR (75.4 MHz, CDCl3, 25 
°C): δ = 142.3 (C5), 140.5 (C9), 128.5 (C7 & C11), 128.4 (C6), 128.3 (C10), 127.0 (C12), 
125.9 (C8), 54.1 (C1), 49.0 (C4), 33.7 (C3), 31.8 (C2); HRMS(ESI-TOF): calcd. for 
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C16H19NH
+
: 226.3362. Found: 226.1712 (MH
+
). This is consistent with literature 
data.
2 
 
N-Benzyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine 2.18 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 9:1, Rf = 0.24, 
det: KMnO4) and isolated as a yellow oil (340 mg, 33%). 
1
H NMR (300 MHz, CDCl3, 
25 °C): δ = 7.15-7.37 (15H, m, arom. H), 3.60 (2H, s, H4), 2.63 (4H, t, J = 7.50 Hz, 
H3), 2.51 (4H, t, J = 7.20 Hz, H1), 1.76-1.86 (4H, m, H2); 
13
C NMR (75.4 MHz, 
CDCl3, 25 °C): δ = 142.7 (C5), 140.1 (C9), 129.0 (C10), 128.5 (C7), 128.4 (C6), 128.3 
(C11), 126.8 (C12), 125.8 (C8), 58.8 (C4), 53.4 (C1), 33.8 (C3), 29.1 (C2); HRMS(ESI-
TOF): calcd. for C25H29NH
+
: 344.2373. Found: 344.2509 (MH
+
). This is consistent 
with literature data.
3 
 
Tris(3-phenylpropyl)amine 2.19 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 2:1, Rf = 0.24, 
det: KMnO4) and isolated as a yellow oil (100 mg, 9%). 
1
H NMR (300 MHz, CDCl3, 
25 °C): δ = 7.19-7.38 (15H, m, arom. H), 2.65 (6H, t, J = 7.50 Hz, H3), 2.52 (6H, t, J 
= 7.2 Hz, H1), 1.74-1.84 (6H, m, H2); 
13
C NMR (75.4 MHz, CDCl3, 25 °C): δ = 142.6 
(C5), 128.5 (C7), 127.1 (C6), 125.8 (C8), 53.7 (C1), 33.9 (C3), 29.0 (C2); HRMS(ESI-
TOF): calcd. for C27H33NH
+
: 372.2686. Found: 372.2802 (MH
+
). This is consistent 
with literature data.
4 
Chapter 7 
121 
 
N-tert-Butyl-3-phenylpropan-1-amine 2.32 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; CH2Cl2/MeOH, 9:1, Rf = 0.15, det: KMnO4) and 
isolated as a brown oil (350 mg, 61%). 
1
H NMR (300 MHz, CDCl3, 25 °C): δ = 7.25-
7.30 (2H, m, arom. H), 7.15-7.22 (3H, m, arom. H), 2.66 (2H, t, J = 7.20 Hz, H3), 
2.60 (2H, t, J = 7.50 Hz, H1), 1.77-1.87 (2H, m, H2), 1.10 (9H, s, H9); 
13
C NMR (75.4 
MHz, CDCl3, 25 °C): δ = 142.2 (C4), 128.5 (C6), 128.4 (C5), 125.9 (C7), 50.7 (C8), 
42.2 (C1), 33.9 (C3), 32.5 (C2), 29. (C9); HRMS(ESI-TOF): calcd. for C13H21NH
+
 : 
192.1752. Found: 192.1717 (MH
+
). This is consistent with literature data.
5 
 
2,4,4-Trimethyl-N-(3-phenylpropyl)pentan-2-amine 2.33 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; Et2O/petroleum ether b. p. 40-60 °C, 2:1, Rf = 0.20, 
det: KMnO4) and isolated as a brown oil (661 mg, 89%). IR: νmax/cm
-1
 (neat) 2951, 
1476, 1454, 1363, 1229, 743, 697; 
1
H NMR (300 MHz, CDCl3, 25 °C): δ = 7.25-7.30 
(2H, m, arom. H), 7.15-7.20 (3H, m, arom. H), 2.66 (2H, t, J = 7.50 Hz, H8), 2.59 
(2H, t, J = 7.20 Hz, H6), 1.73-1.83 (2H, m, H7), 1.43 (2H, s, H2), 1.14 (6H, s, H5), 
1.00 (9H, s, H4); 
13
C NMR (75.4 MHz, CDCl3, 25 °C): δ = 142.5 (C9), 128.5 (C11), 
128.4 (C10), 125.8 (C12), 54.3 (C1), 53.2 (C2), 41.7 (C6), 34.0 (C8), 32.9 (C7), 31.9 
(C4), 31.8 (C3), 29.1 (C5); HRMS(ESI-TOF): calcd. for C17H29NH
+
 : 248.2378. 
Found: 248.2363 (MH
+
); CHN: Anal. Calc. for C17H29N: C, 82.52%, H, 11.81%, N, 
5.66%; Found: C, 82.40%, H, 11.90%, N, 5.61%. 
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4-Methoxy-N-(3-phenylpropyl)aniline 2.34 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 5:1, Rf = 0.17, 
det: KMnO4) and isolated as a yellow oil (432 mg, 60%). 
1
H NMR (300 MHz, CDCl3, 
25 °C): δ = 7.30-7.35 (2H, m, arom. H), 7.20-7.24 (3H, m, arom. H), 6.81 (2H, d, J = 
9.00 Hz, H10), 6.59 (2H, d, J = 9.00 Hz, H9), 3.78 (3H, s, H12), 3.14 (2H, t, J = 6.90 
Hz, H1), 2.77 (2H, t, J = 7.50 Hz, H3), 1.93-2.02 (2H, m, H2); 
13
C NMR (75.4 MHz, 
CDCl3, 25 °C): δ = 152.2 (C11), 142.8 (C4), 141.9 (C8), 128.5 (C5 & C6), 126.0 (C7), 
115.0 (C10), 114.2 (C9), 55.9 (C12), 44.6 (C1), 33.6 (C3), 31.3 (C2); HRMS(ESI-TOF): 
calcd. for C16H19NH
+
: 242.1539. Found: 242.1665 (MH
+
). This is consistent with 
literature data.
1 
 
2-Hydroxyethyl benzoate 2.42 
 
Benzoyl chloride (2.9 mL, 25 mmol) was added to an ice cooled solution of ethylene 
glycol (4.2 mL, 75 mmol) and pyridine (2.25 mL, 28 mmol) in CH2Cl2 (25 mL). The 
reaction was allowed to warm to room temperature before leaving to stir for 26 hours. 
The reaction was then concentrated in vacuo before purifying by silica column 
chromatography (eluent; hexanes/EtOAc, 2:1, Rf = 0.23, det: KMnO4) and isolated as 
a colourless solid (2.70 g, 65%). 
1
H NMR (300 MHz, CDCl3, 25 °C): δ = δ 8.06 (2H, 
dd, J = 8.40, 1.50 Hz, H2), 7.58 (1H, tt, J = 7.35, 1.50 Hz, H4), 7.42-7.48 (2H, m, H3), 
4.47 (2H, t, J = 4.65 Hz, H6), 3.97 (2H, t, J = 4.65 Hz, H7), 2.12 (1H, br s, OH); 
13
C 
NMR (75.4 MHz, CDCl3, 25 °C): δ = 167.9 (C5), 133.3 (C1), 129.9 (C4), 129.8 (C3), 
128.5 (C2), 66.8 (C6), 61.4 (C7); HRMS(ESI-TOF): calcd. for C9H10O3H
+
: 167.0708. 
Found: 167.0707 (MH
+
), 189.0525 (MNa
+
). This is consistent with literature data.
6 
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N-(2-Hydroxyethyl)benzamide 2.43 
 
Benzoyl chloride (2.9 mL, 25 mmol) was added to an ice cooled solution of 
ethanolamine (3.7 mL, 62.5 mmol) in CH2Cl2 (25 mL) dropwise. The reaction was 
then left to stir for 2 hours before H2O (10 mL). The mixture was then acidified with 
HCl (6 M). The organic layer was then separated and washed with HCl (2 M, 2 x 15 
mL). The organic layer was then dried (MgSO4) and concentrated in vacuo. The 
product (1.36 g, 33%) was isolated as a colourless solid. 
1
H NMR: (CDCl3, 300 MHz) 
δ = 7.72 (2H, dd, J = 8.40, 1.50 Hz, H2), 7.33-7.47 (3H, m, H3 & H4), 6.61 (1H, br s, 
NH), 3.77 (2H, app. t, J = 4.95 Hz, H7), 3.54-3.59 (2H, m, H6), 2.67 (1H, br s, OH); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 168.8 (C5), 134.2 (C1), 131.7 (C4), 128.7 (C3), 
127.1 (C2), 62.1 (C7), 42.9 (C6); HRMS(ESI-TOF): calcd. for C9H11NO2H
+
: 166.0868. 
Found: 166.0866 (MH
+
), 188.0678 (MNa
+
). This is consistent with literature data.
7
 
 
3-Phenylpropan-1-amine hydrochloride 2.44 
 
According to representative procedure 7.2.2, the product was isolated as colourless 
crystalline solid (438 mg, 85%). 
1
H NMR (300 MHz, DMSO-d6, 25 °C): δ = 8.11 
(3H, br s, NH3
+
), 7.28-7.37 (2H, m, arom. H6), 7.17-7.23 (3H, m, arom. H), 2.75 (2H, 
t, J = 7.80 Hz, H1), 2.64 (2H, t, J = 7.80 Hz, H3), 1.81-1.91 (2H, m, H2); 
13
C NMR 
(75.4 MHz, DMSO-d6, 25 °C): δ = 140.9 (C4), 128.4 (C6), 128.2 (C5), 125.9 (C7), 
38.2 (C1), 31.8 (C2), 28.6 (C3); HRMS(ESI-TOF): calcd. for C9H13NH
+
: 136.1126. 
Found: 136.1123 (MH
+
). This is consistent with literature data.
8 
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3-Phenylbutan-1-amine hydrochloride 2.45 
 
According to representative procedure 7.2.2, the product was isolated as colourless 
crystalline solid (323 mg, 58%). 
1
H NMR (300 MHz, DMSO-d6, 25 °C): δ = 7.88 
(3H, br s, NH3
+
), 7.18 – 7.35 (5H, m, arom. H), 2.80 (1H, q, J = 6.90 Hz, H3), 2.65 – 
2.74 (1H, m, H2), 2.53 – 2.57 (1H, m, H2), 1.82 (2H, q, J = 7.80 Hz, H1), 1.21 (3H, d, 
J = 6.90 Hz, H4); 
13
C NMR (75.4 MHz, DMSO-d6, 25 °C): δ = 145.8 (C5), 128.5 (C7), 
126.8 (C6), 126.2 (C8), 37.3 (C1), 36.4 (C2), 35.0 (C3), 22.0 (C4); HRMS(ESI-TOF): 
calcd. for C10H15NH
+
: 150.1283. Found: 150.1276 (MH
+
). This is consistent with 
literature data.
9 
 
3,3-Diphenylpropan-1-amine hydrochloride 2.46 
 
According to representative procedure 7.2.2, the product was isolated as colourless 
crystalline solid (557 mg, 75%).  
1
H NMR (300 MHz, DMSO-d6, 25 °C): δ = 8.08 
(3H, br s, NH3
+
), 7.18 – 7.31 (10H, m, arom. H), 4.11 (1H, t, J = 7.80 Hz, H3), 2.63 
(2H, t, J = 7.65 Hz, H1), 2.29 – 2.36 (2H, m, H2); 
13
C NMR (75.4 MHz, DMSO-d6, 25 
°C): δ = 143.9 (C4), 128.5 (C6), 127.4 (C5), 126.3 (C7), 47.2 (C3), 37.5 (C1), 32.3 (C2); 
HRMS(ESI-TOF): calcd. for C15H17NH
+
: 212.1439. Found: 212.1430 (MH
+
). This is 
consistent with literature data.
9 
 
 
 
 
 
Chapter 7 
125 
 
3-(4-Methoxyphenyl)propan-1-amine hydrochloride 2.47 
 
According to representative procedure 7.2.2, the product was isolated as colourless 
crystalline solid (454 mg, 54%). 
1
H NMR (300 MHz, DMSO-d6, 25 °C): δ = 7.81 
(3H, br s, NH3
+
), 7.12 (2H, d, J = 8.55 Hz, H5), 6.86 (2H, d, J = 8.55 Hz, H6), 3.72 
(3H, s, H8), 2.75 (2H, t, J = 7.65 Hz, H1), 2.57 (2H, t, J = 7.65 Hz, H3), 1.80 (2H, m, 
H2); 
13
C NMR (75.4 MHz, DMSO-d6, 25 °C): δ = 157.6 (C7), 132.7 (C4), 129.2 (C5), 
113.8 (C6), 55.0 (C8), 38.2 (C1), 31.0 (C2), 28.9 (C3); HRMS(ESI-TOF): calcd. for 
C10H15NOH
+
: 166.1232. Found: 166.1221 (MH
+
). This is consistent with literature 
data.
10 
 
6-Phenylhexan-1-amine hydrochloride 2.48 
 
According to representative procedure 7.2.2, the product was isolated as colourless 
crystalline solid (417 mg, 65%). 
1
H NMR (300 MHz, DMSO-d6, 25 °C): δ = 7.85 
(3H, br s, NH3
+
), 7.14-7.30 (5H, m, arom. H), 2.73 (2H, t, J = 7.50 Hz, H1), 2.57 (2H, 
t, J = 7.65 Hz, H6), 1.49-1.61 (4H, m, H2 & H5), 1.26-1.38 (4H, m, H3 & H4); 
13
C 
NMR (75.4 MHz, DMSO-d6, 25 °C): δ = 142.1 (C10), 128.2 (C8), 128.2 (C9), 125.6 
(C7), 38.6 (C1), 34.9 (C6), 30.7 (C2), 28.1 (C5), 26.7 (C4), 25.6 (C3); HRMS(ESI-
TOF): calcd. for C12H19NH
+
: 178.1596. Found: 178.1589 (MH
+
). This is consistent 
with literature data.
11
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2-Methylbutan-1-amine hydrochloride 2.49 
 
According to representative procedure 7.2.2, the product was isolated as colourless 
crystalline solid (248 mg, 67%). 
1
H NMR (300 MHz, D2O, 25 °C): δ = 4.45 (3H, br s, 
NH3
+
), 2.58 (1H, dd, J = 12.60 6.30 Hz, H1), 2.41 (1H, dd, J = 12.60 7.80 Hz, H1), 
1.28-1.41 (1H, m, H2), 0.96-1.10 (1H, m, H3), 0.78-0.93 (1H, m, H3), 0.58 (3H, d, J = 
6.90 Hz, H5), 0.51 (3H, t, J = 7.20 Hz, H4); 
13
C NMR (75.4 MHz, D2O, 25 °C): δ = 
45.0 (C1), 32.8 (C2), 26.3 (C3), 16.1 (C5), 10.4 (C4); HRMS(ESI-TOF): calcd. for 
C5H12NH
+
: 87.1048. Found: 87.1059 (MH
+
). This is consistent with literature data.
12 
 
2-(Naphthalen-2-yl)-N-(1-phenylethyl)ethanamine 2.50 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 2:1, Rf = 0.20, det: KMnO4) and 
isolated as a brown oil (653 mg, 79%). IR: νmax/cm
-1
 (neat) 3052, 3024, 2958, 2856, 
1633, 1600, 1508, 1492, 1450, 1367, 1124; 
1
H NMR (300 MHz, CDCl3, 25 °C): δ = 
7.75-7.82 (3H, m, arom. H), 7.61 (1H, br s, H10), 7.40-7.49 (2H, m, arom. H), 7.20-
7.34 (6H, m, arom. H), 3.80 (1H, q, J = 6.60 Hz, H3), 2.79-2.98 (4H, m, H1 & H2), 
1.49 (1H, br s, NH), 1.33 (3H, d, J = 6.60 Hz, H4); 
13
C NMR (75.4 MHz, CDCl3, 25 
°C): δ = 145.7 (C5), 137.7 (C9), 133.7 (C11), 132.3 (C16), 128.5 (C7), 128.1 (C10), 
127.7 (C18), 127.6 (C15), 127.4 (C12), 127.1 (C17), 127.0 (C8), 126.7 (C6), 126.1 (C13), 
125.4 (C14), 58.4 (C3), 48.8 (C2), 36.7 (C1), 24.5 (C4); HRMS(ESI-TOF): calcd. for 
C20H21NH
+
: 276.1752. Found: 276.1730 (MH
+
); CHN: Anal. Calc. for C20H21N: C, 
87.23%, H, 7.69%, N, 5.09%; Found: C, 87.30%, H, 7.75%, N, 4.96%. 
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3,3-diphenyl-N-(1-phenethyl)propan-1-amine (Fendiline) 2.52 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 2:1, Rf = 0.21, det: KMnO4) and 
isolated as a brown oil (672 mg, 71%). 
1
H NMR (300 MHz, CDCl3, 25 °C): δ = 7.12-
7.32 (15H, m, arom. H), 3.97 (1H, t, J = 7.65 Hz, H3), 3.68 (1H, q, J = 6.60 Hz, H4), 
2.40-2.52 (2H, m, H1), 2.15-2.28 (2H, m, H2), 1.46 (1H, br s, NH), 1.30 (3H, d, J = 
6.60 Hz, H5); 
13
C NMR (75.4 MHz, CDCl3, 25 °C): δ = 145.8 (C6), 145.1 (C10), 144.8 
(C14), 128.5 (C12 & C16), 128.5 (C8), 128.0 (C11), 127.8 (C15), 126.9 (C9), 126.6 (C7), 
126.2 (C13), 126.2 (C17), 58.2 (C4), 49.1 (C3), 46.1 (C1), 36.1 (C2), 25.5 (C5); 
HRMS(ESI-TOF): calcd. for C23H25NH
+
: 316.2065. Found: 316.2051 (MH
+
). This is 
consistent with literature data.
13
 
 
(R)-3,3-diphenyl-N-(1-phenethyl)propan-1-amine ((R)-Fendiline) 2.56 
 
According to representative procedure 7.2.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 2:1, Rf = 0.21, det: KMnO4) and 
isolated as a brown oil (672 mg, 71%).  26D  : +12.0° (c 0.5, CHCl3); 
1
H NMR (300 
MHz, CDCl3, 25 °C): δ = 7.12-7.32 (15H, m, arom. H), 3.97 (1H, t, J = 7.65 Hz, H3), 
3.68 (1H, q, J = 6.60 Hz, H4), 2.40-2.52 (2H, m, H1), 2.15-2.28 (2H, m, H2), 1.46 
(1H, br s, NH), 1.30 (3H, d, J = 6.60 Hz, H5); 
13
C NMR (75.4 MHz, CDCl3, 25 °C): δ 
= 145.8 (C6), 145.1 (C10), 144.8 (C14), 128.5 (C12 & C16), 128.5 (C8), 128.0 (C11), 
127.8 (C15), 126.9 (C9), 126.6 (C7), 126.2 (C13), 126.2 (C17), 58.2 (C4), 49.1 (C3), 46.1 
(C1), 36.1 (C2), 25.5 (C5); HRMS(ESI-TOF): calcd. for C23H25NH
+
: 316.2065. Found: 
316.2051 (MH
+
). This is consistent with literature data.
14 
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7.2.3 Representative Procedure for the Determination of Chirality via 
1
H NMR using (S)-O-Acetylmandelic acid 
To a vial containing (S)-O-Acetylmandelic acid (19.4 mg, 0.1 mmol) was added the 
amine (0.1 mmol) and CDCl3 (0.6 mL). The sample was then shaken and analysed by 
1
H NMR. 
 
7.3 Experimental procedures: Chapter 3 
7.3.1  Representative Procedure for the Synthesis of Cyclic Tertiary 
Amines from Primary Amines and Diols 
To an oven-dried, nitrogen purged Young’s tube containing [Ru(p-cymene)Cl2]2 
(45.9 mg, 0.075 mmol) and DPEphos (80.8 mg, 0.15 mmol) were added the amine (3 
mmol), diol (3.6 mmol), triethylamine (42 µL, 0.3 mmol) and toluene (3 mL). The 
reaction vessel was then sealed and heated to reflux for 24 hours. On completion the 
reaction was allowed to cool to room temperature and the solvent removed in vacuo. 
The crude product was then purified by silica column chromatography. 
 
7.3.2 Ruthenium-Catalysed Synthesis of Cyclic Tertiary Amines from 
Primary Alcohols and Diols 
1-Phenylpyrrolidine 3.3 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.52, det: KMnO4) and 
isolated as a yellow oil (344 mg, 78%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.27 (2H, 
dd, J = 8.85 7.35 Hz, H3), 6.70 (1H, tt, J = 7.35 1.05 Hz, H4), 6.61 (2H, dd, J = 8.85 
1.05 Hz, H2), 3.30-3.34 (4H, m, H5), 2.01-2.06 (4H, m, H6); 
13
C NMR: (CDCl3, 75.4 
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MHz) δ = 148.0 (C1), 129.1 (C3), 115.3 (C2), 111.6 (C4), 47.5 (C5), 25.4 (C6); 
HRMS(ESI-TOF): calcd. For C10H13NH
+
: 148.1126. Found: 148.1129 (MH
+
). This is 
consistent with literature data.
15
 
 
1-(2-Fluorophenyl)pyrrolidine 3.4 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.65, det: KMnO4) and 
isolated as a colourless oil (165 mg, 33%). IR: νmax/cm
-1
 (neat) 3065, 2966, 2874, 
2824, 1613, 1504, 1487, 1358, 1204; 
1
H NMR: (CDCl3, 300 MHz) δ = 6.95-7.03 (2H, 
m, H3 & H5), 6.63-6.72 (2H, m, H4 & H6), 3.37-3.43 (4H, m, H7), 1.94-1.99 (4H, m, 
H8); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 152.4 (d, J = 152.4 Hz, C2), 137.6 (d, J = 9.3 
Hz, C1), 124.5 (d, J = 3.0 Hz, C5), 117.3 (d, J = 7.2 Hz, C4), 116.2 (d, J = 21.0 Hz, 
C3), 115.4 (d, J = 5.1 Hz, C6), 49.9 (d, J = 5.0 Hz, C7), 25.3 (d, J = 1.8 Hz, C8); 
19
F 
NMR: (CDCl3, 376 MHz) δ = -126.9 (s); HRMS(ESI-TOF): calcd. for C10H12NFH
+
: 
166.1032. Found: 166.1032 (MH
+
); CHN: Anal. Calc. for C10H12NF: C, 72.70%, H, 
7.32%, N, 8.48%; Found: C, 72.60%, H, 7.34%, N, 8.52%. 
 
1-o-Tolylpyrrolidine 3.6 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.25, det: KMnO4) and 
isolated as a yellow oil (368 mg, 76%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.10-7.14 
(2H, m, H3 & H5), 6.90 (1H, dd, J = 9.00, 1.20 Hz, H6), 6.84 (1H, dt, J = 7.35, 1.10 
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Hz, H4), 3.18 (4H, m, H7), 2.34 (3H, s, H9), 1.92-1.96 (4H, m, H8); 
13
C NMR: (CDCl3, 
75.4 MHz) δ = 149.6 (C1), 131.8 (C3), 128.9 (C5), 126.4 (C2), 120.4 (C4), 115.9 (C6), 
51.1 (C7), 25.1 (C8), 20.7 (C9); HRMS(ESI-TOF): calcd. for C11H15NH
+
: 162.1283. 
Found: 162.1279 (MH
+
). This is consistent with literature data.
16
 
 
1-m-Tolylpyrrolidine 3.9 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.37, det: KMnO4) and 
isolated as a yellow oil (455 mg, 94%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.12 (1H, 
dd, J = 8.85 7.50 Hz, H5), 6.50 (1H, d, J = 7.50 Hz, H4), 6.41 (2H, br s, H2 & H6), 
3.26-3.30 (4H, m, H7), 2.32 (3H, s, H9), 1.97-2.01 (4H, m, H8); 
13
C NMR: (CDCl3, 
75.4 MHz) δ = 148.1 (C1), 138.7 (C3), 128.9 (C5), 116.3 (C4), 112.3 (C2), 108.9 (C6), 
47.5 (C7), 25.4 (C8), 21.8 (C9); HRMS(ESI-TOF): calcd. for C11H15NH
+
: 162.1283. 
Found: 162.1278 (MH
+
). This is consistent with literature data.
16
 
 
1-(3-Chlorophenyl)pyrrolidine 3.10 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.41, det: KMnO4) and 
isolated as a yellow oil (456 mg, 84%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.11 (1H, t, 
J = 8.10 Hz, H5), 6.61 (1H, ddd, J = 8.10 2.10 0.90 Hz, H4), 6.52 (1H, t, J = 2.10 Hz, 
H2), 6.42 (1H, ddd, J = 8.10 2.10 0.90 Hz, H6), 3.24-3.29 (4H, m, H7), 1.98-2.03 (4H, 
m, H8); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 148.8 (C1), 134.9 (C3), 129.9 (C5), 115.1 
(C4), 111.4 (C2), 109.8 (C6), 47.5 (C7), 25.4 (C8); HRMS(ESI-TOF): calcd. for 
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C10H12NClH
+
: 182.0737. Found: 182.0719 (MH
+
). This is consistent with literature 
data.
17 
 
1-(3-(Trifluoromethyl)phenyl)pyrrolidine 3.11 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.42, det: KMnO4) and 
isolated as a colourless oil (387 mg, 60%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.26-
7.32 (1H, m, H5), 6.88 (1H, d, J = 7.50 Hz, H4), 6.74 (1H, s, H2), 6.68 (1H, d, J = 8.25 
Hz, H6), 3.29-3.33 (4H, m, H7), 2.01 – 2.06 (4H, m, H8); 
13
C NMR: (CDCl3, 75.4 
MHz) δ = 148.0 (C1), 131.5 (d, J = 31.4 Hz, C3), 129.6 (C5), 124.8 (d, J = 272.1 Hz, 
C9), 114.7, (d, J = 1.1 Hz, C6), 111.7 (q, J = 3.9 Hz, C4), 107.9 (q, J = 4.0 Hz, C2), 
47.7 (C7), 25.6 (C8); HRMS(ESI-TOF): calcd. for C11H12NF3H
+
: 216.0998. Found: 
216.1000 (MH
+
). This is consistent with literature data.
18 
 
1-p-Tolylpyrrolidine 3.13 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.45, det: KMnO4) and 
isolated as a colourless crystalline solid (314 mg, 65%). 
1
H NMR: (CDCl3, 300 MHz) 
δ = 7.04 (2H, d, J = 8.40 Hz, H3), 6.51 (2H, d, J = 8.40 Hz, H2), 3.24-3.28 (4H, m, 
H5), 2.26 (3H, s, H7), 1.97-2.01 (4H, m, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 146.1 
(C1), 129.6 (C3), 124.4 (C4), 111.7 (C2), 47.8 (C5), 25.4 (C6), 20.2 (C7); HRMS(ESI-
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TOF): calcd. For C11H15NH
+
: 162.1283. Found: 162.1286 (MH
+
). This is consistent 
with literature data.
16 
 
1-(4-Fluorophenyl)pyrrolidine 3.14 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.31, det: KMnO4) and 
isolated as a yellow oil (387 mg, 78%). 
1
H NMR: (CDCl3, 300 MHz) δ = 6.94 (2H, t, 
J = 8.85 Hz, H3), 6.48 (2H, q, J = 4.50 Hz, H2), 3.22-3.27 (4H, m, H5), 1.98-2.03 (4H, 
m, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 154.8 (d, J = 232.84 Hz, C4), 144.8 (d, J = 
1.28 Hz, C1), 115.4 (d, J = 22.02 Hz, C3), 112.0 (d, J = 7.16 Hz, C2), 48.1 (C5), 25.4 
(C6); HRMS(ESI-TOF): calcd. for C10H12NFH
+
: 166.1032. Found: 166.1030 (MH
+
). 
This is consistent with literature data.
19 
 
1-(4-Chlorophenyl)pyrrolidine 3.15 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.29, det: KMnO4) and 
isolated as a colourless solid (474 mg, 87%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.16 
(2H, d, J = 9.00 Hz, H2), 6.47 (2H, d, J = 9.00 Hz, H3), 3.23-3.28 (4H, m, H5), 1.99-
2.04 (4H, m, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 146.5 (C1), 128.8 (C3), 120.0 
(C2), 112.6 (C4), 47.7 (C5), 25.4 (C6); HRMS(ESI-TOF): calcd. For C10H12NClH
+
: 
182.0737. Found: 182.0722 (MH
+
). This is consistent with literature data.
20
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1-(4-tert-Butylphenyl)pyrrolidine 3.16 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.31, det: KMnO4) and 
isolated as a yellow oil (518 mg, 85%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.32 (2H, d, 
J = 8.85 Hz, H3), 6.59 (2H, d, J = 8.85 Hz, H2), 3.30-3.35 (4H, m, H5), 2.01-2.05 (4H, 
m, H6), 1.35 (9H, s, H8); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 145.9 (C1), 137.9 (C4), 
125.9 (C3), 111.3 (C2), 47.7 (C5), 33.7 (C7), 31.6 (C8), 25.4 (C6); HRMS(ESI-TOF): 
calcd. for C14H21NH
+
: 204.1752. Found: 204.1747 (MH
+
). This is consistent with 
literature data.
21 
 
1-(4-Methoxyphenyl)pyrrolidine 3.17 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; CH2Cl2/hexanes, 2:1, Rf = 0.39, det: KMnO4) and 
isolated as a colourless oil (372 mg, 70%). 
1
H NMR: (CDCl3, 300 MHz) δ = 6.87 
(2H, d, J = 9.00 Hz, H3), 6.56 (2H, d, J = 9.00 Hz, H2), 3.78 (3H, s, H7), 3.23-3.28 
(4H, m, H5), 1.99-2.03 (4H, m, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 150.4 (C4), 
143.2 (C1), 115.0 (C2), 112.6 (C3), 56.0 (C7), 48.2 (C5), 25.3 (C6); HRMS(ESI-TOF): 
calcd. For C11H15NOH
+
: 178.1232. Found: 178.1219 (MH
+
). This is consistent with 
literature data.
15
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Methyl 4-(pyrrolidin-1-yl)benzoate 3.18 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.32, det: KMnO4) and 
isolated as a colourless oil (203 mg, 33%). m. p. 126-128 °C; IR: νmax/cm
-1
 (neat) 
2950, 2847, 1693, 1607, 1525, 1436, 1393; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.89 
(2H, d, J = 9.00 Hz, H3), 6.50 (2H, d, J = 9.00 Hz, H2), 3.85 (3H, s, H8), 3.32-3.37 
(4H, m, H5), 2.00-2.05 (4H, m, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 167.6 (C7), 
150.8 (C1), 131.3 (C3), 116.2 (C2), 110.6 (C4), 51.3 (C8), 47.5 (C5), 25.4 (C6); 
HRMS(ESI-TOF): calcd. for C12H15NO2H
+
: 206.1181. Found: 206.1166 (MH
+
), 
228.0985 (MNa
+
); CHN: Anal. Calc. for C12H15NO2: C, 70.22%, H, 7.37%, N, 
6.82%; Found: C, 70.05%, H, 7.26%, N, 6.62%. 
 
1-(2,3-Dihydro-1H-inden-5-yl)pyrrolidine 3.19 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.35, det: KMnO4) and 
isolated as a yellow oil (416 mg, 74%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.12 (1H, d, 
J = 8.10 Hz, H5), 6.54 (1H, s, H2), 6.40 (1H, d, J = 8.10 Hz, H6), 3.28-3.32 (4H, m, 
H7), 2.01-2.05 (4H, m, H9 & H10), 2.08 (2H, quin, J = 7.50 Hz, H11), 2.00-2.05 (4H, 
m, H8); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 147.2 (C1), 145.2 (C3), 131.0 (C4), 124.6 
(C5), 100.0 (C2), 107.8 (C6), 48.0 (C7), 33.3 (C9), 31.8 (C11), 25.8 (C10), 25.4 (C8); 
HRMS(ESI-TOF): calcd. for C13H17NH
+
: 188.1439. Found: 188.1425 (MH
+
). This is 
consistent with literature data.
22
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1-Benzylpyrrolidine 3.20 
 
According to representative procedure 7.3.1, the product was purified by Kugelrohr 
distillation and isolated as a colourless oil (348 mg, 72%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.14-7.29 (5H, m, arom.), 3.55 (2H, s, H5), 2.42-2.47 (4H, m, H6), 1.69-
1.74 (4H, m, H7); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 139.3 (C1), 128.9 (C3), 128.2 
(C2), 126.8 (C4), 60.7 (C5), 54.1 (C6), 23.4 (C7); HRMS(ESI-TOF): calcd. For 
C11H15NH
+
: 162.1283. Found: 162.1272 (MH
+
). This is consistent with literature 
data.
15
 
 
1-Phenethylpyrrolidine 3.21 
 
According to representative procedure 7.3.1, the product was purified by Kugelrohr 
distillation and isolated as a colourless oil (363 mg, 69%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.18-7.33 (5H, m, arom.), 2.84-2.90 (2H, m, H6), 2.69-2.75 (2H, m, H5), 
2.58-2.62 (4H, m, H7), 1.81-1.85 (4H, m, H8); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 
140.5 (C1), 128.6 (C3), 128.3 (C2), 125.9 (C4), 58.3 (C6), 54.2 (C7), 35.8 (C5), 23.4 
(C8); HRMS(ESI-TOF): calcd. For C12H17NH
+
: 176.1439. Found: 176.1430 (MH
+
). 
This is consistent with literature data.
15
 
 
 
 
 
 
 
Chapter 7 
136 
 
1-(Phenethyl)pyrrolidine 3.22 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 2:1, Rf = 0.23, det: KMnO4) and 
isolated as a colourless oil (431 mg, 82%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.14-
7.29 (5H, m, arom. H), 3.12 (1H, q, J = 6.60 Hz, H5), 2.44-2.55 (2H, m, H7), 2.26 – 
2.33 (2H, m, H7), 1.68 – 1.72 (4H, m, H8), 1.34 (3H, d, J = 6.60 Hz, H6); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 145.8 (C1), 128.3 (C2), 127.3 (C3), 126.9 (C4), 66.1 (C5), 53.1 
(C7), 23.5 (C8), 23.3 (C6); HRMS(ESI-TOF): calcd. for C12H17NH
+
: 176.1439. Found: 
176.1427 (MH
+
). This is consistent with literature data.
23
 
 
(S)-1-(Phenethyl)pyrrolidine 3.23 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 2:1, Rf = 0.23, det: KMnO4) and 
isolated as a colourless oil (431 mg, 82%).  26D : -66.5° (c 2.0, CHCl3); 
1
H NMR: 
(CDCl3, 300 MHz) δ = 7.14-7.29 (5H, m, arom. H), 3.12 (1H, q, J = 6.60 Hz, H5), 
2.44-2.55 (2H, m, H7), 2.26-2.33 (2H, m, H7), 1.68-1.72 (4H, m, H8), 1.34 (3H, d, J = 
6.60 Hz, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 145.8 (C1), 128.3 (C2), 127.3 (C3), 
126.9 (C4), 66.1 (C5), 53.1 (C7), 23.5 (C8), 23.3 (C6); HRMS(ESI-TOF): calcd. for 
C12H17NH
+
: 176.1439. Found: 176.1427 (MH
+
). This is consistent with literature 
data.
24 
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1-(Furan-2-ylmethyl)pyrrolidine 3.24 
 
According to representative procedure 7.3.1, the product was purified by Kugelrohr 
distillation and isolated as a colourless oil (286 mg, 63%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.35 (1H, dd, J = 1.80 0.60 Hz, H4), 6.30 (1H, dd, J = 3.15 1.80 Hz, H3), 
6.18 (1H, dd, J = 3.15 0.60 Hz, H2), 3.63 (2H, s, H5), 2.52-2.56 (4H, m, H6), 1.77-
1.81 (4H, m, H7); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 153.0 (C1), 141.7 (C4), 109.9 
(C3), 107.4 (C2), 53.8 (C6), 52.0 (C5), 23.4 (C7); HRMS(ESI-TOF): calcd. For 
C9H13NOH
+
: 152.1075. Found: 152.1071 (MH
+
). This is consistent with literature 
data.
25
 
 
3-(Pyrrolidin-1-yl)pyridine 3.26 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; CH2Cl2/Et2O, 1:1, Rf = 0.23, det: KMnO4) and 
isolated as a yellow oil (256 mg, 58%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.98 (1H, d, 
J = 3.00 Hz, H1), 7.92 (1H, dd, J = 4.80 1.20 Hz, H5), 7.08 (1H, ddd, J = 8.40 4.80 
0.60 Hz, H4), 6.80 (1H, ddd, J = 8.40 3.00 1.20 Hz, H3), 3.27-3.32 (4H, m, H6), 2.00-
2.05 (4H, m, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 143.8 (C2), 136.9 (C5), 134.4 
(C1), 123.6 (C4), 117.8 (C3), 47.3 (C6), 25.5 (C7); HRMS(ESI-TOF): calcd. for 
C9H12N2H
+
: 149.1079. Found: 149.1076 (MH
+
). This is consistent with literature 
data.
26
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1-Phenylpiperidine 3.2 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.45, det: KMnO4) and 
isolated as a yellow oil (348 mg, 72%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.29 (2H, 
dd, J = 9.00 7.20 Hz, H3), 6.98 (2H, dd, J = 9.00 1.05 Hz, H2), 6.86 (1H, tt, J = 7.20 
1.05 Hz, H4), 3.19 (4H, t, J = 5.40 Hz, H5), 1.71-1.79 (4H, m, H6), 1.57-1.65 (2H, m, 
H7); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 152.2 (C1), 129.0 (C3), 119.1 (C2), 116.5 (C4), 
50.6 (C5), 25.8 (C6), 24.3 (C7); HRMS(ESI-TOF): calcd. For C11H15NH
+
: 162.1283 
Found: 162.1277 (MH
+
). This is consistent with literature data.
27
 
 
N
1
,N
6
-Diphenylhexanes-1,6-diamine 3.35 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; CH2Cl2, Rf = 0.32, det: KMnO4) and isolated as a 
colourless solid (443 mg, 55%). m. p. 58-60 °C; IR : νmax/cm
-1
 (neat) 3393, 3051, 
2925, 2854, 1602, 1505, 1478, 1460, 1429, 1322, 1261; 
1
H NMR: (CDCl3, 300 MHz) 
δ = 7.18 (2H, dd, J = 8.55 7.35 Hz, H3), 6.70 (1H, tt, J = 7.35 0.90 Hz, H4), 6.61 (2H, 
dd, J = 8.55 0.90 Hz, H2), 3.66 (2H, br s, NH), 3.12 (4H, t, J = 7.05 Hz, H5), 1.60-
1.69 (4H, m, H6), 1.43-1.48 (4H, m, H7); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 148.4 
(C1), 129.2 (C3), 117.1 (C2), 112.6 (C4), 43.8 (C5), 29.5 (C6), 26.9 (C7); HRMS(ESI-
TOF): calcd. For C18H24NH
+
: 269.2018. Found: 269.2008 (MH
+
); CHN: Anal. Calc. 
for C18H24N2: C, 80.55%, H, 9.01%, N, 10.44%; Found: C, 79.40%, H, 8.88%, N, 
10.25%. 
 
Chapter 7 
139 
 
1-(1-Phenylethyl)azepane 3.36 
 
According to representative procedure 7.3.1, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 10:1, Rf = 0.19, det: KMnO4) and 
isolated as a yellow oil (396 mg, 65%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.20-7.39 
(5H, arom.), 3.78 (1H, q, J = 6.60 Hz, H5), 2.64 (4H, br s, H7), 1.59 (8H, br s, H8 & 
H9), 1.37 (3H, d, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 144.9 (C1), 127.9 (C2), 127.6 
(C3), 126.4 (C4), 63.2 (C5), 52.0 (C7), 28.9 (C8), 27.0 (C9), 18.2 (C6); HRMS(ESI-
TOF): calcd. for C14H21NH
+
: 204.1752. Found: 204.1735 (MH
+
). This is consistent 
with literature data.
28
 
 
2-Methyl-1-phenylpyrrolidine 3.37 
 
According to representative procedure 7.3.1, the product was purified by Kugelrohr 
distillation and isolated as a yellow oil (314 mg, 65%). 
1
H NMR: (CDCl3, 300 MHz) 
δ = 7.22 (2H, dd, J = 8.70, 7.20 Hz, H3), 6.64 (1H, tt, J = 7.20, 0.90 Hz, H4),  6.59 
(2H, dd, J = 8.70, 0.90 Hz, H2), 3.84-3.93 (1H, m, H8), 3.34-3.46 (1H, m, H5), 3.09-
3.21 (1H, m, H5), 1.91-2.16 (3H, m, H6 & H7), 1.68-1.73 (1H, m, H7), 1.18 (3H, d, J = 
6.30 Hz, H9); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 147.4 (C1), 129.3 (C3), 115.3 (C4), 
111.9 (C2), 53.7 (C8), 48.3 (C5), 33.2 (C7), 23.4 (C6), 19.5 (C9); HRMS(ESI-TOF): 
calcd. for C11H15NH
+
: 162.1283. Found: 162.1276 (MH
+
). This is consistent with 
literature data.
29
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7.4 Experimental procedures: Chapter 4 
7.4.1  Representative Procedure for the Synthesis of Tertiary Amines 
from Secondary Amines under Microwave Conditions 
To a microwave vial containing [Ru(p-cymene)Cl2]2 (45.9 mg, 0.075 mmol), 
DPEphos (80.8 mg, 0.15 mmol) was added the amine (3 mmol) and the alcohol (4.8 
mmol, 1.6 eq.) before the vial was sealed. The vial was then purged with N2 for 5 min 
before heating to 115 °C for 90 min. The crude product was then purified by silica 
column chromatography. 
 
7.4.2  Representative Procedure for the Synthesis of 1,2-Amino Alcohols 
from Diols under Microwave Conditions 
To a microwave vial containing (+/-)-1-phenyl-1,2-ethanediol (138 mg, 1 mmol), 
[Ru(p-cymene)Cl2]2 (15.3 mg, 0.025 mmol), DPEphos (0.05 mmol) was added the 
amine (2 mmol) before the vial was sealed. The vial was then purged with N2 for 5 
min before heating to 115 °C for 90 min. The crude product was then purified by 
silica column chromatography. 
 
7.4.3  Representative Procedure for the Synthesis of Secondary Amines 
from Primary Amines under Microwave Conditions 
To a microwave vial containing [Ru(p-cymene)Cl2]2 (15.3 mg, 0.025 mmol), 
DPEphos (0.05 mmol) were added the amine (1 mmol) and the alcohol (1.6 mmol) 
before the vial was sealed. The vial was then purged with N2 for 5 min before heating 
to 125 °C for 90 min. The crude product was then purified by silica column 
chromatography. 
 
7.4.4  Representative Procedure for the Synthesis of Cyclic Tertiary 
Amines from Primary Amines and Diols under Microwave 
Conditions 
To a microwave vial containing [Ru(p-cymene)Cl2]2 (15.3 mg, 0.025 mmol), 
DPEphos (0.05 mmol) were added the amine (1 mmol) and the diol (1.6 mmol) 
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before the vial was sealed. The vial was then purged with N2 for 5 min before heating 
to 135 °C for 90 min. The crude product was then purified by silica column 
chromatography. 
 
7.4.5  Representative Procedure for the Synthesis of Cyclic Tertiary 
Amines from Primary Amines and Diols 
To a microwave vial containing p-toluenesulfonamide (171 mg, 1 mmol), [Ru(p-
cymene)Cl2]2 (15.3 mg, 0.025 mmol), DPEphos (0.05 mmol) was added the alcohol 
(3 mmol) before the vial was sealed. The vial was then purged with N2 for 5 min 
before heating to 165 °C for 180 min. The crude product was then purified by silica 
column chromatography. 
 
7.4.6  Representative Procedure for the Synthesis of Secondary Amides 
from Primary Amides under Microwave Conditions 
To a microwave vial containing benzamide (121 mg, 1 mmol), [Ru(p-cymene)Cl2]2 
(15.3 mg, 0.025 mmol), DPEphos (0.05 mmol) was added the alcohol (3 mmol) 
before the vial was sealed. The vial was then purged with N2 for 5 min before heating 
to 175 °C for 120 min. The crude product was then purified by silica column 
chromatography. 
 
7.4.7  Ruthenium-Catalysed Synthesis of Tertiary Amines from 
Secondary Amines under Microwave Conditions 
 
1-Benzylpyrrolidine 4.12 
 
According to representative procedure 7.4.1, the product was purified by silica 
column chromatography (eluent; CH2Cl2/MeOH, 95:5, Rf = 0.20, det: KMnO4) and 
isolated as a brown oil (382 mg, 79%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.14-7.29 
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(5H, m, arom.), 3.55 (2H, s, H5), 2.42-2.47 (4H, m, H6), 1.69-1.74 (4H, m, H7); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 139.3 (C1), 128.9 (C3), 128.2 (C2), 126.8 (C4), 60.7 
(C5), 54.1 (C6), 23.4 (C7); HRMS(ESI-TOF): calcd. For C11H15NH
+
: 162.1283. 
Found: 162.1272 (MH
+
). This is consistent with literature data.
15
 
 
N-Phenethyl-N-propylpropan-1-amine 4.13 
 
According to representative procedure 7.4.1, the product was purified by silica 
column chromatography (eluent; CH2Cl2/MeOH, 95:5, Rf = 0.19, det: KMnO4) and 
isolated as a yellow oil (579 mg, 94%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.26-7.31 
(2H, m, arom. H5), 7.16-7.21 (3H, m, arom. H), 2.69-2.79 (4H, m, H1 & H2), 2.46-
2.51 (4H, m, H7), 1.44-1.57 (4H, m, H8), 0.89 (6H, t, J = 7.50 Hz, H9); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 141.1 (C3), 128.9 (C5), 128.4 (C4), 126.0 (C6), 56.3 (C1 & C7), 
33.6 (C2), 20.5 (C8), 12.1 (C9); HRMS(ESI-TOF): calcd. for C14H23NH
+
: 206.1909. 
Found: 206.1923 (MH
+
). This is consistent with literature data.
30
 
 
1-Benzyl-4-methylpiperazine 4.14 
 
According to representative procedure 7.4.1, the product was purified by silica 
column chromatography (eluent; CH2Cl2/MeOH, 9:1, Rf = 0.19, det: KMnO4) and 
isolated as a yellow oil (451 mg, 79%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.21-7.32 
(5H, m, arom. H), 3.51 (2H, s, H4), 2.47 (8H, br s, H1 & H2), 2.29 (3H, s, H3); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 138.3 (C5), 129.3 (C6), 128.3 (C7), 127.1 (C8), 63.2 
(C4), 55.3 (C2), 53.2 (C1), 46.2 (C3); HRMS(ESI-TOF): calcd. for C12H18N2H
+
: 
191.1548. Found: 191.1543 (MH
+
). This is consistent with literature data.
31
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4-(3-Phenylpropyl)morpholine 4.15 
 
According to representative procedure 7.4.1, the product was purified by silica 
column chromatography (eluent; Et2O/petroleum ether b. p. 40-60 °C, 3:1, Rf = 0.20, 
det: KMnO4) and isolated as a brown oil (511 mg, 83%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.26-7.31 (2H, m, arom. H), 7.16-7.20 (3H, m, arom. H), 3.73 (4H, app t, J 
= 4.65 Hz, H9), 2.65 (2H, t, J = 7.65 Hz, H3), 2.45 (4H, m, H8), 2.38 (2H, t, J = 7.65 
Hz, H1), 1.78-1.89 (2H, m, H2); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 142.2 (C4), 128.5 
(C6), 128.4 (C5), 125.9 (C7), 67.1 (C9), 58.5 (C8), 53.4 (C1), 33.7 (C3), 28.4 (C2); 
HRMS(ESI-TOF): calcd. for C13H19NOH
+
: 206.1545. Found: 206.1548 (MH
+
). This 
is consistent with literature data.
31
 
 
4-Benzylmorpholine 4.8 
 
According to representative procedure 7.4.1, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/EtOAc, 3:1, Rf = 
0.19, det: KMnO4) and isolated as a brown oil (431 mg, 81%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.20-7.27 (5H, m, arom. H), 3.66 (4H, t, J = 4.65 Hz, H7), 3.45 (2H, s, H5), 
2.39 (4H, t, J = 4.50 Hz, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 137.7 (C1), 129.3 
(C3), 128.3 (C2), 127.2 (C4), 67.0 (C7), 63.5 (C5), 53.6 (C6); HRMS(ESI-TOF): calcd. 
for C11H16NOH
+
: 178.1232. Found: 178.1229 (MH
+
). This is consistent with literature 
data.
31
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7.4.8  Ruthenium-Catalysed Synthesis of 1,2-Amino Alcohols from Diols 
under Microwave Conditions 
 
1-Phenyl-2-(pyrrolidin-1-yl)ethanol 4.16 
 
According to representative procedure 7.4.2, the product was purified by silica 
column chromatography (eluent; Et2O/CH2Cl2, 2:1, Rf = 0.16, det: KMnO4) and 
isolated as a colourless solid (143 mg, 75%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.24-
7.41 (5H, m, arom. H), 4.74 (1H, dd, J = 10.80 3.30 Hz, H1), 3.89 (1H, br s, OH), 
2.78-2.85 (3H, m, H2 & H3), 2.50-2.63 (3H, m, H2 & H3), 1.81-1.85 (4H, m, H4); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 142.5 (C5), 128.4 (C7), 127.5 (C8), 126.0 (C6), 70.8 
(C1), 64.2 (C2), 54.0 (C3), 23.8 (C4); HRMS(ESI-TOF): calcd. for C12H17NOH
+
: 
192.1388. Found: 192.1399 (MH
+
). This is consistent with literature data.
32
 
 
1-Phenyl-2-(piperidin-1-yl)ethanol 4.17 
 
According to representative procedure 7.4.2, the product was purified by silica 
column chromatography (eluent; Et2O/CH2Cl2, 2:1, Rf = 0.23, det: KMnO4) and 
isolated as a colourless solid (162 mg, 79%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.23-
7.40 (5H, m, arom. H), 4.73 (1H, dd, J = 10.50 3.90 Hz, H1), 4.19 (1H, br s, OH), 
2.69-2.71 (2H, m, H2), 2.36-2.53 (4H, m, H3), 1.59-1.66 (4H, m, H4), 1.46-1.51 (2H, 
m, H5); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 142.6 (C6), 128.4 (C8), 127.5 (C9), 126.0 
(C7), 68.8 (C1), 67.1 (C2), 54.6 (C3), 26.3 (C4), 24.4 (C5); HRMS(ESI-TOF): calcd. for 
C13H19NOH
+
: 206.1545. Found: 206.1544 (MH
+
). This is consistent with literature 
data.
32
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2-(Azepan-1-yl)-1-phenylethanol 4.18 
 
According to representative procedure 7.4.2, the product was purified by silica 
column chromatography (eluent; Et2O/CH2Cl2, 3:2, Rf = 0.24, det: KMnO4) and 
isolated as a yellow oil (173 mg, 65%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.23-7.42 
(5H, m, arom. H), 4.70 (1H, dd, J = 10.80 3.30 Hz, H1), 3.59 (1H, br s, OH), 2.88-
2.96 (2H, m, H7), 2.73-2.84 (3H, m, H2 & H7), 2.51 (1H, dd, J = 12.60 10.80 Hz, H2), 
1.63-1.77 (8H, m, H8 & H9); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 142.5 (C3), 128.4 
(C5), 127.5 (C6), 126.0 (C4), 69.4 (C1), 66.3 (C2), 55.7 (C7), 28.3 (C8), 27.1 (C9); 
HRMS(ESI-TOF): calcd. for C14H21NOH
+
: 220.1701. Found: 220.1686 (MH
+
). This 
is consistent with literature data.
33
 
 
2-Morpholino-1-phenylethanol 4.19 
 
According to representative procedure 7.4.2, the product was purified by silica 
column chromatography (eluent; EtOAc/EtOH, 30:1, Rf = 0.26, det: KMnO4) and 
isolated as a colourless solid (187 mg, 90%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.28-
7.39 (5H, m, arom. H), 4.80 (1H, dd, J = 10.20 4.20 Hz, H1), 3.76-3.80 (4H, m, H4), 
2.75-2.82 (2H, m, H2), 2.47-2.57 (4H, m, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 
142.0 (C5), 128.5 (C7), 127.7 (C8), 126.0 (C6), 68.7 (C1), 67.2 (C4), 66.8 (C2), 53.6 
(C3); HRMS(ESI-TOF): calcd. for C12H17NO2H
+
: 208.1338. Found: 208.1338 (MH
+
). 
This is consistent with literature data.
32
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2-(Benzyl(methyl)amino-1-phenylethanol 4.20 
 
According to representative procedure 7.4.2, the product was purified by silica 
column chromatography (eluent; hexane/Et2O, 3:2, Rf = 0.25, det: KMnO4) and 
isolated as a brown oil (147 mg, 61%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.26-7.38 
(10H, m, arom. H), 4.77 (1H, dd, J = 10.20 3.90 Hz, H1), 3.77 (1H, d, J = 13.20 Hz, 
H4), 3.57 (1H, d, J = 13.20 Hz, H4), 2.63 (1H, dd, J = 12.30 10.30 Hz, H2), 2.55 (1H, 
dd, J = 12.60 10.30 Hz, H2), 2.35 (3H, s, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 
142.3 (C9), 138.2 (C5), 129.2 (C11), 128.5 (C6), 128.4 (C7), 127.6 (C8), 127.5 (C12), 
126.0 (C10), 69.5 (C1), 65.6 (C2), 62.5 (C4), 41.9 (C3); HRMS(ESI-TOF): calcd. for 
C16H19NOH
+
: 242.1545. Found: 242.1557 (MH
+
). This is consistent with literature 
data.
34
 
 
7.4.9  Ruthenium-Catalysed Synthesis of Secondary Amines from 
Primary Amines under Microwave Conditions 
 
N-Benzylaniline 4.21 
 
According to representative procedure 7.4.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 20:1, Rf = 
0.30, det: KMnO4) and isolated as a brown oil (112 mg, 61%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.27-7.40 (5H, m, arom. H), 7.15-7.21 (2H, m, H3), 6.76 (1H, t, J = 7.50 
Hz, H4), 6.69 (2H, d, J = 7.50 Hz, H2), 4.88 (1H, br s, NH), 4.34 (2H, s, H5); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 148.2 (C1), 139.5 (C6), 129.4 (C3), 128.8 (C8), 127.7 
(C7), 127.4 (C9), 117.8 (C4), 113.1 (C2), 48.5 (C5); HRMS(ESI-TOF): calcd. for 
C13H13NH
+
: 184.1126. Found: 184.1104 (MH
+
). This is consistent with literature 
data.
31
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N-Butyl-4-methoxyaniline 4.22 
 
According to representative procedure 7.4.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 9:1, Rf = 0.17, 
det: KMnO4) and isolated as a yellow oil (131 mg, 73%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 6.76-6.81 (2H, m, H3), 6.57-6.63 (2H, m, H2), 3.75 (3H, s, H5), 3.07 (2H, t, 
J = 7.20 Hz, H6), 1.55-1.65 (2H, m, H7), 1.36-1.49 (2H, m, H8), 0.95 (3H, t, J = 7.20 
Hz, H9); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 152.1 (C4), 143.0 (C1), 115.0 (C3), 114.2 
(C2), 56.0 (C5), 44.9 (C6), 31.9 (C7), 20.5 (C8), 14.1 (C9); HRMS(ESI-TOF): calcd. for 
C11H17NOH
+
 : 180.1388. Found : 180.1369 (MH
+
). This is consistent with literature 
data.
35
 
 
N-Phenethyl-1-phenethanamine 4.23 
 
According to representative procedure 7.4.3, the product was purified by silica 
column chromatography (eluent; CH2Cl2/Et2O, 4:1, Rf = 0.24, det: KMnO4) and 
isolated as a brown oil (212 mg, 94%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.15-7.34 
(10H, m, arom. H), 3.79 (1H, q, J = 6.60 Hz, H1), 2.68-2.83 (4H, m, H3 & H4), 1.35 
(3H, d, J = 6.60 Hz, H2); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 145.7 (C9), 140.2 (C5), 
128.8 (C12), 128.5 (C7), 128.5 (C10), 127.0 (C11), 126.7 (C6), 126.2 (C8), 58.3 (C1), 
49.0 (C3), 36.5 (C4), 24.4 (C2); HRMS(ESI-TOF): calcd. for C16H19NH
+
: 226.1596. 
Found: 226.1569 (MH
+
). This is consistent with literature data.
31
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2,4,4-Trimethyl-N-phenethylpentan-2-amine 4.24 
 
According to representative procedure 7.4.3, the product was purified by silica 
column chromatography (eluent; CH2Cl2/MeOH, 92:8, Rf = 0.31, det: KMnO4) and 
isolated as a brown oil (191 mg, 82%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.20-7.32 
(5H, m, arom. H), 2.84 (4H, app. br s, H1 & H2), 1.44 (2H, s, H9), 1.16 (6H, s, H8), 
0.95 (9H, s, H11); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 140.5 (C3), 128.9 (C5), 128.5 
(C4), 126.2 (C6), 54.4 (C7), 53.1 (C9), 43.8 (C1), 37.3 (C2), 31.8 (C11), 31.7 (C10), 29.0 
(C8); HRMS(ESI-TOF): calcd. for C16H27NH
+
: 234.2222. Found: 234.2229 (MH
+
). 
This is consistent with literature data.
36
 
 
N-(1-Phenethyl)butan-1-amine 4.25 
 
According to representative procedure 7.4.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 1:1, Rf = 0.25, 
det: KMnO4) and isolated as a yellow oil (142 mg, 80%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.21-7.36 (5H, m, arom. H), 3.77 (1H, q, J = 6.60 Hz, H1), 2.38-2.55 (2H, 
m, H3), 1.78 (1H, br s, NH), 1.41-1.52 (2H, m, H4), 1.38 (3H, d, J = 6.60 Hz, H2), 
1.23-1.34 (2H, m, H5), 0.87 (3H, t, J = 7.20 Hz, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ 
= 146.0 (C7), 128.5 (C9), 126.9 (C10), 126.7 (C8), 58.5 (C1), 47.7 (C3), 32.5 (C4), 24.5 
(C2), 20.6 (C5), 14.1 (C6); HRMS(ESI-TOF): calcd. for C12H19NH
+
: 178.1596. Found: 
178.1592 (MH
+
). This is consistent with literature data.
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7.4.10  Ruthenium-Catalysed Synthesis of Cyclic Tertiary Amines from 
Primary Amines and Diols under Microwave Conditions 
 
1-Phenylpyrrolidine 4.26 
 
According to representative procedure 7.4.4, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.52, det: KMnO4) and 
isolated as a yellow oil (130 mg, 88%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.23 (2H, 
dd, J = 8.70 7.20 Hz, H3), 6.67 (1H, t, J = 7.20 Hz, H4), 6.59 (2H, d, J = 8.10, H2), 
3.27-3.32 (4H, m, H5), 1.97-2.05 (4H, m, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 
148.1 (C1), 129.3 (C3), 115.5 (C2), 111.8 (C4), 47.7 (C5), 25.6 (C6); HRMS(ESI-TOF): 
calcd. For C10H13NH
+
: 148.1126. Found: 148.1106 (MH
+
). This is consistent with 
literature data.
31
 
 
1-Phenylpiperidine 4.27 
 
According to representative procedure 7.4.4, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.45, det: KMnO4) and 
isolated as a yellow oil (131 mg, 81%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.23-7.28 
(2H, m, H3), 6.96-6.98 (2H, br s, H2), 6.82-6.86 (1H, m, H4), 3.16 (4H, t, J = 5.40 Hz, 
H5), 1.73 (4H, br s, H6), 1.58-1.62 (2H, m, H7); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 
152.4 (C1), 129.1 (C3), 119.3 (C2), 116.7 (C4), 50.8 (C5), 26.0 (C6), 24.5 (C7); 
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HRMS(ESI-TOF): calcd. For C11H15NH
+
: 162.1283 Found: 162.1260 (MH
+
). This is 
consistent with literature data.
31
 
 
1-(1-Phenylethyl)azepane 4.28 
 
According to representative procedure 7.4.4, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 10:1, Rf = 0.19, det: KMnO4) and 
isolated as a yellow oil (157 mg, 77%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.19-7.39 
(5H, arom.), 3.77 (1H, q, J = 6.60 Hz, H5), 2.63 (4H, br s, H7), 1.58 (8H, br s, H8 & 
H9), 1.36 (3H, d, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 145.1 (C1), 128.1 (C2), 127.7 
(C3), 126.6 (C4), 63.4 (C5), 52.2 (C7), 29.1 (C8), 27.2 (C9), 18.4 (C6); HRMS(ESI-
TOF): calcd. for C14H21NH
+
: 204.1752. Found: 204.1743 (MH
+
). This is consistent 
with literature data.
31
 
 
(R)-1-(Phenethyl)pyrrolidine 4.29 
 
According to representative procedure 7.4.4, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 2:1, Rf = 0.23, det: KMnO4) and 
isolated as a colourless oil (144 mg, 82%).  26D  : +62.1° (c 2.1, CHCl3); 
1
H NMR: 
(CDCl3, 300 MHz) δ = 7.12-7.29 (5H, m, arom. H), 3.12 (1H, q, J = 6.60 Hz, H5), 
2.46-2.51 (2H, m, H7), 2.27-2.33 (2H, m, H7), 1.67-1.72 (4H, m, H8), 1.34 (3H, d, J = 
6.60 Hz, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 145.9 (C1), 128.4 (C2), 127.3 (C3), 
126.9 (C4), 66.1 (C5), 53.1 (C7), 23.5 (C8), 23.3 (C6); HRMS(ESI-TOF): calcd. for 
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C12H17NH
+
: 176.1439. Found: 176.1422 (MH
+
). This is consistent with literature 
data.
38
 
 
1-(Furan-2-ylmethyl)pyrrolidine 4.30 
 
According to representative procedure 7.4.4, the product was purified by Kugelrohr 
distillation and isolated as a colourless oil (82 mg, 54%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.35 (1H, dd, J = 1.80 0.60 Hz, H4), 6.30 (1H, dd, J = 3.15 1.80 Hz, H3), 
6.18 (1H, dd, J = 3.15 0.60 Hz, H2), 3.63 (2H, s, H5), 2.52-2.56 (4H, m, H6), 1.77-
1.81 (4H, m, H7); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 153.1 (C1), 141.9 (C4), 110.1 
(C3), 107.6 (C2), 54.0 (C6), 52.2 (C5), 23.6 (C7); HRMS(ESI-TOF): calcd. For 
C9H13NOH
+
: 152.1075. Found: 152.1071 (MH
+
). This is consistent with literature 
data.
31 
 
7.4.11  Ruthenium-Catalysed Alkylation of Sulfonamides under 
Microwave Conditions 
 
N-Benzyl-4-methylbenzenesulfonamide 4.31 
 
According to representative procedure 7.4.5, the product was purified by silica 
column chromatography (eluent; CH2Cl2, Rf = 0.27, det: KMnO4) and isolated as an 
off-white solid (238 mg, 91%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.77 (2H, d, J = 
8.40 Hz, H2), 7.26-7.33 (5H, m, arom. H), 7.18-7.23 (2H, m, H8), 4.59 (1H, br t, J = 
5.70 Hz, NH), 4.13 (2H, d, J = 6.00 Hz, H6), 2.44 (3H, s, H5); 
13
C NMR: (CDCl3, 
75.4 MHz) δ = 143.6 (C1), 137.0 (C7), 136.4 (C4), 129.9 (C3), 128.8 (C9), 128.0 (C10), 
128.0 (C2), 127.3 (C8), 47.4 (C6), 21.7 (C5); HRMS(ESI-TOF): calcd. for 
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C14H15NO2SH
+
: 262.0912. Found: 262.0903 (MH
+
), 284.0723 (MNa
+
). This is 
consistent with literature data.
31
 
 
N-Butyl-4-methylbenezenesulfonamide 4.32 
 
According to representative procedure 7.4.5, the product was purified by silica 
column chromatography (eluent; CH2Cl2, Rf = 0.25, det: KMnO4) and isolated as a 
colourless solid (218 mg, 96%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.74 (2H, d, J = 
8.10 Hz, H2), 7.31 (2H, d, J = 8.10 Hz, H3), 4.30 (1H, br s, NH), 2.93 (2H, t, J = 6.90 
Hz, H6), 2.43 (3H, s, H5), 1.39-1.49 (2H, m, H7), 1.23-1.35 (2H, m, H8), 0.85 (3H, t, J 
= 7.20 Hz, H9); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 143.4 (C4), 137.0 (C1), 129.8 (C3), 
127.2 (C2), 43.0 (C6), 31.6 (C7), 21.6 (C5), 19.8 (C8), 13.6 (C9); HRMS(ESI-TOF): 
calcd. for C11H17NO2SH
+
: 228.1058. Found: 228.1051 (MH
+
), 250.0871 (MNa
+
). This 
is consistent with literature data.
39 
 
N-(Cyclopropylmethyl)-4-methylbenzenesulfonamide 4.33 
 
According to representative procedure 7.4.5, the product was purified by silica 
column chromatography (eluent; CH2Cl2, Rf = 0.22, det: KMnO4) and isolated as a 
colourless solid (167 mg, 74%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.75 (2H, d, J = 
8.10 Hz, H2), 7.30 (2H, d, J = 8.10 Hz, H3), 4.45 (1H, br t, J = 5.40 Hz, NH), 2.81 
(2H, dd, J = 7.20 6.00 Hz, H6), 2.43 (3H, s, H5), 0.81-0.94 (1H, m, H7), 0.43-0.49 
(2H, m, H8), 0.06-0.11 (2H, m, H8); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 143.4 (C4), 
137.2 (C1), 129.8 (C3), 127.2 (C2), 48.4 (C6), 21.6 (C5), 10.8 (C7), 3.6 (C8); 
HRMS(ESI-TOF): calcd. for C11H15NO2SH
+
: 226.0902. Found: 226.0902 (MH
+
), 
248.0724 (MNa
+
). This is consistent with literature data.
31
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N-Benzyl-4-methoxybenzenesulfonamide 4.34 
 
According to representative procedure 7.4.5, the product was purified by silica 
column chromatography (eluent; CH2Cl2/MeOH, 99:1, Rf = 0.43, det: KMnO4) and 
isolated as a colourless solid (252 mg, 91%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.82 
(2H, d, J = 8.85 Hz, H2), 7.27-7.29 (3H, m, arom. H), 7.18-7.21 (2H, m, H8), 6.98 
(2H, d, J = 8.85 Hz, H3), 4.53 (1H, br t, J = 6.00 Hz, NH), 4.13 (2H, d, J = 6.30 Hz, 
H6), 3.88 (3H, s, H5); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 163.1 (C4), 136.5 (C7), 131.6 
(C1), 129.4 (C9), 128.8 (C8), 128.0 (C2 & C10), 114.4 (C3), 55.8 (C5), 47.4 (C6); 
HRMS(ESI-TOF): calcd. for C14H15NO3SNa
+
: 300.0670. Found: 300.0636 (MNa
+
). 
This is consistent with literature data.
31
 
 
N-Benzylmethanesulfonamide 4.35 
 
According to representative procedure 7.4.5, the product was purified by silica 
column chromatography (eluent; CH2Cl2/MeOH, 98:2, Rf = 0.37, det: KMnO4) and 
isolated as a yellow solid (159 mg, 86%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.32-7.41 
(5H, m, arom. H), 4.59 (1H, br s, NH), 4.33 (2H, d, J = 6.00 Hz, H2), 2.88 (3H, s, H1); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 136.8 (C3), 129.0 (C5), 128.2 (C6), 128.0 (C4), 47.3 
(C2), 41.2 (C1); HRMS(ESI-TOF): calcd. for C8H11NO2SNa
+
: 208.0408. Found: 
208.0404 (MNa
+
). This is consistent with literature data.
31
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7.4.12  Ruthenium-Catalysed Synthesis of Secondary Amides from 
Primary Amides under Microwave Conditions 
 
N-Benzylbenzamide 4.36 
 
According to representative procedure 7.4.6, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 1:1, Rf = 0.22, 
det: KMnO4) and isolated as a colourless solid (139 mg, 66%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.78-7.81 (2H, m, H2), 7.29-7.53 (8H, arom. H), 6.39 (1H, br s, NH), 4.66 
(2H, d, J = 5.40 Hz, H6); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 167.5 (C5), 138.3 (C7), 
134.5 (C1), 131.7 (C4), 128.9 (C3), 128.7 (C9), 128.0 (C2), 127.7 (C10), 127.1 (C8), 
44.3 (C6); HRMS(ESI-TOF): calcd. for C14H13NOH
+
: 212.1075. Found: 212.1070 
(MH
+
), 234.0885 (MNa
+
). This is consistent with literature data.
40
 
 
N-Hexylbenzamide 4.37 
 
According to representative procedure 7.4.6, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 1:1, Rf = 0.30, 
det: KMnO4) and isolated as a colourless solid (148 mg, 72%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.74-7.77 (2H, m, H3), 7.40-7.52 (3H, m, arom. H), 6.10 (1H, br s, NH), 
3.42-3.49 (2H, m, H6), 1.57-1.67 (2H, m, H7), 1.28-1.44 (6H, m, H8, H9 & H10), 0.90 
(3H, t, J = 6.90 Hz, H11); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 167.6 (C1), 135.0 (C2), 
131.4 (C5), 128.6 (C4), 127.0 (C3), 40.2 (C6), 31.6 (C7), 29.8 (C8), 26.8 (C9), 22.7 
(C10), 14.1 (C11); HRMS(ESI-TOF): calcd. for C13H19NOH
+
: 206.1545. Found: 
206.1535 (MH
+
), 228.1349 (MNa
+
). This is consistent with literature data.
41
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N-Hexylnicotinamide 4.38 
 
According to representative procedure 7.4.6, the product was purified by silica 
column chromatography (eluent; Et2O/MeOH, 50:1, Rf = 0.18, det: KMnO4) and 
isolated as a yellow oil (111 mg, 54%). 
1
H NMR: (CDCl3, 300 MHz) δ = 9.04 (1H, d, 
J = 1.80 Hz, H1), 8.71 (1H, dd, J = 5.10 1.50 Hz, H2), 8.18 (1H, app. dt, J = 7.80 1.95 
Hz, H4), 7.42 (1H, ddd, 7.80 4.80 0.60 Hz, H3), 6.41 (1H, br s, NH), 3.47 (1H, dt, 
7.20 6.00 Hz, H7), 1.59-1.68 (2H, m, H8), 1.29-1.44 (6H, m, H9, H10 & H11), 0.87-0.92 
(3H, m, H12); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 165.7 (C6), 152.0 (C1), 147.9 (C2), 
135.3 (C4), 130.7 (C5), 123.6 (C3), 40.4 (C7), 31.6 (C8), 29.6 (C9), 26.7 (C10), 22.6 
(C11), 14.1 (C12); HRMS(ESI-TOF): calcd. for C12H18N2OH
+
: 207.1497. Found: 
207.1511 (MH
+
), 229.1323 (MNa
+
). This is consistent with literature data.
42
 
 
N-Benzylbutyramide 4.39 
 
According to representative procedure 7.4.6, the product was purified by silica 
column chromatography (eluent; hexanes/EtOAc, 20:1, Rf = 0.32, det: KMnO4) and 
isolated as a colourless solid (131 mg, 74%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.26-
7.36 (5H, m, arom. H), 5.70 (1H, br s, NH), 4.45 (2H, d, J = 5.70 Hz, H5), 2.20 (2H, t, 
J = 7.50 Hz, H2), 1.64-1.76 (2H, m, H3), 0.96 (3H, t, J = 7.50 Hz, H9); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 172.9 (C1), 138.6 (C6), 128.8 (C8), 127.9 (C7), 127.6 (C9), 
43.7 (C5), 38.8 (C2), 19.3 (C3), 13.9 (C4); HRMS(ESI-TOF): calcd. for C11H15NOH
+
: 
178.1232. Found: 178.1218 (MH
+
), 200.1037 (MNa
+
). This is consistent with 
literature data.
43
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N-(3-Phenylpropyl)butyramide 4.40 
 
According to representative procedure 7.4.6, the product was purified by silica 
column chromatography (eluent; Et2O/petroleum ether b. p. 40-60 °C, 3:1, Rf = 0.24, 
det: KMnO4) and isolated as a yellow oil (162 mg, 79%). IR: νmax/cm
-1
 (neat) 3291, 
2962, 2934, 1638, 1546, 1454, 744, 697; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.26-7.31 
(2H, m, arom. H), 7.17-7.21 (3H, m, arom. H), 5.42 (1H, br s, NH), 3.30 (2H, q, J = 
6.60 Hz, H1), 2.66 (2H, t, J = 7.20 Hz, H3), 2.11 (2H, t, J = 7.50 Hz, H9), 1.80-1.89 
(2H, m, H2), 1.57-1.70 (2H, m, H10), 0.94 (3H, t, J = 7.50 Hz, H11); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 173.1 (C8), 141.6 (C4), 128.6 (C6), 128.5 (C5), 126.1 (C7), 
39.3 (C1), 38.9 (C9), 33.5 (C3), 31.4 (C2), 19.3 (C10), 13.9 (C11); HRMS(ESI-TOF): 
calcd. for C13H19NOH
+
: 206.1545. Found: 206.1534 (MH
+
), 228.1349 (MNa
+
). CHN: 
Anal. Calc. for C13H19NO: C, 76.06%, H, 9.33%, N, 6.82%; Found: C, 75.90%, H, 
9.14%, N, 6.74%. 
 
7.4.6  Ruthenium Catalysed Drug Molecule Synthesis under Microwave 
Conditions 
 
2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine 4.41 
 
According to representative procedure 7.4.1, the product was purified by silica 
column chromatography (eluent; Et2O/petroleum ether b. p. 40-60 °C, 20:1, Rf = 
0.22, det: KMnO4) and isolated as a colourless solid (797 mg, 89%). 
1
H NMR: 
(CDCl3, 300 MHz) δ = 8.29 (2H, d, J = 4.80 Hz, H2), 6.89 (1H, s, H8), 6.76 (1H, s, 
H12), 6.76 (1H, s, H11), 6.46 (1H, t, J = 4.80 Hz, H1), 5.95 (2H, s, H13), 3.82 (4H, t, J = 
5.10 Hz, H4), 3.46 (2H, s, H6), 2.48 (4H, t, J = 5.10 Hz, H5); 
13
C NMR: (CDCl3, 75.4 
MHz) δ = 161.8 (C3), 157.8 (C2), 147.8 (C10), 146.8 (C9), 132.0 (C7), 122.4 (C12), 
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109.8 (C1), 109.6 (C8), 108.0 (C11), 101.0 (C13), 63.0 (C6), 53.0 (C5), 43.8 (C4); 
HRMS(ESI-TOF): calcd. for C16H19N4O2H
+
: 299.1508. Found: 299.1522 (MH
+
). This 
is consistent with literature data.
31
 
 
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide 4.42 
 
According to representative procedure 7.4.1, the product was purified by silica 
column chromatography (eluent; Et2O/hexanes, 4:1, Rf = 0.25, det: KMnO4) and 
isolated as a colourless solid (777 mg, 77%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.35-
7.43 (3H, m, arom. H), 7.23-7.29 (2H, m, arom. H), 7.14-7.20 (3H, m, arom. H), 
7.07-7.10 (2H, m, arom. H), 4.69 (1H, tt, J = 12.20 3.90 Hz, H5), 3.02 (2H, d, J = 
11.10 Hz, H3), 2.72-2.77 (2H, m, H2), 2.53-2.58 (2H, m, H1), 2.18 (2H, t, J = 11.10 
Hz, H4), 1.93 (2H, q, J = 7.50 Hz, H7), 1.81 (2H, d, J = 13.20 Hz, H3), 1.48 (2H, t, J = 
12.30 Hz, H4), 1.01 (3H, t, J = 7.50 Hz, H8); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 173.7 
(C6), 140.3 (C13), 139.0 (C9), 130.6 (C11), 129.4 (C15), 128.7 (C14), 128.5 (C10), 128.4 
(C12), 126.1 (C16), 60.6 (C2), 53.2 (C3), 52.3 (C5), 33.9 (C1), 30.7 (C7), 28.6 (C4), 9.7 
(C8); HRMS(ESI-TOF): calcd. for C22H28N2OH
+
: 337.2280. Found: 337.2287 (MH
+
), 
359.2096 (MNa
+
). This is consistent with literature data.
44
 
 
7.5 Experimental procedures: Chapter 5 
7.5.1 Representative Procedure for the Synthesis of Benzylic Alcohols 
To an oven dried, nitrogen purged round bottom flask was added the aldehyde (50 
mmol) and THF (100 mL) before cooling to 0 °C using an ice/water bath. 
Methylmagnesium bromide solution (3.0 M in Et2O, 19 mL, 57 mmol) was then 
added dropwise. Once the addition was complete the reaction was allowed to warm to 
room temperature over 2 hours. NH4Cl (sat. solution, 50 mL) and H2O (50 mL) were 
added before the organic layer was separated. The aqueous layer was then extracted 
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with EtOAc (2 x 50 mL). The combined organic phase was then dried (MgSO4) and 
concentrated in vacuo. The crude product was then purified by silica column 
chromatography. 
 
7.5.2  Representative Procedure for the Tandem Oxidation/C-H 
Activation Followed by Reduction 
To an oven-dried, nitrogen purged Young’s tube containing Ru(PPh3)3(CO)(H)2 (45.9 
mg, 0.05 mmol) were added 1-m-tolylethanol (136 mg, 1 mmol), 3,3-dimethylbut-1-
ene (0.30 mL, 2.3 mmol) and toluene (1 mL). The reaction vessel was then sealed and 
heated to 135 °C for 3 hours. On completion the reaction was allowed to cool to room 
temperature before formic acid (0.19 mL, 5 mmol) was added under nitrogen before 
the reaction was re-sealed and heated to 135 °C for 3 hours. On completion the 
reaction was allowed to cool to room temperature and the solvent removed in vacuo. 
The crude product was then purified by silica column chromatography. 
 
7.5.3  Representative Procedure for the Tandem Oxidation/C-H 
Activation 
To an oven-dried, nitrogen purged Young’s tube containing Ru(PPh3)3(CO)(H)2 (45.9 
mg, 0.05 mmol) were added 1-m-tolylethanol (136 mg, 1 mmol), 3,3-dimethylbut-1-
ene (0.30 mL, 2.3 mmol) and toluene (1 mL). The reaction vessel was then sealed and 
heated to 135 °C for 3 hours. On completion the reaction was allowed to cool to room 
temperature and the solvent removed in vacuo. The crude product was then purified 
by silica column chromatography. 
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7.5.4 Synthesis of Benzylic Alcohol Starting Materials 
 
1-m-Tolylethanol 5.1 
 
According to representative procedure 7.5.1, the product was purified by silica 
column chromatography (eluent; cyclohexane/EtOAc, 0-100% over 60 min, Rf = 0.49 
in 1:1 cyclohexane/EtOAc, det: KMnO4) and isolated as a yellow oil (5.72 g, 84%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.16-7.28 (3H, m, arom. H), 7.10 (1H, d, J = 7.80 
Hz, H5), 4.87 (1H, q, J = 6.60 Hz, H1), 2.37 (3H, s, H3), 1.80 (1H, br s, OH), 1.49 
(3H, d, J = 6.60 Hz, H2); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 145.9 (C4), 138.3 (C8), 
128.5 (C6), 128.3 (C7), 126.2 (C9), 122.5 (C5), 70.5 (C1), 25.2 (C2), 21.6 (C3); CHN: 
Anal. Calc. for C9H12O: C, 79.37%, H, 8.88%; Found: C, 79.50%, H, 8.71%. This is 
consistent with literature data.
45
 
 
(1-Methoxyethyl)benzene 5.3 
 
1-Phenyethanol (25 mL, 207 mmol) was dissolved in MeOH (50 mL) before cooling 
with an ice/water bath. Concentrated H2SO4 (12.5 mL) was then added dropwise. 
After the addition the reaction was heated to 55 °C for 2 hours. The reaction was then 
allowed to cool to room temperature before the solution was extracted with CH2Cl2 (3 
x 50 mL). The combined organic phase was then dried (MgSO4) before concentrating 
in vacuo. The product was then purified by Kugelrohr distillation (5.08 g, 18%) and 
isolated as a colourless oil. 
1
H NMR: (CDCl3, 300 MHz) δ = 7.25-7.39 (5H, m, arom. 
H), 4.30 (1H, q, J = 6.30 Hz, H1), 3.23 (3H, s, H3), 1.44 (3H, d, J = 6.30 Hz, H2); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 143.7 (C4), 128.6 (C6), 127.6 (C7), 126.3 (C5), 79.8 
(C1), 56.6 (C3), 24.0 (C2); HRMS(ESI-TOF): calcd. for C9H12ONa
+
: 159.0780. Found: 
159.0780 (MNa
+
). This is consistent with literature data.
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 1-p-Tolylethanol 5.8 
 
According to representative procedure 7.5.1, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 2:1, Rf = 0.24, 
det: KMnO4) and isolated as a colourless oil (5.86 g, 86%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.27 (2H, d, J = 8.10 Hz, H4), 7.16 (2H, d, J = 8.10 Hz, H5), 4.88 (1H, q, J 
= 6.60 Hz, H1), 2.35 (3H, s, H7), 1.74 (1H, br s, OH), 1.49 (3H, d, J = 6.60 Hz, H2); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 143.0 (C3), 137.1 (C6), 129.2 (C5), 125.4 (C4), 70.2 
(C1), 25.1 (C2), 21.2 (C7); HRMS(ESI-TOF): calcd. for C9H12OH
+
: 159.0786. Found: 
159.0780 (MH
+
). This is consistent with literature data.
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1-o-Tolylethanol 5.13 
 
According to representative procedure 7.5.1, the product was purified by silica 
column chromatography (eluent; cyclohexane/EtOAc, 0-100% over 60 min, Rf = 0.46 
in 1:1 cyclohexane/EtOAc, det: KMnO4) and isolated as a yellow oil (5.92 g, 87%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.52 (2H, d, J = 7.20 Hz, H8), 7.13-7.29 (3H, m, 
arom. H), 5.14 (1H, q, J = 6.60 Hz, H1), 2.35 (3H, s, H3), 1.69 (1H, br s, OH), 1.47 
(3H, d, J = 6.60 Hz, H2); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 144.0 (C4), 134.3 (C9), 
130.5 (C8), 127.3 (C7), 126.5 (C5), 124.6 (C6), 66.9 (C1), 24.0 (C2), 19.0 (C3); CHN: 
Anal. Calc. for C9H12O: C, 79.37%, H, 8.88%; Found: C, 79.40%, H, 8.77%. This is 
consistent with literature data.
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1-(3-Fluorophenyl)ethanol 5.15 
 
According to representative procedure 7.5.1, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 2:1, Rf = 0.24, 
det: KMnO4) and isolated as a yellow oil (4.84 g, 69%). 
1
H NMR: (CDCl3, 300 MHz) 
δ = 7.27-7.34 (1H, m, H7), 7.08-7.14 (2H, m, H6 & H8), 6.92-6.99 (1H, m, H4), 4.90 
(1H, q, J = 6.30 Hz, H1), 1.74 (1H, br s, OH), 1.49 (3H, d, J = 6.30 Hz, H2); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 163.1 (d, J = 245.4 Hz, C5), 148.7 (d, J = 6.6 Hz, C3), 
130.1 (d, J = 8.1 Hz, C7), 121.1 (d, J = 2.8 Hz, C8), 114.3 (d, J = 21.2 Hz, C6), 112.4 
(d, J = 21.8 Hz, C4), 69.9 (d, J = 1.7 Hz, C1), 25.3 (C2); CHN: Anal. Calc. for 
C8H9FO: C, 68.56%, H, 6.47%; Found: C, 68.60%, H, 6.60%. This is consistent with 
literature data.
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1-(3-Methoxyphenyl)ethanol 5.16 
 
According to representative procedure 7.5.1, the product was purified by silica 
column chromatography (eluent; cyclohexane/EtOAc, 0-100% over 60 min, Rf = 0.44 
in 1:1 cyclohexane/EtOAc, det: KMnO4) and isolated as a yellow oil (5.25 g, 87%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.27 (1H, app. t, J = 8.10 Hz, H6), 6.94-6.96 (2H, 
m, arom. H), 6.82 (1H, ddd, J = 8.10 2.40 1.20 Hz, H7), 4.88 (1H, q, J = 6.60 Hz, H1), 
3.82 (3H, s, H3), 1.74 (1H, br s, OH), 1.50 (3H, d, J = 6.60 Hz, H2); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 159.9 (C8), 147.7 (C4), 129.6 (C6), 117.8 (C5), 113.0 (C7), 
111.0 (C9), 70.4 (C1), 55.3 (C3), 25.2 (C2); CHN: Anal. Calc. for C9H12O2: C, 71.03%, 
H, 7.95%; Found: C, 71.20%, H, 7.85%. This is consistent with literature data.
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1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanol 5.21 
 
According to representative procedure 7.5.1, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 1:1, Rf = 0.18, 
det: KMnO4) and isolated as a yellow oil (6.76 g, 75%). 
1
H NMR: (CDCl3, 300 MHz) 
δ = 6.90 (1H, s, H4), 6.84-6.84 (2H, m, arom. H), 4.80 (1H, q, J = 6.30 Hz, H1), 4.25 
(4H, s, H9 & H10), 1.63 (1H, br s, OH), 1.46 (3H, d, J = 6.30 Hz, H2); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 143.5 (C6), 142.9 (C5), 139.5 (C3), 118.6 (C8), 117.3 (C7), 
114.5 (C4), 70.0 (C1), 64.5 (C9), 64.5 (C10), 25.1 (C2); CHN: Anal. Calc. for C10H12O3: 
C, 66.65%, H, 6.71%; Found: C, 66.60%, H, 6.62%. This is consistent with literature 
data.
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1-(Pyridin-3-yl)ethanol 5.23 
 
According to representative procedure 7.5.1, the product was purified by silica 
column chromatography (eluent; EtOAc/MeOH, 20:1, Rf = 0.24, det: KMnO4) and 
isolated as a yellow oil (5.11 g, 83%). 
1
H NMR: (CDCl3, 300 MHz) δ = 8.56 (1H, d, J 
= 2.10 Hz, H7), 8.49 (1H, dd, J = 4.80 1.50 Hz, H6), 7.72-7.76 (1H, m, H4), 7.28 (1H, 
ddd, J = 7.80 4.80 0.60 Hz, H5), 4.95 (1H, q, J = 6.60 Hz, H2), 2.53 (1H, br s, OH), 
1.52 (3H, d, J = 6.60 Hz, H1); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 148.1 (C7), 147.1 
(C6), 141.8 (C3), 133.6 (C4), 123.7 (C5), 67.6 (C2), 25.3 (C1); HRMS(ESI-TOF): 
calcd. for C7H10NOH
+
: 124.0762. Found: 124.0763 (MH
+
). This is consistent with 
literature data.
50
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1-(Thiophen-2-yl)ethanol 5.24 
 
According to representative procedure 7.5.1, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 2:1, Rf = 0.21, 
det: KMnO4) and isolated as a yellow oil (5.06 g, 79%). 
1
H NMR: (CDCl3, 300 MHz) 
δ = 7.24 (1H, dd, J = 4.80 1.50 Hz, H6), 6.95-7.00 (2H, m, H4 & H5), 5.14 (1H, q, J = 
6.30 Hz, H1), 1.93 (1H, br s, OH), 1.61 (3H, d, J = 6.30 Hz, H2); 
13
C NMR: (CDCl3, 
75.4 MHz) δ = 150.0 (C3), 126.8 (C6), 124.6 (C5), 123.3 (C4), 66.4 (C1), 25.4 (C2); 
CHN: calcd. for C6H8OSH
+
: 151.0188. Found: 151.0188 (MNa
+
). This is consistent 
with literature data.
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7.5.5 Ruthenium-Catalysed Synthesis of Alkylated Benzylic Alcohols 
Using A Tandem Oxidation/C-H Activation Process Followed by 
Reduction 
 
1-(2-(3,3-Dimethylbutyl)phenyl)ethanol 5.10 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.21, 
det: KMnO4) and isolated as a brown oil (157 mg, 76%). IR: νmax/cm
-1
 (neat) 3351, 
2953, 1467, 1364, 1246, 1075, 1003, 756; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.51-7.54 
(1H, m, H6), 7.12-7.24 (3H, m, arom. H), 5.17 (1H, q, J = 6.60 Hz, H1), 2.61 (2H, t, J 
= 8.70 Hz, H9), 1.61 (1H, br s, OH), 1.51 (3H, d, J = 6.60 Hz, H2), 1.41-1.473 (2H, m, 
H10), 0.98 (9H, s, H12); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 143.4 (C3), 139.9 (C8), 
129.6 (C7), 127.5 (C6), 126.5 (C5), 125.1 (C4), 66.3 (C1), 46.8 (C10), 30.8 (C11), 29.4 
(C12), 27.7 (C9), 25.0 (C2); HRMS(ESI-TOF): calcd. for C14H22ONa
+
: 229.1568. 
Chapter 7 
164 
 
Found: 229.1560 (MNa
+
); CHN: Anal. Calc. for C14H22O: C, 81.50%, H, 10.75%; 
Found: C, 81.40%, H, 10.60%. 
 
1-(2-(3,3,-Dimethylbutyl)-4-methylphenyl)ethanol 5.11 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.21, 
det: KMnO4) and isolated as a yellow oil (123 mg, 56%). IR: νmax/cm
-1
 (neat) 3351, 
2953, 1466, 1364, 1076, 1007, 890, 820; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.41 (1H, 
d, J = 8.10 Hz, H4), 7.04 (1H, d, J = 8.10 Hz, H5), 6.96 (1H, s, H7), 5.13 (1H, q, J = 
6.30 Hz, H1), 2.58 (2H, t, J = 8.70 Hz, H10), 2.31 (3H, s, H9), 1.57 (1H, br s, OH), 
1.49 (3H, d, J = 6.30 Hz, H2), 1.40-1.46 (2H, m, H11), 0.98 (9H, s, H13); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 140.4 (C6), 139.9 (C3), 137.1 (C8), 130.3 (C7), 127.2 (C4), 
125.2 (C5), 66.2 (C1), 46.9 (C11), 30.8 (C12), 29.4 (C13), 27.7 (C10), 24.9 (C2), 21.2 
(C9); HRMS(ESI-TOF): calcd. for C15H24ONa
+
: 243.1725. Found: 243.1727 (MNa
+
); 
CHN: Anal. Calc. for C15H24O: C, 81.76%, H, 10.98%; Found: C, 81.63%, H, 
10.80%. 
 
1-(2-(3,3-Dimethylbutyl)-4-fluorophenyl)ethanol 5.12 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 3:1, Rf = 0.23, 
det: KMnO4) and isolated as a yellow oil (139 mg, 62%). IR: νmax/cm
-1
 (neat) 3351, 
2954, 1613, 1591, 1497, 1365, 1239, 1074, 865, 819; 
1
H NMR: (CDCl3, 300 MHz) δ 
= 7.49 (1H, dd, J = 8.40 6.00 Hz, H8), 6.82-6.94 (2H, m, H5 & H7), 5.12 (1H, dq, J = 
6.60 3.00 Hz, H1), 2.59 (2H, t, J = 8.85 Hz, H9), 1.63 (1H, d, J = 3.30 Hz, OH), 1.48 
(3H, d, J = 6.60 Hz, H2), 1.36-1.51 (2H, m, H10), 0.98 (9H, s, H12); 
13
C NMR: (CDCl3, 
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75.4 MHz) δ = 162.1 (d, J = 244.7 Hz, C6), 142.4 (d, J = 7.1 Hz, C4), 139.1 (d, J = 3.0 
Hz, C3), 127.0 (d, J = 8.4 Hz, C8), 115.8 (d, J = 23.0 Hz, C5), 113.1 (d, J = 20.9 Hz, 
C7), 65.9 (C1), 46.3 (C10), 30.8 (C11), 29.3 (C12), 27.7 (d, J = 1.28 Hz, C9), 25.1 (C2); 
19
F NMR: (CDCl3, 376 MHz) δ = -619.4 (ddd, J = 9.8, 8.3, 6.0 Hz); HRMS(ESI-
TOF): calcd. for C14H21OFNa
+
: 247.1474. Found: 247.1463 (MNa
+
); CHN: Anal. 
Calc. for C14H21OF: C, 74.96%, H, 9.44%; Found: C, 75.00%, H, 9.24%. 
 
1-(2-(3,3-Dimethylbutyl)-6-methylphenyl)ethanol 5.17 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 5:1, Rf = 0.23, 
det: KMnO4) and isolated as a yellow oil (90 mg, 41%). IR: νmax/cm
-1
 (neat) 3350, 
2952, 1465, 1364, 109, 893, 756; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.08 (1H, dd, J = 
7.50 6.90 Hz, H6), 6.98-7.00 (2H, m, H5 & H7), 5.39 (1H, qd, J = 6.90 2.40 Hz, H1), 
2.63-2.79 (2H, m, H10), 2.50 (3H, s, H9), 1.68 (1H, d, J = 2.70 Hz, OH), 1.58 (3H, d, J 
= 6.90 Hz, H2), 1.45 (2H, dd, J = 9.60 8.10 Hz, H11), 0.98 (9H, s, H13); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 141.4 (C4), 140.2 (C3), 136.4 (C8), 129.7 (C5), 128.6 (C6), 
127.3 (C7), 67.5 (C1), 47.4 (C11), 30.9 (C12), 29.4 (C13), 29.0 (C10), 22.6 (C2), 20.9 
(C9); HRMS(ESI-TOF): calcd. for C15H24ONa
+
: 243.1725. Found: 243.1718 (MNa
+
); 
CHN: Anal. Calc. for C15H24O: C, 81.76%, H, 10.98%; Found: C, 81.60%, H, 
11.10%. 
 
1-(2-(3,3-Dimethylbutyl)-5-methylphenyl)ethanol 5.3 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.21, 
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det: KMnO4) and isolated as a brown oil (159 mg, 72%). IR: νmax/cm
-1
 (neat) 3336, 
2954, 1467, 1364, 1246, 1074, 1026, 823; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.34 (1H, 
s, H4), 7.03 (2H, s, H7 & H8), 5.14 (1H, q, J = 6.30 Hz, H1), 2.57 (2H, t, J = 8.85 Hz, 
H10), 2.33 (3H, s, H5), 1.61 (1H, br s, OH), 1.49 (3H, d, J = 6.30 Hz, H2), 1.39-1.47 
(2H, m, H11), 0.98 (9H, s, H13); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 143.1 (C1), 136.8 
(C6), 135.9 (C9), 129.6 (C8), 128.3 (C4), 125.7 (C7), 66.3 (C1), 47.0 (C11), 30.8 (C12), 
29.4 (C13), 27.3 (C10), 25.0 (C2), 21.3 (C5); HRMS(ESI-TOF): calcd. for C15H24ONa
+
: 
243.1722. Found: 243.1725 (MNa
+
); CHN: Anal. Calc. for C15H24O: C, 81.76%, H, 
10.98%; Found: C, 81.72%, H, 10.80%. 
 
1-(2-(3,3-Dimethylbutyl)-5-(trifluoromethyl)phenyl)ethanol 5.18 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 6:1, Rf = 0.20, 
det: KMnO4) and isolated as a brown solid (239 mg, 87%). m. p. = 61-63 °C; IR: 
νmax/cm
-1
 (neat) 3353, 3288, 2954, 1366, 1324, 1149, 1129, 1116, 1087, 916, 830; 
1
H 
NMR: (CDCl3, 300 MHz) δ = 7.81 (1H, s, H8), 7.44 (1H, dd, J = 8.10 1.50 Hz, H6), 
7.24 (1H, d, J = 8.10 Hz, H5), 5.19 (1H, q, J = 6.60 Hz, H1), 2.64 (2H, t, J = 8.85 Hz, 
H10), 1.62 (1H, br s, OH), 1.41-1.49 (2H, m, H11), 0.99 (9H, s, H13); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 144.2 (C4), 143.8 (d, J = 1.1 Hz, C3), 130.0 (C5), 128.8 (d, J = 
32.3 Hz, C7), 124.5 (q, J = 271.7 Hz, C9), 124.2 (q, J = 3.8 Hz, C8), 122.3 (q, J = 3.9 
Hz, C6), 66.1 (C1), 46.4 (C11), 30.9 (C12), 29.3 (C13), 27.7 (C10), 25.1 (C2); 
19
F NMR: 
(CDCl3, 376 MHz) δ = -62.4 (s); HRMS(ESI-TOF): calcd. for C15H21OF3Na
+
: 
297.1437. Found: 297.1437 (MNa
+
); CHN: Anal. Calc. for C15H21OF3: C, 65.67%, H, 
7.72%; Found: C, 65.70%, H, 7.73%. 
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1-(2-(3,3-Dimethylbutyl)-5-fluorophenyl)ethanol 5.19 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.19, 
det: KMnO4) and isolated as a brown oil (139 mg, 62%). IR: νmax/cm
-1
 (neat) 3345, 
2956,1463, 1365, 1243, 1061, 864, 793; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.32 (1H, 
d, J = 7.80 Hz, H7), 7.15-7.22 (1H, m, H6), 6.93 (1H, app. t, J = 9.00 Hz, H4), 5.13 
(1H, q, J = 6.30 Hz, H1), 2.52-2.75 (2H, m, H9), 1.60 (1H, br s, OH), 1.50 (3H, d, J = 
6.30 Hz, H2), 1.37-1.44 (2H, m, H10), 0.99 (9H, s, H12); 
13
C NMR: (CDCl3, 75.4 
MHz) δ = 161.2 (d, J = 243.6 Hz, C5), 145.8 (d, J = 3.8 Hz, C3), 127.4 (d, J = 15.5 
Hz, C6), 127.3 (d, J = 9.0 Hz, C7), 120.7 (d, J = 3.1 Hz, C8) 114.1 (d, J = 23.1 Hz, C4), 
66.2 (d, J = 3.10 Hz, C1), 45.0 (C10), 30.9 (C11), 29.2 (C12), 25.1 (C2), 20.3 (d, J = 4.3 
Hz, C9); 
19
F NMR: (CDCl3, 376 MHz) δ = - 118.7 (dddt, J = 9.8, 5.6, 1.9 Hz); 
HRMS(ESI-TOF): calcd. for C14H21OFNa
+
: 247.1474. Found: 247.1481 (MNa
+
); 
CHN: Anal. Calc. for C14H21OF: C, 74.96%, H, 9.44%; Found: C, 75.10%, H, 9.33%. 
 
1-(2-(3,3-Dimethylbutyl)-5-methoxyphenyl)ethanol 5.20 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 7:2, Rf = 0.22, 
det: KMnO4) and isolated as a yellow oil (147 mg, 70%). IR: νmax/cm
-1
 (neat) 3226, 
2950, 1585, 1466, 1362, 1260, 1245, 1071, 1009, 847, 788, 725; 
1
H NMR: (CDCl3, 
300 MHz) δ = 7.13-7.21 (2H, m, arom. H), 6.76-6.79 (1H, m, arom. H), 5.15 (1H, q, J 
= 6.30 Hz, H1), 3.82 (3H, s, H9), 2.51-2.75 (2H, m, H10), 1.64 (1H, br s, OH), 1.49 
(3H, d, J = 6.30 Hz, H2), 1.31-1.41 (2H, m, H11), 0.98 (9H, s, H13); Minor 7.04-7.23 
(2H, m, arom. H), 6.74-6.77 (1H, m, arom. H), 5.15 (1H, q, J = 6.30 Hz, H1), 3.81 
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(3H, s, H9), 2.51-2.75 (2H, m, H10), 1.64 (1H, br s, OH), 1.49 (3H, d, J = 6.30 Hz, 
H2), 1.31-1.41 (2H, m, H11), 0.97 (9H, s, H13); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 
Major 157.4 (C5), 144.8 (C3), 128.7 (C7), 126.9 (C4), 117.2 (C8), 109.4 (C6), 66.4 
(C1), 55.7 (C9), 44.5 (C11), 30.9 (C12), 29.3 (C13), 25.1 (C2), 20.7 (C10); Minor 158.3 
(C5), 131.8 (C3), 130.6 (C7), 128.7 (C8), 113.2 (C6), 110.4 (C4), 66.4 (C1), 55.4 (C9), 
47.0 (C11), 30.8 (C12), 29.4 (C13), 26.9 (C10), 25.1 (C2); HRMS(ESI-TOF): calcd. for 
C15H24O2Na
+
: 259.1674. Found: 259.1654 (MNa
+
); CHN: Anal. Calc. for C15H24O2: 
C, 76.23%, H, 10.24%; Found: C, 76.20%, H, 10.40%. 
 
1-(5-(3,3-Dimethylbutyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)ethanol 5.25 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 2:1, Rf = 0.23, 
det: KMnO4) and isolated as a brown solid (139 mg, 53%). m. p. = 69-71 °C; IR: 
νmax/cm
-1
 (neat) 3317, 2958, 2866, 2160, 2032, 1978, 1606, 1487, 1435, 1367, 1283, 
1072; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.02 (1H, d, J = 8.70 Hz, H8), 6.76 (1H, d, J = 
8.70 Hz, H7), 5.06 (1H, q, J = 6.30 Hz, H1), 4.21-4.28 (4H, m, H9 & H10), 2.51-2.70 
(2H, m, H11), 1.57 (1H, br s, OH), 1.47 (3H, d, J = 6.30 Hz, H2), 1.31-1.40 (2H, m, 
H12), 0.98 (9H, s, H14); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 142.6 (C5), 141.0 (C6), 
136.6 (C3), 129.4 (C4), 117.6 (C8), 115.0 (C7), 66.1 (C1), 64.4 (C9), 64.3 (C10), 44.5 
(C12), 30.9 (C13), 29.3 (C14), 24.9 (C2), 20.6 (C11); HRMS(ESI-TOF): calcd. for 
C16H24O3Na
+
: 287.1623. Found: 287.1617 (MNa
+
); CHN: Anal. Calc. for C16H24O3: 
C, 72.69%, H, 9.15%; Found: C, 72.80%, H, 9.20%. 
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1-(1-(3,3-Dimethylbutyl)naphthalen-2-yl)ethanol 5.26 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 3:1, Rf = 0.25, 
det: KMnO4) and isolated as a brown solid (228 mg, 89%). m. p. = 98-100 °C; IR: 
νmax/cm
-1
 (neat) 3282, 2948, 2905, 2865, 1478, 1364, 1284, 1101, 1067, 818, 745; 
1
H 
NMR: (CDCl3, 300 MHz) δ = 8.03 (1H, d, J = 8.40 Hz, H6), 7.69-7.84 (3H, m, arom. 
H), 7.43-7.54 (2H, m, arom. H), 5.42 (1H, q, J = 6.30 Hz, H1), 2.98-3.18 (2H, m, 
H13), 1.61 (1H, br s, OH), 1.57 (3H, d, J = 6.30 Hz, H2), 1.45-1.62 (2H, m, H14), 1.08 
(9H, s, H16); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 140.0 (C3), 134.6 (C4), 133.4 (C5), 
131.9 (C10), 128.8 (C9), 127.1 (C12), 126.2 (C11), 125.4 (C7), 124.1 (C6), 123.3 (C8), 
66.6 (C1), 45.5 (C14), 31.2 (C15), 29.4 (C16), 25.1 (C2), 22.9 (C13); HRMS(ESI-TOF): 
calcd. for C18H24ONa
+
: 279.1725. Found: 279.1717 (MNa
+
); CHN: Anal. Calc. for 
C18H24O: C, 84.32%, H, 9.44%; Found: C, 84.30%, H, 9.44%. 
 
1-(4-(3,3-Dimethylbutyl)pyridine-3-yl)ethanol 5.27 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; Et2O, Rf = 0.16, det: KMnO4) and isolated as a 
colourless oil (114 mg, 55%). IR: νmax/cm
-1
 (neat) 3220, 2953, 1600, 1365, 1096, 
1067, 904, 730; 
1
H NMR: (CDCl3, 300 MHz) δ = 8.49 (1H, s, H3), 8.12 (1H, d, J = 
5.10 Hz, H7), 6.94 (1H, d, J = 5.10 Hz, H6), 5.07 (1H, q, J = 6.30 Hz, H1), 4.87 (1H, 
br s, OH), 2.53 (2H, t, J = 8.70 Hz, H8), 1.45 (3H, d, J = 6.30 Hz, H2), 1.30-1.41 (2H, 
m, H9), 0.90 (9H, s, H11); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 149.3 (C3), 147.4 (C7), 
147.2 (C4), 139.6 (C5), 124.0 (C6), 64.6 (C1), 45.3 (C9), 30.7 (C10), 29.2 (C11), 26.9 
Chapter 7 
170 
 
(C8), 24.9 (C2); HRMS(ESI-TOF): calcd. for C13H21NOH
+
: 208.1701. Found: 
208.1695 (MH
+
); CHN: Anal. Calc. for C13H21NO: C, 75.32%, H, 10.21%, N, 6.76%; 
Found: C, 75.40%, H, 10.30%, N, 6.86%. 
 
1-(3-(3,3-Dimethylbutyl)thiophen-2-yl)ethanol 5.28 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 5:1, Rf = 0.22, 
det: KMnO4) and isolated as a brown oil (117 mg, 55%). IR: νmax/cm
-1
 (neat) 3354, 
2953, 1467, 1364, 1064, 883, 716, 656; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.15 (1H, d, 
J = 5.10 Hz, H10), 6.83 (1H, d, J = 5.10 Hz, H9), 5.21 (1H, q, J = 6.60 Hz, H6), 2.53-
2.59 (2H, m, H1), 1.69 (1H, br s, OH), 1.58 (2H, d, J = 6.60 Hz, H5), 1.41-1.49 (2H, 
m, H2), 0.96 (9H, s, H4); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 142.6 (C7), 139.1 (C8), 
129.1 (C10), 123.1 (C9), 64.4 (C6), 45.8 (C2), 30.7 (C3), 29.4 (C4), 25.5 (C1), 23.7 (C5); 
HRMS(ESI-TOF): calcd. for C12H20OSNa
+
: 235.1127. Found: 235.1127 (MNa
+
); 
CHN: Anal. Calc. for C12H20OS: C, 67.87%, H, 9.49%; Found: C, 67.70%, H, 9.39%. 
 
1-(5-Methyl-2-(3-(trimethylsilyl)propyl)phenyl)ethanol 5.39 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 6:1, Rf = 0.20, 
det: KMnO4) and isolated as a brown oil (170 mg, 68%). IR: νmax/cm
-1
 (neat) 3363, 
2952, 1247, 1072, 833, 691; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.35 (1H, s, H4), 7.00-
7.06 (2H, m, arom. H), 5.16 (1H, q, J = 6.60 Hz, H1), 2.63 (2H, t, J = 7.80 Hz, H9), 
2.34 (3H, s, H13), 1.62 (1H, br s, OH), 1.49-1.60 (2H, m, H10), 1.48 (3H, d, J = 6.60 
Hz, H2), 0.56-0.61 (2H, m, H11), -0.02 (9H, s, H12); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 
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143.3 (C3), 136.1 (C5), 136.0 (C8), 129.6 (C7), 128.2 (C4), 125.7 (C6), 66.4 (C1), 36.1 
(C9), 29.6 (C10), 25.0 (C2), 21.3 (C13), 17.2 (C11), -1.54 (C12); HRMS(ESI-TOF): 
calcd. for C15H26OSiNa
+
: 273.1651. Found: 273.1653 (MNa
+
); CHN: Anal. Calc. for 
C15H26O: C, 71.93%, H, 10.46%; Found: C, 71.90%, H, 10.46%. 
 
1-(2-(Bicyclo[2.2.1]heptan-2-yl)-5-methylphenyl)ethanol 5.40 
 
According to representative procedure 7.5.2, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 3:1, Rf = 0.20, 
det: KMnO4) and isolated as an off-white solid oil (193 mg, 84%). IR: νmax/cm
-1
 
(neat) 3314, 2945, 2866,1499, 1451, 1365, 1289, 1075, 811; 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.36 (1H, m, H4), 7.16 (1H, dd, J = 7.80 0.90 Hz, H7), 7.04 (1H, dd, J = 
8.10, 0.60 Hz, H6), 5.18 (1H, q, J = 6.30 Hz, H1), 2.87 (1H, m, H10), 2.36 (1H, br s, 
OH), 2.33 (3H, s, H9), 1.53-1.90 (7H, m, alk. H), 1.48 (3H, dd, J = 6.30 3.30 Hz, H2), 
1.24-1.40 (3H, m, alk. H); Analysis of the 
13
C NMR showed that the two 
diastereomers were clearly visible. Both diastereomers are reported here. 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 143.5 & 143.4 (C8), 140.9 & 140.7 (C3), 135.5 (C5), 128.1 & 
128.1 (C4), 126.1 & 125.9 (C6), 125.3 & 125.2 (C7), 66.2 & 66.1 (C1), 42.6 & 42. 
4(C10), 42.4 & 42.2 (C12), 40.5 & 40.4 (C11), 37.1 & 37.0 (C14), 36.7 & 36.7 (C13), 
30.9 & 30.8 (C16), 29.0 (C15), 25.0 & 24.8 (C2), 21.1 (C9); HRMS(ESI-TOF): calcd. 
for C16H22ONa
+
: 253.1568. Found: 253.1565 (MNa
+
); CHN: Anal. Calc. for C16H22O: 
C, 83.43%, H, 9.63%; Found: C, 83.49%, H, 9.62%. 
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7.6.5 Ruthenium-Catalysed Synthesis of Alkylated Aromatic Ketones 
Using A Tandem Oxidation/C-H Activation Process 
 
1-(2,6-Bis(3,3-dimethylbutyl)phenylethanone 5.29 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 20:1, Rf = 
0.20, det: KMnO4) and isolated as a brown oil (283 mg, 98%). IR: νmax/cm
-1
 (neat) 
2953, 1699, 1464, 1364, 1246, 758; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.21 (1H, t, J = 
7.50 Hz, H6), 7.03 (2H, d, J = 7.50 Hz, H5), 2.50 (3H, s, H2), 2.41-2.47 (4H, m, H7), 
1.43-1.49 (4H, m, H8), 0.93 (18H, s, H10); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 208.2 
(C1), 142.1 (C3), 138.0 (C4), 128.8 (C6), 126.9 (C5), 46.7 (C8), 33.2 (C2), 30.7 (C9), 
29.3 (C10), 28.7 (C7); HRMS(ESI-TOF): calcd. for C20H32OH
+
: 289.2531. Found: 
289.2531 (MH
+
), 311.2338 (MNa
+
); CHN: Anal. Calc. for C20H32O: C, 83.27%, H, 
11.18%; Found: C, 83.16%, H, 11.10%. 
 
1-(2-(3,3-Dimethylbutyl)-6-methylphenyl)ethanone 5.30 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 20:1, Rf = 
0.21, det: KMnO4) and isolated as a brown oil (212 mg, 97%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.16-7.21 (1H, m, H7), 7.00-7.05 (2H, m, arom. H), 2.49 (3H, s, H1), 2.42-
2.48 (2H, m, H10), 2.25 (3H, s, H4), 1.42-1.48 (2H, m, H11), 0.93 (9H, s, H13); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 208.4 (C2), 142.4 (C3), 138.1 (C9), 132.2 (C5), 128.7 
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(C7), 127.8 (C6), 127.0 (C8), 46.7 (C11), 32.7 (C1), 30.7 (C12), 29.3 (C13), 28.6 (C10), 
19.3 (C4); HRMS(ESI-TOF): calcd. for C15H22OH
+
: 219.1749. Found: 219.1742 
(MH
+
). This is consistent with literature data.
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1-(2-(3,3-Dimethylbutyl)-5-methylphenyl)ethanone 5.31 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 20:1, Rf = 
0.21, det: KMnO4) and isolated as a brown oil (210 mg, 96%). IR: νmax/cm
-1
 (neat) 
2953, 1685, 1467, 1354, 1264, 1186, 951, 828, 619; 
1
H NMR: (CDCl3, 300 MHz) δ = 
7.41 (1H, s, H4), 7.20 (1H, dd, J = 7.80 1.50 Hz, H7), 7.13 (1H, d, J = 7.80 Hz, H8), 
2.73-2.79 (2H, m, H10), 2.57 (3H, s, H1), 2.36 (3H, s, H5), 1.38-1.44 (2H, m, H11), 
0.96 (9H, s, H13); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 202.4 (C2), 140.6 (C3), 138.1 
(C9), 135.1 (C6), 132.2 (C7), 131.3 (C8), 129.7 (C4), 46.7 (C11), 30.8 (C12), 30.0 (C1), 
29.4 (C13), 21.0 (C5); HRMS(ESI-TOF): calcd. for C15H22ONa
+
: 241.1568. Found: 
241.1554 (MNa
+
); CHN: Anal. Calc. for C15H22O: C, 82.52%, H, 10.16%; Found: C, 
82.50%, H, 9.96%. 
 
8-(3,3-Dimethylbutyl)-3,4-dihydronaphthalen-1(2H)-one 5.32 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 17:1, Rf = 
0.19, det: KMnO4) and isolated as a brown oil (187 mg, 81%). 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.32 (1H, dd, J = 7.80 7.20 Hz, H7), 7.09 (1H, d, J = 7.80 Hz, H6), 7.08 
(1H, d, J = 7.80 Hz, H8), 2.93-3.03 (4H, m, H4 & H11), 2.65 (2H, t, J = 6.60 Hz, H2), 
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2.03-2.12 (2H, m, H3), 1.40-1.46 (2H, m, H12), 1.00 (9H, s, H14); 
13
C NMR: (CDCl3, 
75.4 MHz) δ = 200.0 (C1), 147.2 (C10), 146.0 (C9), 132.4 (C7), 131.1 (C5), 130.1 (C8), 
126.8 (C6), 46.1 (C12), 41.3 (C2), 31.3 (C4), 30.9 (C13), 30.9 (C11), 29.5 (C14), 23.1 
(C3); HRMS(ESI-TOF): calcd. for C16H22OH
+
: 231.1749. Found: 231.1741 (MH
+
), 
253.1556 (MNa
+
). This is consistent with literature data.
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1-(2-(3,3-Dimethylbutyl)naphthalene-1-yl)ethanone 5.33 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 16:1, Rf = 
0.22, det: KMnO4) and isolated as a brown oil (252 mg, 99%). IR: νmax/cm
-1
 (neat) 
2953, 1699, 1467, 1364, 1350, 1205, 955, 818, 741; 
1
H NMR: (CDCl3, 300 MHz) δ = 
7.72-7.87 (2H, m, H6 & H11), 7.56-7.63 (1H, m, H8), 7.42-7.53 (2H, m, H9 & H10), 
7.32 (1H, d, J = 8.40 Hz, H5), 2.65 (3H, s, H2), 2.60-2.66 (2H, m, H13), 1.51-1.57 (2H, 
m, H14), 0.98 (9H, s, H16); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 208.2 (C1), 138.5 (C4), 
135.6 (C6), 131.9 (C7), 129.1 (C12), 129.0 (C8), 128.4 (C10), 127.8 (C3), 126.9 (C5), 
125.6 (C11), 124.1 (C9), 46.6 (C14), 33.5 (C2), 30.8 (C15), 29.3 (C16), 29.1 (C13); 
HRMS(ESI-TOF): calcd. for C18H22OH
+
: 255.1749. Found: 255.1733 (MH
+
), 
277.1552 (MNa
+
); CHN: Anal. Calc. for C18H22O: C, 84.99%, H, 8.72%; Found: C, 
84.90%, H, 8.72%. 
 
1-(3-(3,3-Dimethylbutyl)thiophen-2-yl)ethanone 5.34 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 20:1, Rf = 
0.25, det: KMnO4) and isolated as a brown oil (160 mg, 76%). IR: νmax/cm
-1
 (neat) 
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2953, 1664, 1521, 1409 1380, 1264, 1242, 846, 731; 
1
H NMR: (CDCl3, 300 MHz) δ 
= 7.40 (1H, d, J = 5.10 Hz, H10), 6.99 (1H, d, J = 5.10 Hz, H9), 2.95-3.01 (2H, m, H1), 
2.54 (3H, s, H5), 1.44-1.49 (2H, m, H2), 0.98 (9H, s, H4); 
13
C NMR: (CDCl3, 75.4 
MHz) δ = 191.0 (C6), 151.2 (C7), 135.5 (C8), 131.7 (C10), 129.9 (C9), 44.7 (C2), 30.7 
(C3), 29.9 (C5), 29.4 (C4), 25.9 (C1); HRMS(ESI-TOF): calcd. for C12H18OSH
+
: 
211.1157. Found: 211.1157 (MH
+
), 233.0969 (MNa
+
); CHN: Anal. Calc. for 
C12H18OS: C, 68.52%, H, 8.63%; Found: C, 68.40%, H, 8.53%. 
 
1-(2,6-Bis(3,3-dimethylbutyl)-4-methoxyphenyl)ethanone 5.35 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 20:1, Rf = 
0.21, det: KMnO4) and isolated as a brown oil (271 mg, 85%). IR: νmax/cm
-1
 (neat) 
2953, 1694, 1601, 1466, 1364, 1320, 1154, 1079, 966; 
1
H NMR: (CDCl3, 300 MHz) δ 
= 6.56 (2H, s, H5), 3.80 (3H, s, H7), 2.48 (3H, s, H2), 2.40-2.45 (4H, m, H8), 1.43-1.48 
(4H, m, H9), 0.93 (18H, s, H11); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 208.1 (C1), 159.8 
(C6), 140.2 (C4), 135.1 (C3), 112.3 (C5), 55.3 (C7), 46.5 (C9), 33.5 (C2), 30.7 (C10), 
29.3 (C11), 28.9 (C8); HRMS(ESI-TOF): calcd. for C21H34O2H
+
: 319.2637. Found: 
319.2632 (MH
+
), 341.2441 (MNa
+
); CHN: Anal. Calc. for C21H34O2: C, 79.19%, H, 
10.76%; Found: C, 79.09%, H, 10.67%. 
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1-(5-Methyl-2-phenethylphenyl)ethanone 5.37 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 14:1, Rf = 
0.20, det: KMnO4) and isolated as a brown oil (160 mg, 67%).  IR: νmax/cm
-1
 (neat) 
3026, 2923, 1681, 1495, 1354, 1272, 1187, 750, 698; 
1
H NMR: (CDCl3, 300 MHz) δ 
= 7.46 (1H, s, H4), 7.11-7.30 (7H, m, arom. H), 3.08-3.13 (2H, m, H9), 2.83-2.88 (2H, 
m, H10), 2.52 (3H, s, H2), 2.38 (3H, s, H15); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 202.2 
(C1), 142.2 (C11), 139.0 (C3), 138.0 (C8), 135.6 (C5), 132.3 (C6), 131.5 (C7), 129.9 
(C14), 128.8 (C13), 128.4 (C12), 125.9 (C4), 38.4 (C9), 36.1 (C10), 29.8 (C2), 21.1 (C15); 
HRMS(ESI-TOF): calcd. for C17H18OH
+
: 239.1436. Found: 239.1436 (MH
+
), 
261.1254 (MNa
+
); CHN: Anal. Calc. for C17H18O: C, 85.67%, H, 7.61%; Found: C, 
85.77%, H, 7.62%. 
 
1-(5-(Methyl-2-(trimethylsilyl)ethyl)phenyl)ethanone 5.38 
 
According to representative procedure 7.5.3, the product was purified by silica 
column chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 24:1, Rf = 0.37 
& 0.23, det: KMnO4) and isolated as a brown oil (151 mg, 59%). IR: νmax/cm
-1
 (neat) 
2953, 1685, 1415, 1247, 860, 827, 691; 
1
H NMR: (CDCl3, 300 MHz) δ = Major 7.41 
(1H, s, H4), 7.20 (1H, dd, J = 7.80 1.50 Hz, H6), 7.15 (1H, d, J = 7.80 Hz, H7), 2.76-
2.82 (2H, m, H10), 2.56 (3H, s, H2), 2.36 (3H, s, H9), 0.76-0.82 (2H, m, H11), 0.03 
(9H, s, H12); Minor 7.07 (1H, d, J = 7.80 Hz, H6), 6.97 (1H, d, J = 7.80 Hz, H7), 2.47 
(3H, s, H2), 2.38-2.45 (4H, m, H10 & H13), 2.27 (3H, s, H9), 0.68-0.83 (4H, m, H11 & 
H14), 0.01 (18H, s, H12 & H15); 
13
C NMR: (CDCl3, 75.4 MHz) δ = Major 202.4 (C1), 
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142.9 (C3), 137.5 (C8), 135.0 (C5), 132.3 (C6), 130.5 (C7), 129.8 (C4), 30.0 (C2), 28.0 
(C10), 21.0 (C9), 19.7 (C11), -1.65 (C12); Minor 208.7 (C1), 141.5 (C4), 138.0 (C5), 
137.6 (C6), 133.3 (C3), 130.9 (C7), 126.0 (C8), 33.4 (C2), 27.2 (C13), 24.9 (C10), 19.5 
(C9), 18.9 (C11), 18.4 (C14), -1.76 (C15), -1.87 (C2); HRMS(ESI-TOF): calcd. for 
C14H22OSiNa
+
: 257.1338. Found: 257.1337 (MNa
+
); HRMS(ESI-TOF): calcd. for 
C19H34OSi2H
+
: 335.2221. Found: 335.2224 (MH
+
); CHN: Anal. Calc. for C15H24O2: 
C, 71.73%, H, 9.46%; Found: C, 71.90%, H, 9.53%. 
 
7.6 Experimental procedures: Chapter 6 
7.6.1 Representative Procedure for the Synthesis of Vinylic Alcohols 
To an oven dried, nitrogen purged round bottom flask was added the aldehyde (30 
mmol) and THF (100 mL) before cooling to 0 °C using an ice/water bath. 
Vinylmagnesium bromide solution (1.0 M in THF, 33 mL, 33 mmol) was then added 
dropwise. Once the addition was complete the reaction was allowed to warm to room 
temperature over 2 hours. NH4Cl (sat. solution, 50 mL) and H2O (50 mL) were added 
before the organic layer was separated. The aqueous layer was then extracted with 
EtOAc (2 x 50 mL). The combined organic phase was then dried (MgSO4) and 
concentrated in vacuo. The crude product was then purified by silica column 
chromatography. 
 
7.6.2  Representative Procedure for the Ruthenium Catalysed Tandem 
Isomerisation/Substitution 
To an oven-dried, nitrogen purged Young’s tube containing Ru(PPh3)3(CO)(H)2 (110 
mg, 0.12 mmol) were added 1-(4-Fluorophenyl)prop-2-en-1-ol (457 mg, 3 mmol), 
morpholine (0.58 mL, 6.6 mmol) and DMSO (3 mL). The reaction vessel was then 
sealed and heated to 115 °C for 24 hours. On completion the reaction was allowed to 
cool to room temperature before H2O (20 mL) and brine (5 mL) were added. The 
solution was then extracted with Et2O (3 x 25 mL). The combined organic phase was 
then concentrated in vacuo. The crude product was then purified by silica column 
chromatography. 
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7.6.3  Synthesis of Materials for Initial Testing 
 
1-(4-morpholinophenyl)ethanone 6.3 
 
4-Fluoroacetophenone (5 mL, 41 mmol) and morpholine (11.5 mL, 131 mmol) were 
dissolved in DMSO (100 mL) before heating to 125 °C overnight. The reaction was 
allowed to cool to room temperature before adding H2O (300 mL). The precipitate 
was then filtered and washed with H2O (2 x 150 mL). The crude product was then 
dissolved in a minimum of Et2O before precipitating with hexane. The product 
(3.49g, 41%) was isolated as a yellow crystalline solid. 
1
H NMR: (CDCl3, 300 MHz) 
δ = 7.91 (2H, d, J = 9.00 Hz, H4), 6.89 (2H, d, J = 8.70 Hz, H5), 3.88 (4H, app. t, J = 
4.95 Hz, H8), 3.32 (4H, app. t, J = 4.95 Hz, H7), 2.54 (3H, s, H1); 
13
C NMR: (CDCl3, 
75.4 MHz) δ = 196.7 (C2), 154.3 (C6), 130.5 (C4), 128.2 (C3), 113.4 (C5), 66.7 (C8), 
47.6 (C7), 26.3 (C1); HRMS(ESI-TOF): calcd. for C16H22OH
+
: 231.1749. Found: 
231.1741 (MH
+
), 253.1556 (MNa
+
). This is consistent with literature data.
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1-(4-Morpholinophenyl)ethanol 6.4 
 
1-(4-Morpholinophenyl)ethanone (6.3) (2.89 g, 14 mmol) was dissolved in EtOH 
(100 mL) before NaBH4 (0.76 g, 20 mmol) was added portionwise before leaving to 
stir overnight. H2O (50 mL) and brine (150 mL) were added before leaving to stir for 
2 hours. The solution was then transferred to a separating funnel and extracted with 
EtOAc (3 x 100 mL). The combined organic layers were then dried (MgSO4) before 
concentrating in vacuo. The crude material was then dissolved in a minimum of 
CH2Cl2 before precipitating with hexane. The product (2.52 g, 87%) was isolated as a 
colourless crystalline solid. 
1
H NMR: (CDCl3, 300 MHz) δ = 7.30 (2H, d, J = 8.70 
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Hz, H4), 6.91 (2H, d, J = 8.40 Hz, H5), 4.84 (1H, q, J = 6.60 Hz, H2), 3.86 (4H, app. t, 
J = 4.80 Hz, H8), 3.13 (4H, app. t, J = 4.95 Hz, H7), 1.74 (1H, br s, OH), 1.48 (3H, d, 
J = 6.60 Hz, H1); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 150.8 (C6), 137.5 (C3), 126.5 
(C4), 115.8 (C5), 67.0 (C2), 67.0 (C8), 49.5 (C7), 25.0 (C1); HRMS(ESI-TOF): calcd. 
for C12H17NOH
+
: 208.1332. Found: 208.1417 (MH
+
), 230.1153 (MNa
+
). This is 
consistent with literature data.
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7.6.4  Synthesis of Vinylic Alcohol Starting Materials 
 
1-(4-Fluorophenyl)prop-2-en-1-ol 6.11 
 
According to literature procedure 7.6.1, the product was purified by silica column 
chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.19, det: 
KMnO4) and isolated as a yellow oil (10.1 g, 71%). 
1
H NMR: (CDCl3, 300 MHz) δ = 
7.35 (2H, dd, J = 8.70 5.40 Hz, H5), 7.04 (2H, app. t, J = 8.70 Hz, H6), 5.97-6.08 (1H, 
m, H2), 5.31-5.38 (1H, m, H3), 5.19-5.23 (2H, m, H1 & H3) 1.80 (1H, br s, OH); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 162.4 (d, J = 245.4 Hz, C7), 140.2 (C2), 138.4 (d, J = 
3.1 Hz, C4), 128.2 (d, J = 8.1 Hz, C5), 115.5 (d, J = 21.4 Hz, C6), 115.5 (C3), 74.8 
(C1); HRMS(ESI-TOF): calcd. for C9H8OF
-
: 151.0559. Found: 151.0571 (M
-
). This is 
consistent with literature data.
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1-(4-Fluorophenyl)-2-methylprop-2-en-1-ol 6.28 
 
According to literature procedure 7.6.1 using isopropenylmagnesium bromide 
solution, the product was purified by silica column chromatography (eluent; 
petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.19, det: KMnO4) and isolated as a 
yellow oil (10.1 g, 71%). IR: νmax/cm
-1
 (neat) 3359, 1603, 1507, 1220, 1156, 1046, 
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903, 830; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.34 (2H, dd, J = 8.70 5.40 Hz, H6), 7.03 
(2H, app. t, J = 8.70 Hz, H7), 5.19-5.20 (1H, m, H1), 5.13 (1H, s, H3), 4.95-4.97 (1H, 
m, H3), 1.89 (1H, br s, OH), 1.60 (3H, s, H4); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 
162.4 (d, J = 246.8 Hz, C8), 146.9 (C2), 137.8 (d, J = 3.1 Hz, C5), 128.3 (d, J = 8.1 
Hz, C7), 115.3 (d, J = 21.3 Hz, C6), 111.5 (C3), 77.3 (C1), 18.3 (C4); 
19
F NMR: 
(CDCl3, 376 MHz) δ = -115.1 (tt, J = 8.6 5.6 Hz); HRMS(ESI-TOF): calcd. for 
C10H11FONa
+
: 189.0692. Found: 189.0679 (MNa
+
); CHN: Anal. Calc. for C10H11FO: 
C, 72.27%, H, 6.67%; Found: C, 72.45%, H, 6.68%. 
 
1-(4-Fluorophenyl)-3-methylbut-2-en-1-ol 6.29 
 
According to literature procedure 7.6.1 using 2-methyl-1-propenylmagnesium 
bromide solution, the product was purified by silica column chromatography (eluent; 
petroleum ether b. p. 40-60 °C/Et2O, 1:1, Rf = 0.28, det: KMnO4) and isolated as a 
yellow oil (4.59 g, 85%). IR: νmax/cm
-1
 (neat) 3339, 2975, 1603, 1507, 1220, 1156, 
816; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.35 (2H, dd, J = 8.70 5.40 Hz, H7), 7.02 (2H, 
app. t, J = 8.70 Hz, H8), 5.45 (1H, d, J = 8.70 Hz, H2), 5.35-5.40 (1H, m, H1), 1.80 
(3H, d, J = 1.50 Hz, H4), 1.76 (3H, d, J = 1.20 Hz, H5); 
13
C NMR: (CDCl3, 75.4 MHz) 
δ = 162.1 (d, J = 244.7 Hz, C9), 140.0 (d, J = 3.0 Hz, C6), 135.6 (C3), 127.6 (C2), 
127.6 (d, J = 8.1 Hz, C7), 115.3 (d, J = 21.3 Hz, C8), 70.2 (C1), 26.0 (C4), 18.4 (C5); 
19
F NMR: (CDCl3, 376 MHz) δ = -114.7 (tt, J = 8.6 5.6 Hz); HRMS(ESI-TOF): 
calcd. for C11H12FO
-
: 179.0872. Found: 179.0860 (M
-
); CHN: Anal. Calc. for 
C11H13FO: C, 73.31%, H, 7.27%; Found: C, 73.39%, H, 7.40%. 
 
 
 
 
 
 
Chapter 7 
181 
 
1-(4-Fluorophenyl)-2-methylbut-2-en-1-ol 6.30 
 
According to literature procedure 7.6.1 using 1-methyl-1-propenylmagnesium 
bromide solution, the product was purified by silica column chromatography (eluent; 
cyclohexane/EtOAc, 0-100% over 60 min, det: KMnO4) and isolated as a yellow oil 
(3.46 g, 64%). IR: νmax/cm
-1
 (neat) 3345, 2921, 1602, 1506, 1221, 1155, 1011, 839; 
1
H NMR: (CDCl3, 300 MHz) δ = Major 7.296-7.35 (2H, m, H7), 6.99-7.05 (2H, m, 
H8), 5.78 (1H, s, H1), 5.47 (1H, q, J = 6.90 Hz, H3), 1.79 (3H, d, J = 6.90 Hz, H4), 
1.56 (3H, s, H5); Minor 7.296-7.35 (2H, m, H7), 6.99-7.05 (2H, m, H8), 5.71 (1H, q, J 
= 6.60 Hz, H3), 5.12 (1H, s, H1), 1.66 (3H, d, J = 6.60 Hz, H4), 1.47 (3H, s, H5); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = Major 162.0 (d, J = 244.4 Hz, C9), 138.3 (d, J = 3.0 
Hz, C6), 137.1 (C2), 127.2 (d, J = 7.9 Hz, C7), 122.8 (C3), 115.1 (d, J = 21.3 Hz, C8), 
70.1 (C1), 17.4 (C4), 13.4 (C5); Minor 162.2 (d, J = 244.6 Hz, C9), 138.2 (d, J = 3.0 
Hz, C6),137.6 (C2),127.9 (d, J = 8.0 Hz, C7), 121.7 (C3), 115.1 (d, J = 21.3 Hz, C8), 
78.9 (C1), 13.3 (C5), 11.7 (C4); 
19
F NMR: (CDCl3, 376 MHz) δ = Major -116.3 (tt, J = 
8.6 5.6 1.1 Hz); Minor -115.9 (dtt, J = 8.6 5.6 0.8 Hz); HRMS(ESI-TOF): calcd. for 
C11H13FONa
+
: 203.0848. Found: 203.0843 (MNa
+
); CHN: Anal. Calc. for C11H13FO: 
C, 73.31%, H, 7.27%; Found: C, 73.30%, H, 7.30%. 
 
(E)-1-(4-Fluorophenyl)-3-phenylprop-2-en-1-ol 6.31 
 
(E)-1-(4-Fluorophenyl)-3-phenylprop-2-en-1-one (4.37 g, 19 mmol) was dissolved in 
MeOH (50 mL). NaBH4 (0.87 g, 23 mmol) was added portionwise before leaving to 
stir at room temperature overnight. H2O (50 mL) and brine (50 mL) were added 
before the organic layer was separated and the aqueous layer extracted with EtOAc (2 
x 50 mL). The combined organic phase was then dried (MgSO4) and concentrated in 
vacuo. The crude material was then purified by silica column chromatography 
(eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.20) and isolated as a 
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colourless oil (3.73 g, 86%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.22-7.44 (7H, m, 
arom. H), 7.06 (2H, app. t, J = 8.70 Hz, H8), 6.68 (1H, d, J = 15.60 Hz, H3), 6.35 (1H, 
dd, J = 15.90 6.60 Hz, H2), 5.38 (1H, d, J = 6.60 Hz, H1), 2.01 (1H, d, J = 2.40 Hz, 
OH); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 162.5 (d, J = 245.7 Hz, C11), 138.6 (d, J = 
3.1 Hz, C8), 136.5 (C4), 131.4 (C3), 130.9 (C7), 128.8 (C6), 128.2 (d, J = 8.1 Hz, C9), 
128.1 (C2), 126.8 (C5), 115.6 (d, J = 21.4 Hz, C10), 74.6 (C1); HRMS(ESI-TOF): 
calcd. for C15H12FONa
-
: 227.0872. Found: 227.0866 (M
-
). This is consistent with 
literature data.
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1-(4-Fluorophenyl)but-3-en-1-ol 6.32 
 
According to literature procedure 7.6.1 using allylmagnesium bromide solution, the 
product was then purified by Kugelrohr distillation and isolated as a colourless oil 
(3.98 g, 80%). 
1
H NMR: (CDCl3, 300 MHz) δ = 7.33 (2H, dd, J = 8.70 5.40 Hz, H6), 
7.04 (2H, app. t, J = 8.70 Hz, H7), 5.73-5.86 (1H, m, H3), 5.14-5.20 (2H, m, H4), 4.73 
(1H, dd, J = 7.20 5.70 Hz, H1), 2.46-2.52 (2H, m, H2), 2.00 (1H, d, J = 1.50 Hz, OH); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 162.3 (d, J = 245.0 Hz, C8), 139.7 (d, J = 3.1 Hz, 
C5), 134.3 (C3), 127.6 (d, J = 8.1 Hz, C6), 118.8 (C4), 115.3 (d, J = 21.3 Hz, C7), 72.8 
(C1), 44.1 (C2); HRMS(ESI-TOF): calcd. for C10H11FONa
+
: 189.0692. Found: 
189.0691 (MNa
+
). This is consistent with literature data.
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1-(4-Fluoro-2-methylphenyl)prop-2-en-1-ol 6.38 
 
According to literature procedure 7.6.1, the product was purified by Kugelrohr 
distillation and isolated as a colourless oil (4.21 g, 84%). IR: νmax/cm
-1
 (neat) 3316, 
2981, 1614, 1590, 1495, 1237, 987, 955, 924, 861, 805; 
1
H NMR: (CDCl3, 300 MHz) 
δ = 7.41 (1H, dd, J = 8.40 6.00 Hz, H9), 6.92 (1H, dd, J = 8.40 2.70 Hz, H8), 6.86 
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(1H, dd, J = 9.30 2.70 Hz, H6), 6.01 (1H, ddd, J = 17.10 10.20 5.70 Hz, H2), 5.38 
(1H, dd, J = 5.10 4.20 Hz, H1), 5.31 (1H, dt, J = 17.10 1.20 Hz, H3), 5.22 (1H, dt, J = 
10.20 1.20 Hz, H3), 2.35 (3H, s, H10), 1.79 (1H, d, J = 3.90 Hz, OH); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 162.1 (d, J = 245.1 Hz, H7), 139.4 (C2), 138.0 (d, J = 7.8 Hz, 
C5), 136.3 (d, J = 3.1 Hz, C4), 127.8 (d, J = 8.5 Hz, C9), 117.2 (d, J = 21.0 Hz, C6), 
115.5 (C3), 113.0 (d, J = 20.8 Hz, C8), 71.7 (C1), 19.3 (d, J = 1.4 Hz, C10); 
19
F NMR: 
(CDCl3, 376 MHz) δ = -115.8 (ddd, J = 9.8 8.6 6.0 Hz); HRMS(ESI-TOF): calcd. for 
C11H11FONa
+
: 189.0692. Found: 189.0683 (MNa
+
); CHN: Anal. Calc. for C10H11FO: 
C, 72.27%, H, 6.67%; Found: C, 72.45%, H, 6.69%. 
 
1-(4-Fluoro-3-methylphenyl)prop-2-en-1-ol 6.39 
 
According to literature procedure 7.6.1, the product was purified by silica column 
chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 3:1, Rf = 0.23, det: 
KMnO4) and isolated as a yellow oil (4.58 g, 77%). IR: νmax/cm
-1
 (neat) 3344, 2928, 
1499, 1247, 1206, 1115, 987, 925, 822, 756; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.12-
7.21 (2H, m, H5 & H9), 6.98 (1H, dd, J = 9.30 8.70 Hz, H8), 6.03 (1H, ddd, J =17.10 
10.20 6.00 Hz, H2), 5.34 (1H, dt, J = 17.10 1.20 Hz, H3), 5.20 (1H, dt, J = 10.20 1.20 
Hz, H3), 5.16 (1H, m, H1), 2.28 (3H, d, J = 1.80 Hz, H10), 1.87 (1H, d, J = 3.60 Hz, 
OH); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 161.0 (d, J = 244.4 Hz, C7), 140.3 (C2), 
138.1 (d, J = 3.5 Hz, C4), 129.6 (d, J = 5.3 Hz, C5), 125.4 (d, J = 8.1 Hz, C9), 125.1 
(d, J = 17.4 Hz, C6), 115.3 (C3), 115.1 (d, J = 22.6 Hz, C8), 74.9 (C1), 14.7 (d, J = 3.5 
Hz, C10); 
19
F NMR: (CDCl3, 376 MHz) δ = -119.2 (m); HRMS(ESI-TOF): calcd. for 
C10H10FO
-
: 165.0716. Found: 165.0705 (M
-
); CHN: Anal. Calc. for C10H11FO: C, 
72.27%, H, 6.67%; Found: C, 72.40%, H, 6.73%. 
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1-(3-Chloro-4-fluorophenyl)prop-2-en-1-ol 6.40 
 
According to literature procedure 7.6.1, the product was purified by silica column 
chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 3:1, Rf = 0.21, det: 
KMnO4) and isolated as a yellow oil (2.98 g, 50%). IR: νmax/cm
-1
 (neat) 3339, 1497, 
1407, 1248, 1059, 987, 930, 823, 713, 696; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.44 
(1H, dd, J = 7.20 1.20 Hz, H5), 7.24 (1H, dddd, J = 8.4 4.2 2.1 0.3 Hz, H9), 7.12 (1H, 
app. t, J = 8.70 Hz, H8), 5.98 (1H, ddd, J = 16.50 10.20 6.60 Hz, H2), 5.36 (1H, dt, J = 
17.10 1.20 Hz, H3), 5.24 (1H, dt, J = 10.20 1.20 Hz, H3), 5.18 (1H, app. t, J = 4.20 
Hz, H1), 1.95 (1H, d, J = 3.60 Hz, OH); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 157.6 (d, J 
= 248.3 Hz, C7), 139.7 (C2), 139.6 (d, J = 3.8 Hz, C4), 128.7 (C5), 126.2 (d, J = 7.2 
Hz, C9), 121.1 (d, J = 17.9 Hz, C6), 116.7 (d, J = 21.1 Hz, C8), 116.2 (C3), 74.3 (C1); 
19
F NMR: (CDCl3, 376 MHz) δ = -117.2 (dddd, J = 9.0 7.1 4.5 0.8 Hz); HRMS(ESI-
TOF): calcd. for C9H7ClFO
-
: 185.0169. Found: 185.0157 (M
-
); CHN: Anal. Calc. for 
C9H8ClFO: C, 57.93%, H, 4.32%; Found: C, 57.90%, H, 4.36%. 
 
1-(3,4-Difluorophenyl)prop-2-en-1-ol 6.41 
 
According to literature procedure 7.6.1, the product was purified by silica column 
chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.20, det: 
KMnO4) and isolated as a yellow oil (4.19 g, 70%). IR: νmax/cm
-1
 (neat) 3338, 1610, 
1514, 1432, 1278, 1208, 1111, 988, 930, 875, 822, 770, 760; 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.06-7.25 (3H, m, arom. H), 5.98 (1H, ddd, J = 17.10 10.20 6.00 Hz, H2), 
5.36 (1H, dt, J = 17.10 1.20 Hz, H3), 5.24 (1H, dt, J = 10.20 1.20 Hz, H3), 5.17 (1H, 
d, J = 6.00 Hz, H1), 1.79 (1H, br s, OH); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 150.4 (dd, 
J = 247.8 12.7 Hz, C6), 149.8 (dd, J = 247.4 12.7 Hz, C7), 139.6 (C2), 139.6 (d, J = 
8.6 Hz, C4), 122.4 (dd, J = 6.4 3.6 Hz, C9), 117.2 (d, J = 17.3 Hz, C8), 116.2 (C3), 
115.4 (d, J = 17.8 Hz, C5), 74.3 (d, J = 1.3 Hz, C1); 
19
F NMR: (CDCl3, 376 MHz) δ = 
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-137.5 (m), -139.6 (m); HRMS(ESI-TOF): calcd. for C9H7F2O
-
: 169.0465. Found: 
169.0476 (M
-
); CHN: Anal. Calc. for C9H8F2O: C, 63.53%, H, 4.74%; Found: C, 
63.40%, H, 4.70%. 
 
1-(4-Fluoro-3-(trifluoromethyl)phenyl)prop-2-en-1-ol 6.42 
 
According to literature procedure 7.6.1, the product was purified by silica column 
chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.21, det: 
KMnO4) and isolated as a yellow oil (4.53 g, 79%). IR: νmax/cm
-1
 (neat) 3343, 1624, 
1505, 1435, 1322, 1240, 1123, 1056, 988, 933, 833, 679; 
1
H NMR: (CDCl3, 300 
MHz) δ = 7.63 (1H, dd, J = 6.90 2.10 Hz, H5), 7.56 (1H, ddd, J = 8.40 4.80 2.40 Hz, 
H9), 7.18 (1H, app. t, J = 9.30 Hz, H8), 6.00 (1H, ddd, J = 17.10 10.20 6.30 Hz, H2), 
5.38 (1H, dt, J = 17.10 1.20 Hz, H3), 5.27 (1H, dt, J = 10.20 1.20 Hz, H3), 5.24 (1H, 
d, J = 6.30 Hz, H1), 1.80 (1H, br s, OH); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 159.3 (dd, 
J = 256.7 2.1 Hz, C7), 139.6 (C2), 138.8 (d, J = 3.7 Hz, C4), 125.2 (qd, J = 4.6 1.7 Hz, 
C9), 124.5 (C5), 122.7 (q, J = 272.0 Hz, C10), 118.5 (dd, J = 32.9 12.6 Hz, C6), 117.1 
(d, J = 20.7 Hz, C8), 116.6 (C3), 74.4 (C1); 
19
F NMR: (CDCl3, 376 MHz) δ = -61.5 
(dd, J = 12.8 0.8 Hz), -116.4 (m); HRMS(ESI-TOF): calcd. for C10H7F4O
-
: 219.0433. 
Found: 219.0429 (M
-
); CHN: Anal. Calc. for C10H8F4O: C, 54.55%, H, 3.66%; 
Found: C, 54.50%, H, 3.68%. 
 
1-(2-Fluorophenyl)prop-2-en-1-ol 6.43 
 
According to literature procedure 7.6.1, the product was purified by silica column 
chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 4:1, Rf = 0.16, det: 
KMnO4) and isolated as a yellow oil (3.26 g, 71%). 
1
H NMR: (CDCl3, 300 MHz) δ = 
7.45 (1H, td, J = 7.50 1.80 Hz, H7), 7.24-7.31 (1H, m, H8), 7.16 (1H, td, J = 7.50 1.20 
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Hz, H5), 7.04 (1H, ddd, J = 10.50 8.10 1.20 Hz, H6), 6.08 (1H, dddd, J = 17.10 10.50 
5.70 0.90 Hz, H2), 5.53 (1H, app. t, J = 5.10 Hz, H1), 5.36 (1H, dq, J = 17.10 1.20 Hz, 
H3), 5.22 (1H, dt, J = 10.20 1.20 Hz, H3), 2.01 (1H, dd, J = 4.80 0.90 Hz, OH); 
13
C 
NMR: (CDCl3, 75.4 MHz) δ = 160.2 (d, J = 246.1 Hz, C9), 139.0 (d, J = 0.5 Hz, C2), 
129.8 (d, J = 13.2 Hz, C4), 129.4 (d, J = 8.3 Hz, C7), 127.8 (d, J = 4.2 Hz, C5), 124.5 
(d, J = 3.5 Hz, C6), 115.6 (d, J = 21.6 Hz, C8), 115.5 (C3), 69.4 (d, J = 3.1 Hz, C1); 
HRMS(ESI-TOF): calcd. for C9H8FO
-
: 151.0559. Found: 151.0570 (M
-
). This is 
consistent with literature data.
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7.6.5  Ruthenium Catalysed Isomerisation of 4-Fluoro Vinylic Alcohols 
& Nucleophilic Substitution 
 
1-(4-(Pyrrolidin-1-yl)phenyl)propan-1-one 6.23 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; hexanes/EtOAc, 3:2, Rf = 0.43, det: KMnO4) and isolated as 
a yellow crystalline solid (470 mg, 77%). m. p. = 135-137 °C; IR: νmax/cm
-1
 (neat) 
2850, 1657, 1592, 1349, 1181, 1161, 798; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.88 (2H, 
d, J = 9.00 Hz, H5), 6.52 (2H, d, J = 9.00 Hz, H6), 3.34-3.39 (4H, m, H8), 2.90 (2H, q, 
J = 7.20 Hz, H2), 2.01-2.06 (4H, m, H9), 1.21 (3H, t, J = 7.20 Hz, H3); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 199.2 (C1), 151.0 (C7), 130.4 (C5), 124.6 (C4), 110.8 (C6), 
47.7 (C8), 31.0 (C2), 25.5 (C9), 9.02 (C3); HRMS(ESI-TOF): calcd. for C13H17NOH
+
: 
204.1388. Found: 204.1384 (MH
+
), 226.1195 (MNa
+
); CHN: Anal. Calc. for 
C13H17NO: C, 76.81%, H, 8.43%, N, 6.89%; Found: C, 76.80%, H, 8.36%, N, 6.69%. 
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1-(4-(Piperidin-1-yl)phenyl)propan-1-one 6.24 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; hexanes/EtOAc, 4:1, Rf = 0.35, det: KMnO4) and isolated as 
a yellow crystalline solid (567 mg, 87%). m. p. = 85-87 °C;  IR: νmax/cm
-1
 (neat) 
2940, 2836, 1662, 1593, 1350, 1222, 1192, 1124, 796; 
1
H NMR: (CDCl3, 300 MHz) δ 
= 7.87 (2H, d, J = 9.00 Hz, H5), 6.85 (2H, d, J = 9.00 Hz, H6), 3.33-3.36 (4H, m, H8), 
2.91 (2H, q, J = 7.20 Hz, H2), 1.66-1.70 (6H, m, H9 & H10), 1.20 (3H, t, J = 7.20 Hz, 
H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 199.3 (C1), 154.5 (C7), 130.2 (C5), 126.5 (C4), 
113.5 (C6), 48.8 (C8), 31.2 (C2), 25.5 (C9), 24.5 (C10), 8.9 (C3); HRMS(ESI-TOF): 
calcd. for C14H19NONa
+
: 240.1364. Found: 240.1362 (MNa
+
); CHN: Anal. Calc. for 
C14H19NO: C, 77.38%, H, 8.81%, N, 6.45%; Found: C, 77.36%, H, 8.84%, N, 6.60%. 
 
1-(4-(Azepan-1-yl)phenyl)propan-1-one 6.25 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; hexanes/EtOAc, 5:1, Rf = 0.27, det: KMnO4) and isolated as 
a yellow crystalline solid (562 mg, 81%). m. p. = 85-87 °C; IR: νmax/cm
-1
 (neat) 2919, 
1657, 1589, 1520, 1405, 1348, 1184, 796; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.86 (2H, 
d, J = 9.30 Hz, H5), 6.65 (2H, d, J = 9.30 Hz, H6), 3.52 (4H, t, J = 6.00 Hz, H8), 2.89 
(2H, q, J = 7.20 Hz, H2), 1.79-1.82 (4H, m, H9), 1.53-1.57 (4H, m, H10), 1.20 (3H, t, J 
= 7.20 Hz, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 199.1 (C1), 152.3 (C7), 130.6 (C5), 
124.5 (C4), 110.2 (C6), 49.5 (C8), 31.0 (C2), 27.5 (C9), 27.0 (C10), 9.0 (C3); 
HRMS(ESI-TOF): calcd. for C15H21NOH
+
: 232.1701. Found: 232.1742 (MH
+
), 
254.1505 (MNa
+
); CHN: Anal. Calc. for C14H19NO: C, 77.88%, H, 9.15%, N, 6.05%; 
Found: C, 77.68%, H, 8.96%, N, 5.93%. 
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1-(4-Morpholinophenyl)propan-1-one 6.26 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; hexanes/EtOAc, 1:1, Rf = 0.36, det: KMnO4) and isolated as 
a yellow crystalline solid (566 mg, 86%). m. p. = 77-79 °C; IR: νmax/cm
-1
 (neat) 2972, 
2858, 1665, 1598, 1227, 1190, 1122, 923, 795; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.91 
(2H, d, J = 9.00 Hz, H5), 6.87 (2H, d, J = 9.00 Hz, H6), 3.86 (4H, app. t, J = 4.95 Hz, 
H9), 3.30 (4H, app. t, J = 4.95 Hz, H8), 2.93 (2H, q, J = 7.20 Hz, H2), 1.21 (3H, t, J = 
7.20 Hz, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 199.4 (C1), 154.2 (C7), 130.1 (C5), 
128.0 (C4), 113.5 (C6), 66.7 (C9), 47.7 (C8), 31.3 (C2), 8.7 (C3); HRMS(ESI-TOF): 
calcd. for C13H17NO2H
+
: 220.1338. Found: 220.1321 (MH
+
), 242.1140 (MNa
+
); 
CHN: Anal. Calc. for C13H17NO2: C, 71.21%, H, 7.81%, N, 6.39%; Found: C, 
71.02%, H, 7.79%, N, 6.27%. 
 
1-(4-(4-Methylpiperazin-1-yl)phenyl)propan-1-one 6.27 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; CH2Cl2/MeOH, 92:8, Rf = 0.33, det: KMnO4) and isolated as 
a yellow crystalline solid (495 mg, 71%). m. p. = 105-107 °C; IR: νmax/cm
-1
 (neat) 
2849, 2858, 1668, 1594, 1348, 1292, 1223, 1190, 997, 919, 798; 
1
H NMR: (CDCl3, 
300 MHz) δ = 7.89 (2H, d, J = 9.00 Hz, H5), 6.87 (2H, d, J = 9.00 Hz, H6), 3.36 (4H, 
app. t, J = 5.10 Hz, H8), 2.92 (2H, q, J = 7.20 Hz, H2), 2.56 (4H, app. t, J = 5.10 Hz, 
H9), 2.35 (3H, s, H10), 1.20 (3H, t, J = 7.20 Hz, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ 
= 199.4 (C1), 154.1 (C7), 130.1 (C5), 127.4 (C4), 113.6 (C6), 54.9 (C9), 47.4 (C8), 46.3 
(C10), 31.3 (C2), 8.8 (C3); HRMS(ESI-TOF): calcd. for C14H20N2OH
+
: 233.1648. 
Found: 233.1723 (MH
+
); CHN: Anal. Calc. for C14H20N2O: C, 72.38%, H, 8.68%, N, 
12.06%; Found: C, 72.19%, H, 8.61%, N, 12.00%. 
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2-Methyl-1-(4-morpholinophenyl)propan-1-one 6.33 
 
According to literature procedure 7.6.2 run for 48 hours with 5 mol% catalyst, the 
product was purified by silica column chromatography (eluent; hexanes/EtOAc, 2:1, 
Rf = 0.33, det: KMnO4) and isolated as a yellow crystalline solid (364 mg, 52%). m. 
p. = 69-71 °C; IR: νmax/cm
-1
 (neat) 2963, 2858, 1662, 1597, 1222, 1207, 1112, 923, 
844, 645; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.91 (2H, d, J = 9.00 Hz, H5), 6.87 (2H, d, 
J = 9.00 Hz, H6), 3.85 (4H, app. t, J = 4.95 Hz, H9), 3.50 (1H, sept, J = 6.90 Hz, H2), 
3.29 (4H, app. t, J = 4.95 Hz, H8), 1.19 (6H, d, J = 6.90 Hz, H3); 
13
C NMR: (CDCl3, 
75.4 MHz) δ = 202.9 (C1), 154.2 (C7), 130.4 (C5), 127.1 (C4), 113.5 (C6), 66.7 (C9), 
47.7 (C8), 34.8 (C2), 19.5 (C3); HRMS(ESI-TOF): calcd. for C14H19NO2H
+
: 234.1494. 
Found: 234.1488 (MH
+
), 256.1292 (MNa
+
); CHN: Anal. Calc. for C14H19NO2: C, 
72.07%, H, 8.21%, N, 6.00%; Found: C, 72.20%, H, 8.19%, N, 5.89%. 
 
3-Methyl-1-(4-morpholinophenyl)butan-1-one 6.34 
 
According to literature procedure 7.6.2 run for 48 hours with 5 mol% catalyst, the 
product was purified by silica column chromatography (eluent; hexanes/EtOAc, 0-
100% over 60 min, det: KMnO4) and isolated as a yellow crystalline solid (423 mg, 
57%). m. p. = 72-74 °C; IR: νmax/cm
-1
 (neat) 2959, 1659, 1595, 1516, 1449, 1364, 
1218, 1181, 1125, 926, 815; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.90 (2H, d, J = 9.00 
Hz, H6), 6.87 (2H, d, J = 9.00 Hz, H7), 3.86 (4H, app. t, J = 4.80 Hz, H10), 3.30 (4H, 
app. t, J = 4.95 Hz, H9), 2.75 (2H, d, J = 6.90 Hz, H2), 2.27 (1H, sept, J = 6.60 Hz, 
H3), 0.98 (3H, d, J = 6.6 Hz, H4); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 198.8 (C1), 154.2 
(C8), 130.3 (C6), 128.5 (C5), 113.4 (C7), 66.7 (C10), 47.7 (C9), 47.1 (C2), 25.7 (C3), 
23.0 (C4); HRMS(ESI-TOF): calcd. for C15H21NO2H
+
: 248.1645. Found: 248.1718 
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(MH
+
), 270.1520 (MNa
+
); CHN: Anal. Calc. for C15H21NO2: C, 72.84%, H, 8.56%, 
N, 5.66%; Found: C, 72.80%, H, 8.66%, N, 5.56%. 
 
1-(4-Morpholinophenyl)-3-phenylpropan-1-one 6.36 
 
According to literature procedure 7.6.2 run for 48 hours with 5 mol% catalyst, the 
product was purified by silica column chromatography (eluent; hexanes/EtOAc, 1:1, 
Rf = 0.36, det: KMnO4) and isolated as an orange crystalline solid (328 mg, 37%). m. 
p. = 66-68 °C; IR: νmax/cm
-1
 (neat) 2960, 2869, 2848, 1655, 1603, 1448, 1382, 1248, 
1186, 1122, 1053, 926, 818, 696; 
1
H NMR: (CDCl3, 300 MHz) δ =  7.90 (2H, d, J = 
9.00 Hz, H9), 7.18-7.32 (5H, m, arom. H), 6.87 (2H, d, J = 9.00 Hz, H10), 3.86 (4H, 
app. t, J = 4.95 Hz, H13), 3.30 (4H, app. t, J = 4.95 Hz, H12), 3.20-3.25 (2H, m, H2), 
3.03-3.08 (2H, m, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 197.6 (C1), 154.3 (C11), 
141.7 (C4), 130.2 (C9), 128.6 (C6), 128.5 (C5), 127.8 (C7), 126.1 (C8), 113.4 (C10), 
66.7 (C13), 47.6 (C12), 40.0 (C2), 30.6 (C3); HRMS(ESI-TOF): calcd. for 
C19H21NO2H
+
: 296.1651. Found: 296.1641 (MH
+
); CHN: Anal. Calc. for C19H21NO2: 
C, 77.26%, H, 7.17%, N, 4.74%; Found: C, 72.36%, H, 7.29%, N, 4.85%. 
 
1-(4-Morpholinophenyl)-3-phenylpropan-1-one 6.37 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; hexanes/EtOAc, 1:1, Rf = 0.31, det: KMnO4) and isolated as 
a yellow crystalline solid (593 mg, 85%). m. p. = 67-69 °C; IR: νmax/cm
-1
 (neat) 2965, 
1665, 1594, 1219, 1186, 1123, 925, 818; 
1
H NMR: (CDCl3, 300 MHz) δ =  7.90 (2H, 
d, J = 9.00 Hz, H6), 6.87 (2H, d, J = 9.00 Hz, H7), 3.86 (4H, app. t, J = 4.95 Hz, H10), 
3.30 (4H, app. t, J = 4.95 Hz, H9), 2.87 (2H, t, J = 7.20 Hz, H2), 1.69-1.82 (2H, m, 
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H3), 0.99 (3H, t, J = 7.50 Hz, H4); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 199.0 (C1), 
154.2 (C8), 130.2 (C6), 128.2 (C5), 113.5 (C7), 66.7 (C10), 47.7 (C9), 40.2 (C2), 18.3 
(C3), 14.1 (C4); HRMS(ESI-TOF): calcd. for C14H19NO2H
+
: 234.1489. Found: 
234.1562 (MH
+
); CHN: Anal. Calc. for C14H19NO2: C, 72.07%, H, 8.21%, N, 6.00%; 
Found: C, 72.04%, H, 8.25%, N, 5.99%. 
 
1-(2-Methyl-4-morpholinophenyl)propan-1-one 6.44 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; hexanes/EtOAc, 3:1, Rf = 0.31, det: KMnO4) and isolated as 
a yellow crystalline solid (357 mg, 51%). m. p. = 69-70 °C; IR: νmax/cm
-1
 (neat) 2971, 
1653, 1601, 1549, 1453, 1361, 1217, 1123, 1111, 1054, 967, 877, 785, 645; 
1
H NMR: 
(CDCl3, 300 MHz) δ = 7.72 (1H, d, J = 9.30 Hz, H9), 6.68-6.71 (2H, m, arom. H), 
3.84 (4H, app. t, J = 4.95 Hz, H12), 3.26 (4H, app. t, J = 4.80 Hz, H11), 2.89 (2H, q, J 
= 7.20 Hz, H2), 2.56 (3H, s, H10), 1.17 (3H, t, J = 7.50 Hz, H3); 
13
C NMR: (CDCl3, 
75.4 MHz) δ = 202.1 (C1), 152.9 (C7), 141.7 (C5), 131.7 (C9), 127.8 (C4), 117.5 (C6), 
110.9 (C8), 66.7 (C12), 47.8 (C11), 33.5 (C2), 23.1 (C10), 8.9 (C3); HRMS(ESI-TOF): 
calcd. for C14H19NO2H
+
: 234.1494. Found: 234.1478 (MH
+
), 256.1291 (MNa
+
); 
CHN: Anal. Calc. for C14H19NO2: C, 72.07%, H, 8.21%, N, 6.00%; Found: C, 
72.00%, H, 8.10%, N, 5.93%. 
 
1-(3-Chloro-4-morpholinophenyl)propan-1-one 6.46 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 2:1, Rf = 0.36, det: 
KMnO4) and isolated as a yellow crystalline solid (560 mg, 58%). m. p. = 70-71 °C; 
Chapter 7 
192 
 
IR: νmax/cm
-1
 (neat) 2971, 1677, 1593, 1446, 1374, 1223, 1114, 1039, 965, 797, 690, 
642; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.96 (1H, d, J = 2.10 Hz, H5), 7.82 (1H, dd, J = 
8.40 2.10 Hz, H9), 7.02 (1H, d, J = 8.40 Hz, H8), 3.87 (4H, app. t, J = 4.65 Hz, H11), 
3.13-3.16 (4H, m, H10), 2.92 (2H, q, J = 7.20 Hz, H2), 1.20 (3H, t, J = 7.20 Hz, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 198.8 (C1), 152.9 (C7), 132.3 (C6), 131.0 (C5), 
128.2 (C4), 127.9 (C9), 119.6 (C8), 67.0 (C11), 51.3 (C10), 31.7 (C2), 8.4 (C3); 
HRMS(ESI-TOF): calcd. for C13H16ClNO2H
+
: 254.0948. Found: 254.0920 (MH
+
), 
276.0740 (MNa
+
); CHN: Anal. Calc. for C13H16ClNO2: C, 61.54%, H, 6.36%, N, 
5.52%; Found: C, 61.39%, H, 6.39%, N, 5.42%. 
 
1-(3-Fluoro-4-morpholinophenyl)propan-1-one 6.47 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; petroleum ether b. p. 40-60 °C/Et2O, 1:1, Rf = 0.33, det: 
KMnO4) and isolated as a yellow crystalline solid (479 mg, 67%). m. p. = 116-117 
°C; IR: νmax/cm
-1
 (neat) 2857, 1675, 1611, 1562, 1517, 1382, 1248, 1110, 1048, 923, 
883, 796; 
1
H NMR: (CDCl3, 300 MHz) δ = 7.69 (1H, dd, J = 8.40 2.10 Hz, H9), 7.63 
(1H, dd, J = 14.10 2.10 Hz, H5), 6.90 (1H, app. t, J = 8.40 Hz, H8), 3.86 (4H, app. t, J 
= 4.80 Hz, H11), 3.19 (4H, app. t, J = 4.65 Hz, H10), 2.91 (2H, q, J = 7.20 Hz, H2), 
1.20 (3H, t, J = 7.20 Hz, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 198.7 (d, J = 1.7 Hz, 
C1), 154.7 (d, J = 246.7 Hz, C6), 143.9 (d, J = 8.2 Hz, C4), 131.0 (d, J = 6.0 Hz, C7), 
125.2 (d, J = 3.0 Hz, C9), 117.5 (d, J = 3.2 Hz, C8), 116.0 (d, J = 21.9 Hz, C5), 66.9 
(C11), 50.3 (d, J = 4.4 Hz, C10), 31.6 (C2), 8.5 (C3); 
19
F NMR: (CDCl3, 376 MHz) δ = -
121.5 (dd, J = 13.9 8.6 Hz); HRMS(ESI-TOF): calcd. for C13H16FNO2H
+
: 238.1243. 
Found: 238.1227 (MH
+
), 260.1038 (MNa
+
); CHN: Anal. Calc. for C13H16FNO2: C, 
65.81%, H, 6.80%, N, 5.90%; Found: C, 66.01%, H, 6.90%, N, 5.91%. 
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1-(4-Morpholino-3-(trifluoromethyl)phenyl)propan-1-one 6.48 
 
According to literature procedure 7.6.2, the product was purified by silica column 
chromatography (eluent; hexanes/EtOAc, 4:1, Rf = 0.13, det: KMnO4) and isolated as 
a yellow crystalline solid (525 mg, 61%). m. p. = 62-64 °C; IR: νmax/cm
-1
 (neat) 2978, 
1678, 1602, 1501, 1457, 1318, 1235, 1209, 1114, 1092,1040, 924, 801, 663; 
1
H 
NMR: (CDCl3, 300 MHz) δ = 8.23 (1H, d, J = 2.10 Hz, H5), 8.11 (1H, d, J = 8.40 Hz, 
H9), 7.32 (1H, d, J = 8.40 Hz, H8), 3.85 (4H, app. t, J = 4.50 Hz, H11), 2.95-3.04 (6H, 
m, H10 & H2), 1.23 (3H, t, J = 7.20 Hz, H3); 
13
C NMR: (CDCl3, 75.4 MHz) δ = 198.9 
(C1), 155.7 (d, J = 1.1 Hz,C7), 132.6 (C9), 132.5 (C4), 128.2 (q, J = 5.4 Hz, C5), 125.8 
(d, J = 29.6 Hz, C6), 123.9 (q, J = 273.3 Hz, C12), 122.8 (C8), 67.2 (C11), 53.4 (C10), 
31.8 (C2), 8.3 (C3); 
19
F NMR: (CDCl3, 376 MHz) δ = -60.1 (s); HRMS(ESI-TOF): 
calcd. for C14H16F3NO2Na
+
: 310.1025. Found: 310.1115 (MNa
+
); CHN: Anal. Calc. 
for C14H16F3NO2: C, 58.53%, H, 5.61%, N, 4.88%; Found: C, 58.50%, H, 5.45%, N, 
4.64%. 
 
1-(2-Morpholinophenyl)propan-1-one 6.49 
 
According to literature procedure 7.6.2 with 5 mol% catalyst for 48 hours, the 
product was purified by silica column chromatography (eluent; cyclohexane/EtOAc, 
0-100%, det: KMnO4) and isolated as a yellow oil (230 mg, 35%). IR: νmax/cm
-1
 (neat) 
2966, 2854, 1680, 1593, 1484, 1445, 1223, 1207, 1115, 929, 921, 758; 
1
H NMR: 
(CDCl3, 300 MHz) δ = 7.40 (1H, t, J = 7.80 Hz, H5), 7.32 (1H, d, J = 8.10 Hz, H7), 
7.06-7.11 (2H, m, arom. H), 3.82 (4H, app. t, J = 4.50 Hz, H11), 3.05 (2H, q, J = 7.20 
Hz, H2), 2.97 (4H, app. t, J = 4.50 Hz, H10), 1.17 (3H, t, J = 7.20 Hz, H3); 
13
C NMR: 
(CDCl3, 75.4 MHz) δ = 208.7 (C1), 150.6 (C9), 136.2 (C4), 131.5 (C7), 128.8 (C5), 
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123.3 (C8), 118.8 (C6), 67.2 (C11), 53.4 (C10), 35.3 (C2), 8.8 (C3); HRMS(ESI-TOF): 
calcd. for C13H17NO2Na
+
: 242.1157. Found: 242.1196 (MNa
+
); CHN: Anal. Calc. for 
C13H17NO2: C, 77.38%, H, 8.81%, N, 6.45%; Found: C, 77.25%, H, 8.96%, N, 
6.61%. 
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7.7 Relevant NMR Spectra 
7.7.1 Racemic Fendiline (2.52) + (S)-O-Acetylmandelic Acid 
 
 
According to representative procedure 7.2.3, the sample run on a 300 MHz NMR 
machine. Analysis of the peaks above show that there are two compounds present, 
with the hydrogen atom indicated in the diagram present at 3.92 ppm and 3.51 ppm. 
For reference, the quoted shift for this proton in both Fendiline (2.52) and (R)-
Fendiline (2.56) is 3.68 ppm. 
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7.7.2 (R)-Fendiline (2.56) + (S)-O-Acetylmandelic Acid 
 
 
According to representative procedure 7.2.3, the sample run on a 300 MHz NMR 
machine. Analysis of the peaks above show that there is only one compound present, 
with the hydrogen atom indicated in the diagram present at 3.92 ppm and there is no 
peak at 3.51 ppm as seen in the case of the racemic sample (7.7.1). For reference, the 
quoted shift for this proton in both Fendiline (2.52) and (R)-Fendiline (2.56) is 3.68 
ppm. 
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7.7.3 Fendiline (2.52) + (R)-Fendiline (2.56) + (S)-O-Acetylmandelic Acid 
 
 
According to representative procedure 7.2.3, the sample run on a 300 MHz NMR 
machine. Analysis of the peaks above show that there are two compounds present, 
with the hydrogen atom indicated in the diagram present at 3.92 ppm and at a lower 
intensity 3.51 ppm. For reference, the quoted shift for this proton in both Fendiline 
(2.52) and (R)-Fendiline (2.56) is 3.68 ppm. 
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7.7.4 Racemic 1-(Phenethyl)pyrrolidine (3.22) + (S)-O-Acetylmandelic 
Acid 
 
 
According to representative procedure 7.2.3, the sample run on a 300 MHz NMR 
machine. Analysis of the peaks above show that there are two compounds present, 
with the methyl group indicated in the diagram present at 1.62 ppm and 1.54 ppm. 
For reference, the quoted shift for this proton in both 1-(phenethyl)pyrrolidine (3.22) 
and (S)-1-(phenethyl)pyrrolidine (3.23) is 1.34 ppm. 
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7.7.5 (S)-1-(Phenethyl)pyrrolidine (3.23) + (S)-O-Acetylmandelic Acid 
 
 
According to representative procedure 7.2.3, the sample run on a 300 MHz NMR 
machine. Analysis of the peaks above show that there is only one compound present, 
with the hydrogen atom indicated in the diagram present at 1.61 ppm and there is no 
peak at 1.54 ppm as seen in the case of the racemic sample (7.7.4). For reference, the 
quoted shift for this proton in both 1-(phenethyl)pyrrolidine (3.22) and (S)-1-
(phenethyl)pyrrolidine (3.23) is 1.34 ppm. 
 
 
 
 
ppm (t1)
1.5001.5501.6001.6501.700
1
.6
2
9
1
.6
0
2
Chapter 7 
200 
 
7.7.6 1-(Phenethyl)pyrrolidine (3.22) + (S)-1-(Phenethyl)pyrrolidine (3.23) 
+ (S)-O-Acetylmandelic Acid 
 
 
According to representative procedure 7.2.3, the sample run on a 300 MHz NMR 
machine. Analysis of the peaks above show that there are two compounds present, 
with the hydrogen atom indicated in the diagram present at 1.61 ppm and at a lower 
intensity 1.54 ppm. For reference, the quoted shift for this proton in both 1-
(phenethyl)pyrrolidine (3.22) and (S)-1-(phenethyl)pyrrolidine (3.23) is 1.34 ppm. 
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7.7.7 Racemic 1-(Phenethyl)pyrrolidine (4.22) + (S)-O-Acetylmandelic 
Acid 
 
 
According to representative procedure 7.2.3, the sample run on a 300 MHz NMR 
machine. Analysis of the peaks above show that there are two compounds present, 
with the methyl group indicated in the diagram present at 1.62 ppm and 1.54 ppm. 
For reference, the quoted shift for this proton in both 1-(phenethyl)pyrrolidine (3.22) 
and (R)-1-(phenethyl)pyrrolidine (4.29) is 1.34 ppm. 
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7.7.8 (R)-1-(Phenethyl)pyrrolidine (4.29) + (S)-O-Acetylmandelic Acid 
 
 
According to representative procedure 7.2.3, the sample run on a 300 MHz NMR 
machine. Analysis of the peaks above show that there is only one compound present, 
with the hydrogen atom indicated in the diagram present at 1.61 ppm and there is no 
peak at 1.54 ppm as seen in the case of the racemic sample (7.7.4). For reference, the 
quoted shift for this proton in both 1-(phenethyl)pyrrolidine (3.22) and (S)-1-
(phenethyl)pyrrolidine (4.29) is 1.34 ppm. 
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